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Extreme physical exertion is commonly associated with acute physiological changes in 
immune variables known to disturb host defences. Likely induced by the production of stress 
hormones (e.g., cortisol), partaking in ultra-endurance events with accompanying 
physiological stressors ((e.g., environmental extremes, sleep deprivation and compromised 
hydration and (or) nutritional status)) may amplify stress hormone responses and compromise 
immune status to a greater extent. To date, research investigating the impact of extreme 
physical exertion (e.g., ultra-marathon events) on physiological variables is extremely 
limited. More recently, the potential use of probiotics with known immunomodulatory effects 
may be considered an appropriate nutritional strategy to improve host defences and minimise 
and (or) prevent sub-clinical or clinically significant outcomes in active populations. 
 
With this in mind, the purpose of this thesis was to investigate the effects of: 1) a multi-stage 
ultra-marathon (total distance: 230 km) in hot ambient conditions (32-40°C), and a 24 h 
continuous ultra-marathon (total distance range: 122-208 km) in temperate ambient 
conditions (0-20°C) on salivary anti-microbial protein (S-AMP) and stress hormone response, 
and self-reported incidence of upper respiratory symptoms (URS); 2) a multi-stage ultra-
marathon in hot ambient conditions, and a 24 h continuous ultra-marathon in temperate 
ambient conditions on circulatory endotoxin concentration, cytokine profile, and self-reported 
incidence of gastrointestinal (GI) symptoms; and 3), acute high dose supplementation of 
Lactobacillus casei (L.casei) on S-AMP responses, circulatory endotoxin concentration and 






A multi-stage ultra-marathon in hot ambient conditions (Chapter 4) decreased post-stage 
salivary IgA (S-IgA) responses. Salivary alpha-amylase (S-α-amylase) and salivary lysozyme 
(S-lysozyme) responses increased and (or) remained unchanged post-stage throughout. 
Salivary cortisol (S-cortisol) responses fluctuated throughout the multi-stage ultra-marathon 
competition. URS were minimally reported (n=1) during and in the one month period 
following the ultra-marathon.  
 
A 24 h continuous ultra-marathon in temperate ambient conditions (Chapter 5) decreased S-
IgA and S-lysozyme responses post-competition. S-α-amylase and S-cortisol responses 
increased post-competition. No URS were reported during and in the one month following 
the ultra-marathon. 
 
The implications of the results in Chapter 4 and Chapter 5 demonstrated perturbations to 
oral-respiratory mucosal immune responses during extreme physical exertion; however, this 
did not result in URS. Therefore, it would be prudent to minimise accompanying 
physiological stressors during periods of extreme physical exertion. The results in Chapter 4 
and Chapter 5 cannot be generalised to other times of the year. Appropriate education (e.g., 
hydration maintenance, non-infectious episode management, medical management of 
established respiratory illness) and information (i.e., pollen and pollution counts at the 
location of the event or competition) may help prevent unwanted URS manifestations and 
performance decrements. However, limitations of the multi-stage ultra-marathon study 
(Chapter 4) include the failure to measure other S-AMPs with other anti-bacterial and anti-
viral properties and the inability to assess and accurately differentiate between infectious vs. 
non-infectious episodes. Limitations of the 24 h continuous ultra-marathon study (Chapter 5) 





time mucosal immune status is depressed). Notably, both studies also took place during the 
summer months (Chapter 4: second week of July, Chapter 5: first week of September) 
when infectious episodes (e.g., verified Epstein-Barr virus reactivation, Rhinovirus and 
Influenza infections) are fewer compared to winter months. Thus, the prevalence of URSI 
reported is in part, likely dependent on the time of year the event or competition takes place.  
 
A multi-stage ultra-marathon in hot ambient conditions (Chapter 6) increased resting and 
post-stage circulatory gram-negative bacterial endotoxin concentration. Increases in pro-
inflammatory cytokines post-stage (i.e., interleukin-1 beta (IL-1β), tumour necrosis factor-
alpha (TNF-α), and interferon-gamma (IFN-γ)) were counteracted by a compensatory anti-
inflammatory cytokine response (i.e., interleukin-10 (IL-10) and interleukin-1 receptor 
antagonist (IL-1ra)). GI symptoms were commonly reported (58% reported at least one 
severe GI symptom) during the multi-stage ultra-marathon.  
 
A 24 h continuous ultra-marathon in temperate ambient conditions (Chapter 7) increased 
post-competition circulatory gram-negative bacterial endotoxin concentration. Increases in 
pro-inflammatory cytokines (i.e., interleukin-6 (IL-6) IL-1β, TNF-α)) post-competition were 
counteracted by a compensatory anti-inflammatory cytokine response (i.e., IL-10). GI 
symptoms were commonly reported (75% reported at least one severe GI symptom) during 
the ultra-marathon. 
 
The implications of the results in Chapter 6 and Chapter 7 suggest that whilst in well-
trained individuals where the exertional-heat stress is well tolerated, clinically significant 
episodes ((e.g., exertional-heat illness, systemic inflammatory response syndrome (SIRS), 





may pose a greater risk for development of clinically significant episodes. Notably, 
exertional-heat illness continues to be a military problem during training and operations 
whereby the hospitalization rate of heat stroke has markedly increased (i.e., a five-fold 
increase; 1.8 per 100,000 in 1980 to 14.5 per 100,000 in 2001) (Carter et al. 2005). 
Additionally, delayed elevation of inflammatory variables ((e.g., C-reactive protein (CRP) 
and cytokine profile)) after competition may play a role in the aetiology of undefined 
underperformance and chronic fatigue syndromes. Appropriate education and competition 
preparation (e.g., the need to be well-trained to complete the required distance, heat 
acclimation protocols, hydration maintenance, cooling strategies) may help prevent clinically 
significant episodes occurring in ‘high-risk’ and (or) illness prone individuals. However, 
limitations of the multi-stage ultra-marathon study (Chapter 6) include the failure to measure 
other variables (e.g., anti-endotoxin antibodies or endotoxin neutralising capacity) and 
measurements (e.g., core body temperature; Tcore). Limitations of the 24 h continuous ultra-
marathon study (Chapter 7) include the failure to determine the time-course of recovery of 
CRP and cytokine profile (i.e., the length of time inflammatory variables remain elevated).  
 
These observational studies applied exercise models of an extreme nature (Chapter 4 to 
Chapter 7) unlike the majority of previous research. Additionally, measuring a number of 
time-related immune variables and tracking over a five day period (Chapter 4 and Chapter 
6) is currently absent. Whilst these studies attempted to identify the key immune variables 
that may lead to potential sub-clinical and clinically significant outcomes, a lack of adequate 
research control did not allow for definitive conclusions to be made about the effects of 
individual and combined physiological stressors on the immune variables measured. For 
example, the degree and duration to which an individual is exposed to a single or 





during the ultra-marathons) Therefore, determining which individual or combination of 
stressors is responsible for the perturbations in immune variables observed, whether a 
cumulative effect of stressor exposure is present or whether a particular stressor (s) exerts a 
greater influence over others is limited.  
 
Seven consecutive days probiotic supplementation containing L.casei (x 1011 colony forming 
units (CFU)/day)) did not influence S-IgA, S-α-amylase or S-lysozyme responses at rest after 
EHS, and during the recovery period compared with a placebo (Chapter 8). Probiotic 
supplementation did not prevent or attenuate EHS induced endotoxaemia and cytokinaemia; 
nor is it more positively favourable over a placebo (Chapter 9).  
 
The implications of the results in Chapter 8 and Chapter 9 suggest that whilst in healthy 
individuals probiotic supplementation is not justified, further investigation into ‘high-risk’ 
and (or) illness prone individuals (i.e., those who commonly experience URS or GI 
symptoms) may be warranted. Limitations of the probiotic-EHS (Chapter 8 and Chapter 9) 
include the failure for further exploration of the mechanistic responses of probiotics. For 
example, additional measurements such as intestinal permeability tests (e.g., urinary 
excretion ratio of lactulose to rhamnose). Whilst these laboratory-controlled studies (Chapter 
8 and Chapter 9) provide insight into the impact of a specific probiotic strategy as observed 
in athletic populations on key immune variables, a larger sample size including both males 
and females would be considered more representative of the endurance running population 
and would have allowed for further sub-group analysis (e.g., hydration status); whilst a longer 
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The general introduction (Chapter 1) and literature review (Chapter 2) provides a summary 
of previous research, identified research gaps, and provides the rationale and justification for 
the aims of the current research. A description of the general methods proceeds (Chapter 3), 
which explains the common procedures, techniques and analyses performed in the subsequent 
studies. The thesis consists of six independent studies. The first study investigated the effects 
of a multi-stage ultra-marathon competition in hot ambient conditions (32-40°C) on S-AMP 
responses, stress hormone response, and incidence of URS (Chapter 4). The second study 
investigated the effects of a 24 h continuous ultra-marathon in temperate ambient conditions 
(0-20°C) on S-AMP responses, stress hormone response, and incidence of URS (Chapter 5). 
The third study investigated the effects of a multi-stage ultra-marathon competition in hot 
ambient conditions (32-40°C) on circulatory endotoxin concentration, cytokine profile, and 
GI symptoms (Chapter 6). The fourth study investigated the effects of a 24 h continuous 
ultra-marathon in temperate ambient conditions (0-20°C) on circulatory endotoxin 
concentration, cytokine profile, and GI symptoms (Chapter 7). The final two studies 
investigated the influence of acute high dose probiotic (L.casei) supplementation on S-AMP 
responses (Chapter 8); and circulatory endotoxin concentration and cytokine profile 
(Chapter 9) in response to EHS. A general discussion (Chapter 10) contains a summary and 
critical appraisal of the main findings of the research programme, including limitations and 
directions for future research. An additional methodological study investigating the influence 
of saliva flow rate (SFR) within a range of specified collection times, and after mouth rinsing 
with differing water temperatures can be found in the Appendix (Appendix A). Throughout 





references and figures legends appear prior to Chapter 1. Due to the relatedness between 
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230 km multi-stage ultra-marathon competition conducted in a hot ambient 
environment.  
 
Figure 6.3 Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
interleukin-6 concentration of ultra-endurance runners participating in a 230 
km multi-stage ultra-marathon competition conducted in a hot ambient 
environment. 
 
Figure 6.4 Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 





km multi-stage ultra-marathon competition conducted in a hot ambient 
environment. 
 
Figure 6.5 Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
tumour necrosis factor-α concentration of ultra-endurance runners 
participating in a 230 km multi-stage ultra-marathon competition conducted in 
a hot ambient environment. 
 
Figure 6.6 Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
interferon-γ concentration of ultra-endurance runners participating in a 230 km 
multi-stage ultra-marathon competition conducted in a hot ambient 
environment. 
 
Figure 6.7 Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
interleukin-10 concentration of ultra-endurance runners participating in a 230 
km multi-stage ultra-marathon competition conducted in a hot ambient 
environment. 
 
Figure 6.8 Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
interleukin-1ra concentration of ultra-endurance runners participating in a 230 
km multi-stage ultra-marathon competition conducted in a hot ambient 
environment. 
 
Figure 7.1 Circulatory gram-negative bacterial endotoxin concentration of ultra-






Figure 7.2 Plasma C-reactive protein concentration of ultra-endurance runners 
participating in a 24 h continuous ultra-marathon. 
 
Figure 8.1 CONSORT Flow Diagram. 
 
Figure 8.2 Changes in salivary IgA concentration (A) and secretion rate (B) in response 
to 2 h running at 60% VO2max in hot ambient conditions (exertional-heat 
stress) following seven consecutive days of probiotic and placebo 
supplementation.  
 
Figure 8.3 Changes in salivary α-amylase concentration (A) and secretion rate (B) in 
response to 2 h running at 60% VO2max in hot ambient conditions (exertional-
heat stress) following seven consecutive days of probiotic and placebo 
supplementation.  
 
Figure 8.4 Changes in salivary lysozyme concentration (A) and secretion rate (B) in 
response to 2 h running at 60% VO2max in hot ambient conditions (exertional-
heat stress) following seven consecutive days of probiotic and placebo 
supplementation.  
 
Figure 9.1  Heart rate responses during 2 h running at 60% VO2max in hot ambient 
conditions (exertional-heat stress) following seven consecutive days of 






Figure 9.2  Rectal temperature responses during 2 h running at 60% VO2max in hot 
ambient conditions (exertional-heat stress) following seven consecutive days 
of probiotic and placebo supplementation. 
 
Figure 9.3  Thermal comfort rating during 2 h running at 60% VO2max in hot ambient 
conditions (exertional-heat stress) following seven consecutive days of 
probiotic and placebo supplementation. 
 
Figure 9.4 Relative changes in circulatory gram-negative bacterial endotoxin in response 
to 2 h running at 60% VO2max in hot ambient conditions (exertional-heat 
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General Introduction  
 
Consisting of primary lymphoid organs (e.g., bone marrow and thymus) and secondary 
lymphoid organs (e.g., lymph nodes and Peyer’s patches), linked by complex networks (e.g. 
lymphatic and circulatory systems) of circulating immune cells (i.e.,  leukocytes) and protein 
molecules ((e.g., antibodies, anti-microbial proteins (AMPs), cytokines and complement)); 
the immune system is a dynamic multi-faceted surveillance system strategically distributed 
throughout the body, with the ability to monitor, identify and differentiate between self-
antigens and foreign antigens in order to maintain protection, defence and homeostasis. 
 
An integral part of the immune system is the mucosa-associated lymphoid tissue (MALT), a 
highly specialised mono-layered structure estimated 400m2 juxtaposed to mucosal surfaces 
(Montilla et al. 2004) and further sub-divided according to anatomical site. The MALT 
loosely comprises of gut-associated lymphoid tissue (GALT), nasopharynx-associated 
lymphoid tissue ((NALT; upper respiratory tract (URT)), and bronchus/tracheal-associated 
lymphoid tissue ((BALT; lower respiratory tract (LRT)) (Cesta 2006). The overlapping links 
and cross-talk communication between different mucosal sites is often termed the common 
mucosal immune system (CMIS).  
 
These mucosal surfaces comprise of highly specialised epithelial cells (e.g., enterocytes, 
Paneth and goblet cells) and their tight junctions, interspersed with structured lymphoid 
tissues (e.g., tonsils and adenoids in the BALT and NALT, and Peyer’s patches in the GALT) 
and specialised microfold cells, beneath of which is heavily populated by intra-epithelial 





antigenic environment and the primary site for exogenous pathogen invasion whereby most 
bacterial and viral infections are most likely to gain entry and initiate an immune response, 
the innate physical and mechanical barriers (e.g., skin, mucous membranes, and ciliary 
function), secretions (e.g., saliva and tears) which contain anti-microbial proteins (e.g., 
mucins and lysozyme), cellular ((e.g., natural killer (NK)) cells, macrophages, neutrophils. 
and dendritic cells)) and acquired biochemical defences ((e.g., immunoglobulins (Igs)) of the 
MALT work synergistically to provide host protection and are considered the first line of 
defence against the colonisation of pathogens at the mucosal surface. For example, S-AMPs 
contain anti-bacterial and anti-viral properties that inhibit bacterial colonisation and neutralise 
viruses at the oral-respiratory mucosal epithelial surface (Brandtzaeg et al. 1999, McNabb 
and Tomasi 1981, Norderhaug et al. 1999, Tenovuo 1998, West et al. 2006), whilst the 
mucosal epithelium lining the GI tract is colonised by a plethora of microorganisms which 
serve a number of important metabolic, immunological and structural functions. 
 
The normal immunological response is tightly controlled, regulated and maintained within 
homeostatic boundaries. The degree and direction ((e.g., innate, humeral-mediated and (or) 
cell-mediated)) of the normal immunological response is dependent upon the type of 
pathogen present (e.g., intracellular pathogens and extracellular pathogens), individual health 
status (e.g., tissue damage, injury, autoimmune disorders), circadian variations and (or) 
neuroendocrine control (Dimitriou, Sharp, and Doherty 2002, Dinges et al. 1995, Shepard 
and Shek 1997, Shephard, Castellani, and Shek 1998). In particular, stimulation of the 
hypothalamic-pituitary adrenal (HPA) and sympatheticoadrenal-medullary (SAM) axes and 
subsequent production of glucocorticoid hormones and catecholamines are the two main 
delineated pathways through which changes in immune function occur (Padgett and Glaser 





(e.g., T- and B-lymphocyte cells) immune cell activity (e.g., cellular maturation, 
differentiation, proliferation and trafficking, alterations in antibody production and cytokine 
secretion) through bi-directional communication between the immune system and 
neuroendocrine system due to receptors (e.g., glucocorticoid and adrenergic) for 
neurotransmitters, neuropeptides and hormones located on leukocytes and lymphoid tissue 
(Felten et al. 1998, Madden 2003, Sternberg 2006). 
 
Various physiological stressors have been shown to stimulate neuroendocrine responses 
(namely cortisol and catecholamines) and influence host defences, resulting in either a 
depressed or enhanced immune status depending on the degree of the stress stimulus (Costa 
et al. 2010, Gleeson 2006, Nieman 1997, Shephard, Castellani, and Shek 1998, Walsh and 
Whitham 2006). For example, whilst transient, acute stress is associated with immuno-
enhancing effects (Dhabhar and McEwen 1997, Dhabhar 2002, Dhabhar 2008); 
paradoxically, it is frequently reported that prolonged or extreme stress resulting in 
amplification and (or) chronic activation of the HPA and SAM axes, suppresses innate and 
adaptive immune function (Gleeson et al. 1995, Nieman 1997) potentially increasing the 
susceptibility to illness and (or) infection. Notably, the nature of field-based studies allows 
for limited interpretation of which individual stressor or combination of stressors impact upon 
immune variables, and to what degree.  
 
 
Whilst the hypothalamic temperature set-point remains stable with heat exposure during 
prolonged physical exertion, heat-stress occurs when difficulty with heat dissipation and 
subsequent overheating initiate body temperature increases (Shephard 1998). Indeed, 





oral-respiratory mucosal immune status (e.g., depressions in S-AMPs) and an increased risk 
of URSI (e.g., verified Epstein-Barr virus reactivation, Rhinovirus and Influenza infections, 
allergen or damage induced localised inflammation) (Gleeson 2006, Gleeson and Pyne 2000, 
Peters and Bateman 1983, Matthews et al. 2002). Additionally, prolonged physical exertion 
(with and without heat-stress) is associated with disturbances to intestinal epithelial integrity 
(ter Steege and Kolkman 2012, Rehrer and Meijer 1991). Such disturbances have been linked 
to an endotoxin-induced cytokine-mediated inflammatory response which has been 
implicated in the aetiology of heat-related illness (e.g., heat stroke) (Lim and Mackinnon 
2006, Opal 2010), and in the manifestation of GI symptoms (Jeukendrup et al. 2000, Lambert 
2008, Øktedalen et al 1992, Peters et al. 1999, van Leeuwen et al. 1994). As a result, it is 
plausible that participating in extreme physical exertion (with or without heat stress) may 
initiate amplified or cumulative perturbations to oral-respiratory mucosal immunity and (or) 
to intestinal epithelial integrity, and promote sub-clinical or clinically significant outcomes in 
active populations (i.e., moderately and highly-trained individuals).  
 
Several published reviews have reported depressed oral-respiratory mucosal immune status 
(Gleeson 2000, Gleeson and Pyne 2000, Walsh et al. 2011a) and disturbances to intestinal 
epithelial integrity (Lambert 2009, Lim and Mackinnon 2006), proportional to the degree of 
the exercise-stress.  More recently, probiotic supplementation has been suggested as a 
possible nutritional strategy in active populations to counteract the depressions in oral-
respiratory mucosal immunity and disturbances to intestinal epithelial integrity commonly 
observed following participation in prolonged physical exertion and (or) intensified training 
periods (Gleeson et al. 2011a, West et al. 2009). To date, the impact of extreme physical 
exertion (particularly running exercise), which promotes the greatest physiological responses, 





counteracting depressions in oral-respiratory mucosal immunity and disturbances to intestinal 
epithelial integrity (i.e., increases in intestinal permeability and a subsequent endotoxin-
induced cytokine-mediated inflammatory response) commonly reported after exercise-stress 
has not yet been thoroughly investigated. 
 
With this in mind, the focus of this thesis was to firstly assess oral-respiratory mucosal 
immune status (S-IgA, S-α-amylase, S-lysozyme), stress hormone response (S-cortisol) and 
incidence of URS; in addition to intestinal epithelial integrity (assessed by circulatory 
endotoxin concentration), cytokine profile and incidence of GI symptoms in response to 
extreme physical exertion (with and without heat-stress) with accompanying physiological 
stressors and; secondly, to identify whether probiotic supplementation may prevent unwanted 
perturbations to oral-respiratory mucosal immune status and intestinal epithelial integrity 


















Literature Review  
 
Extreme, sustained activities (e.g., ultra-endurance, adventure and exploration events, 
military training and expeditionary operations) with or without heat-stress are commonly 
associated with accompanying physiological stressors which may firstly; initiate amplified 
and (or) cumulative perturbations to oral-respiratory mucosal immune status, leading to 
subsequent depressions in S-AMPs and an increased risk of sub-clinical or clinically 
significant outcomes (e.g., URSI) and secondly; may initiate amplified and (or) cumulative 
perturbations to intestinal epithelial integrity, promoting an over-exaggerated endotoxin-
induced cytokine-mediated inflammatory response and an increased risk of sub-clinical or 
clinically significant outcomes (e.g., heat-related illness and GI symptoms) during the period 
after stress stimuli (Martinez-Lopez et al. 1993, Neville, Gleeson, and Folland 2008, Nieman 
1997, Shephard, Castellani, and Shek 1998). Moreover, active populations participating in 
such extreme activities are potentially at high-risk for pathogen transfer and contracting 
illness and (or) infection (Gleeson et al. 2000). Indeed, unfamiliar environments (e.g., foreign 
locations) may harbour and expose an individual to pathogens (e.g., airborne and food) 
unrecognised by the immune system. Such outcomes may further jeopardise immune status 
and increase vulnerability to illness and (or) infection in the field (Martinez-Lopez et al. 
1993, Neville, Gleeson, and Folland 2008, Nieman 1997, Shephard, Castellani, and Shek 
1998). Additionally, exposure to unavoidable cross-contamination factors such as close 
contact and (or) sharing eating and drinking vessels with the surrounding population, and (or) 
unhygienic food and (or) drink preparation facilities may expose an individual to 






The following literature review will address the current evidence behind prolonged physical 
exertion (with and without heat-stress) with accompanying physiological stressors on selected 
immune responses, and the potential role of probiotic supplementation in counteracting 
perturbations to oral-respiratory mucosal immunity and in attenuating endotoxaemia. In 
Section 2.1.1, oral-respiratory mucosal immune (S-IgA, S-α-amylase, S-lysozyme) and stress 
hormone (S-cortisol) responses measured within Chapter 4, Chapter 5 and Chapter 8 will 
be reviewed. In Section 2.1.2, circulatory endotoxin concentration and cytokine profile 
measured within Chapter 6, Chapter 7 and Chapter 9 will be reviewed. Following this, 
Section 2.2.1 to 2.2.2 and Section 2.3.1 to 2.3.2 will independently review the impact of 
prolonged physical exertion and EHS, respectively, on oral-respiratory mucosal immune and 
stress hormone responses; and on circulatory endotoxin concentration and cytokine profile. 
Section 2.4.1 to 2.4.3 will proceed and review the influence of probiotic supplementation on 

















2.1.1 Oral-Respiratory Mucosal Immunity  
 
The anti-bacterial and anti-viral properties of mucosal secretions, in particular S-IgA, protect 
oral-respiratory mucosal surfaces against foreign pathogens and provide an important first 
line defensive barrier (Woof and Kerr 2006). Given that pathogen colonisation is typically 
initiated at the mucosal surface with a high prevalence of all oral-respiratory infections 
originating here (~90-95%) (Bosch et al. 2002), the importance of the mucosal epithelium 
providing a protective barrier between the internal and external environment cannot be 
underestimated, particularly during periods of increased physiological stress when oral-
respiratory mucosal immune status may be compromised (Bosch et al. 2003a, Bosch et al. 
2003b, Gleeson and Pyne 2000, Neville, Gleeson, and Folland 2008). Since S-AMP 
responses will vary in accordance to SFR (Chicharro et al. 1998), a continuous saliva flow 
provides a mechanical washing effect, ensuring a constant supply of anti-bacterial and anti-
viral constituents (e.g., S-IgA, S-α-amylase, S-lysozyme, S-lactoferrin and defensins) at the 
oral-respiratory mucosal surface (Tenovuo 1998) that inhibit bacterial colonisation to the 
mucosal epithelium, and neutralise, inactivate and prevent viral replication (Brandtzaeg et al. 
1999, McNabb and Tomasi 1981, Norderhaug et al. 1999, Tenovuo 1998, West et al. 2006).  
 
The primary mechanism by which S-IgA exerts its protective action is immune exclusion, 
rendering pathogens ineffective locally at the oral-respiratory mucosal surface without 
systemic immune activation. S-IgA inhibits pathogen colonisation (adherence) to the mucosal 
epithelium and invasion of the oral-respiratory pathway, in addition to neutralising and 
preventing replication of intra-epithelial viruses (Brandtzaeg et al. 1999, Mazanec et al. 1993, 
Woof and Mestecky 2005). To date, S-IgA is the only immune parameter that has 





Gleeson 2009, Gleeson 2000, Neville, Gleeson, and Folland 2008, Nieman et al. 2006a, 
Nieman 1997, Nieman 1994) whereby transient depressions in S-IgA are associated with an 
increased incidence of URSI; possibly due to compromised oral-respiratory mucosal 
immunity providing the opportunity for external pathogens to gain a hold on mucosal 
surfaces (Walsh et al. 2011a). URSI reports appear to be particularly common during 
prolonged physical exertion, intensified training periods and (or) heightened pathogen 
exposure (e.g., travelling and residing in foreign locations) (Bishop and Gleeson 2009, 
Gleeson and Pyne 2000, Libicz et al. 2006, Neville, Gleeson, and Folland 2008). For 
example, 12.9% of runners reported infectious episodes during the week following a 
marathon race, whilst 33.3% of runners reported infectious episodes during the two weeks 
after a 56 km running competition (Nieman et al. 1990, Peters and Bateman 1983). However, 
infectious episodes were assessed through self-report thus questioning the reliability of 
bacterial or viral infection presence. Equally, for runners participating in competitive events, 
URS per se (whether infectious or non-infectious) may lead to competing at a sub-optimal 
level or complete withdrawal from the event. 
 
Immunoglobulin A (IgA) is originally synthesised and secreted from plasma cells residing in 
the mucosa and sub-mucosa. Whilst the long-term (days) regulation of S-IgA secretion is 
through modification of S-IgA synthesis, the short-term (minutes) regulation of S-IgA 
secretion is through transcytosis (mobilisation) stimulated by sympathetic nervous system 









Figure 2.1 Salivary secretory IgA synthesis and translocation.   
  
 
Created by thesis author, based on Bishop and Gleeson (2009) 
 
In vitro, the linking of the J-chain to the IgA has been shown to be essential for the initial 
complexing and stabilisation between the polymeric IgA and the tSC (Brandtzaeg and Prydz 
1984). Importantly, only polymeric IgA have high affinity with the tSC which optimises the 
transepithelial transport of S-IgA (Johansen, Braathen, and Brandtzaeg 2000). The 
acquisition of the J-chain increases the effectiveness of antigen-binding sites and binding of 
bacteria and viruses, in addition to inducing minimal systemic immune activation (e.g., the 
This item has been removed due to 3rd Party Copyright. The unabridged version of the thesis can be found in 





complement pathway), thereby allowing S-IgA to function in a non-inflammatory manner. 
Moreover, the glycosylated tSC protects the S-IgA against proteolytic degradation after 
secretion on the oral-respiratory mucosal surface (Woof and Mestecky 2005). Taking into 
account that considerably low concentrations of S-IgA have been observed in tSC deficient 
mice (Shimada et al. 1999), the physiological importance of the tSC cannot be 
underestimated. Moreover, both tSC and free secretory component (SC) exhibit several 
innate immune properties (e.g., bacterial neutralisation, inhibiting adherence of some gram-
negative bacteria to the mucosal epithelium) (Corthesy 2010).  
 
More recently, other constituent S-AMPs have been shown to exhibit protective properties in 
the oral respiratory pathway, working synergistically and in combination with S-IgA to 
support oral respiratory mucosal immunity, and provide an important first line defensive 
barrier against external pathogen invasion at oral-respiratory mucosal surfaces (Fábián et al. 
2012, Woof and Kerr 2006). Indeed, S-α-amylase which is derived from the major salivary 
glands (i.e., parotid, submandibular and sublingual) in differing amounts, has been shown to 
assist in the prevention of bacterial attachment to mucosal surfaces, and when coupled with 
mucin 1, helps bacterial clearance from saliva. Additionally, S-α-amylase binds with high 
affinity to several oral streptococci species (Scannapieco et al. 1993). S-α-amylase secretion 
is influenced by exercise-induced sympathetic nervous system activation, the degree of which 
appears to be dependent on exercise intensity (Li and Gleeson 2004). For example, a five-fold 
increase in S-α-amylase activity was observed after a high intensity 60 min cycle exercise 
bout consisting of twenty 1 min periods at 100% maximal oxygen uptake (VO2max), each 
separated by 2 min recovery at 30% VO2max (Walsh et al. 1999). S-lysozyme, another 
constituent S-AMP derived from different sources (i.e., major and minor salivary glands, 





bacterial outer membranes, activate autolysins and initiate degradation. S-lysozyme can also 
bind bacteria and aggregate to facilitate clearance from the oral respiratory pathway (McNabb 
and Tomasi 1981, Tenovuo 1998, West et al. 2006). S-lysozyme also appears to be dependent 
upon exercise intensity, whereby a 55% increase in S-lysozyme concentration was observed 
after a graded exercise test to exhaustion (West et al. 2010).  Extensive research has focused 
primarily on S-IgA as the predominant marker of oral-respiratory mucosal immunity during 
physical exertion, whereas other S-AMPs such as S-α-amylase and S-lysozyme have been 
investigated to a lesser degree and have been potentially underestimated as protective factors. 
Given the innate anti-bacterial and anti-viral properties of these S-AMPs and the lack of 
research investigating the potential impact of these individually or in combination with S-
IgA, assessing the collective impact of these S-AMPs will provide a deeper understanding 
into how the oral-respiratory mucosal immune system responds during prolonged 
physiological stress (e.g., extreme physical exertion). To date, previous studies have shown 
variations in S-AMP responses in response to exercise. For example, 2 h of running at 75% 
VO2max in thermoneutral conditions (20°C) resulted in a 42% decrease in S-IgA concentration 
during recovery, but increases in S-α-amylase and S-lysozyme concentrations (81% and 
109%, respectively) that remained elevated throughout recovery (Costa et al. 2012). 
Moreover, transient increases in S-IgA secretion rate (50%) were observed after an 
incremental exercise test to exhaustion (22.3 ± 0.8 min), while no change was observed at 
75% VO2max of the same duration. Whereas, increases in S-lysozyme (160%) and S-α-
amylase secretion rate (60%) were observed after both the exhaustion and 75% VO2max trials 
(Allgrove et al. 2008). These results suggest that other S-AMPs with similar protective 
properties as S-IgA, may counteract the depressions in S-IgA commonly observed after 
physical exertion. A more accurate interpretation of oral-respiratory mucosal immune status 





would potentially provide a more accurate indicator of URSI risk and subsequently allow for 
a more tailored intervention approach depending on whether the anticipatory outcome was 
infectious or non-infectious episode management.  
 
In relation to oral-respiratory mucosal immunity, SFR is physiologically regulated by the 
autonomic nervous system with salivary glands innervated by both parasympathetic and 
sympathetic nerve endings. Hence, activation of neuroendocrine responses and subsequent 
increases in stress hormone release induced by stress stimuli have the potential to modulate 
oral-respiratory mucosal immunity through alterations in SFR (e.g., reduced volume of 
viscous saliva with increased osmolality and total protein concentration) and subsequent 
constituent S-AMP secretions (Bosch et al. 2003a, Chicharro et al. 1998, Gleeson and Pyne 
2000, Teeuw et al. 2004). For example, partaking in prolonged physical exertion is generally 
associated with disturbances to a consistent saliva flow (i.e., decreases in SFR) (Bishop et al. 
2000, Blannin et al. 1998, Walsh et al. 1999). Commonly used in clinical research settings, 
S-cortisol is considered an appropriate indicator of the stress response (activation of the HPA 
axis) to exercise. Firstly, concentrations are unaffected by changes in SFR; secondly, S-
cortisol concentrations do closely reflect, and are highly correlated with plasma free cortisol 
concentrations, the biologically active component (Umeda et al. 1981); and thirdly, S-cortisol 
sample collection is considered methodologically advantageous (e.g., non-invasive). Indeed, 
stress hormones are considered to be immunosuppressive and are linked to the immune 
perturbations reported during the period after stress stimuli (Gleeson and Pyne 2000, Nieman 
1997, Pedersen and Hoffman-Goetz 2000, Pedersen et al. 1997, Pedersen and Toft 2000, 
Shephard, Castellani, and Shek 1998, Walsh and Whitham 2006). Subsequently, S-cortisol 
was used to indicate acute changes in the stress response in Chapter 4, Chapter 5 and 






While perturbations to oral respiratory mucosal immune status are transient with the majority 
of published research reporting S-IgA returning to pre-exercise within 1 h of exercise 
cessation (Blannin et al. 1998, Ljungberg et al. 1997, McDowell et al. 1992), S-IgA recovery 
can be hindered (≤72 h) (Gleeson and Pyne 2000, Nieman 2000, Nieman 1997, Nieman et al. 
1990, Peters and Bateman 1983) compared with regular, moderate physical exertion whereby 
increased S-IgA responses have been reported (Akimoto et al. 2003, Allgrove et al. 2008, 
Bishop and Gleeson 2009, Blannin et al. 1998, Gleeson, Pyne, and Callister 2004, Klentrou et 
al. 2002, Libicz et al. 2006, McDowell et al. 1991).  
 
In summary, several constituent S-AMPs bathe the oral-respiratory pathway, offering 
protective immune properties that inhibit pathogen colonisation. Indeed, dissimilarities in 
responses of different S-AMPs ((e.g., decreases in S-IgA concomitant with increases in S-α-
amylase and (or) S-lysozyme)) have been reported after stress stimuli. Hence, a more 
comprehensive indicator of oral-respiratory mucosal immune status may be provided when S-
AMPs are assessed collectively, thus potentially providing a more accurate indicator of URSI 
risk. Chapter 4 and Chapter 5 aimed to assess the influence of extreme physical exertion on 
S-AMP responses during a multi-stage ultra-marathon and a 24 hour continuous ultra-
marathon, respectively. 
 
2.1.2 Circulatory Endotoxin Concentration and Cytokine Profile  
 
Comprising of enterocytes, Paneth and goblet cells, the epithelial lining along the GI tract 
plays a crucial role in preventing translocation of harmful microorganisms, some of which 





systemic circulation (Ganz 2003, Lambert 2008, Lim and Mackinnon 2006, Tuma and 
Hubbard 2003, Ulluwishewa et al. 2011). In addition, the multi-protein, semi-permeable tight 
junctions that close the gap between adjacent enterocytes continuously regulate the 
transcellular and paracellular absorption of substances (i.e., fluid and macromolecules) across 
the intestinal epithelium. 
 
Gram-negative bacterial endotoxins are high-molecular weight lipopolysaccharides (LPS) 
complexes (>100,000 dalton (Da)) with known pathogenic properties, and the major 
component of the outer membranes of the cell walls in all gram-negative bacteria. 
Endogenous bacterial endotoxins are non-toxic if they remain within the GI tract; although 
small quantities can routinely leak through the intestinal epithelium via the tight junctions 
and enter the portal circulation during daily function, representing a normal physiological 
state when cell lysis occurs (Jacob et al. 1977, Marshall 1998, Nolan 1981). Indeed, bacterial 
endotoxin translocation has been substantiated in human studies, whereby translocation 
occurrence as examined by bacterial analysis of intestinal serosa and mesenteric lymph nodes 
was identified in 10.3% of general surgical patients (n= 267); although this was noticeably 
reduced to 5% when patients with distal intestinal obstruction and inflammatory bowel 
disease were excluded (Sedman et al. 1994). While O’Boyle et al. (1998) cultured mesenteric 
lymph nodes, serosal scrapings and peripheral blood in surgical patients (n= 448) undergoing 
laparotomy and found bacterial translocation in 15.4% (n= 69) of all patients. Equally, these 
results were verified in a clinical population, whilst the methods used to vertify presence of 
endotoxin may have unestimated the true occurrence of endotoxin translocation. In 
comparison to exercise models, intestinal permeability is commonly determined through 






The liver promotes detoxification and clearance of transient bacterial endotoxins derived 
from the GI tract (via the portal vein) or from the systemic circulation (via the hepatic artery). 
Bacterial endotoxins are neutralised, degraded and removed from circulation through both 
innate and adaptive mechanisms such as the reticuloendothelial system (RES) (primarily 
hepatic Kupffer cells) (Marshall 1998), enzymes (e.g., phosphatases and hydrolases) (Poelstra 
et al. 1997), leukocytes (e.g., monocytes, neutrophils, basophils and mast cells), and 
lipoproteins (e.g., high-density lipoprotein, low-density lipoprotein, apolipoprotein) 
(Emancipator, Csako, and Elin 1992, Flegel et al. 1993); although anti-endotoxin antibodies 
(e.g., IgM, IgG and IgA class) (Camus et al. 1998) create the most prevalent and effective 
defence against bacterial endotoxins by inhibiting their biological effects.  
 
However, disturbances to intestinal epithelial integrity (e.g., exercise-induced trauma and 
injury) can cause deterioration of the protective epithelial lining, leading to subsequent 
increases in intestinal permeability (i.e., widening of the epithelial tight junction spaces), 
which by definition, is the non-mediated translocation of large molecular weight molecules 
(>150 Da) such as bacterial endotoxins (alongside other noxious substances such as bacteria, 
bacterial by-products, bile, food antigens, foreign particles and hydrolytic enzymes) across 
the intestinal epithelium into the portal circulation (Lambert 2009, Marshall 1998, Pals et al. 
1997). The liver has a limited bacterial endotoxin-removal capacity and when the threshold 
for bacterial endotoxin flux is met, whereby anti-endotoxin mechanisms are overwhelmed 
and the rate of bacterial endotoxin translocation from the GI tract prevails over clearance, 
bacterial endotoxin translocation into the systemic circulation ensues, termed endotoxaemia 
(Camus et al. 1998, Camus et al. 1997, Lim and Mackinnon 2006); which is considered the 
initial phase of heat stroke aetiology, mirroring the pathophysiological mechanisms of sepsis 





concentrations (5 pg·ml to 294 pg·ml) have been observed following marathon, ultra-
marathon and triathlon events (Bosenberg et al. 1988, Brock-Utne et al. 1988, Camus et al. 
1997, Jeukendrup et al. 2000). The variations observed between and within previous field-
based studies are likely due to alterations in intestinal permeability induced by the varying 
degrees and durations of individual or combined stressors such as the competition/event 
protocols (e.g., duration), the ambient temperature (Tamb) and the population group (e.g., 
training status) and number.  
 
Endotoxaemia is a potent activator of leukocytes which in turn, stimulate the secretion of pro-
inflammatory cytokines, namely TNF-α, IL-1β and IL-6 (Bouchama et al. 1991, Camus et al. 
1998, Pedersen 2000, van Deventer et al. 1990), counterbalanced by the secretion of anti-
inflammatory cytokines such as IL-10 and IL-1ra (Ostrowski et al. 1999, Pedersen 2000, 
Petersen and Pedersen 2005). The initiation of a cytokine-mediated inflammatory response 
has been shown to modify tight junction function (e.g., changes in protein composition and 
structure) and enhance intestinal permeability; in particular, TNF-α and IFN-γ (Capaldo and 
Nusrat 2009, Gitter et al. 2000, Madara and Stafford 1989, McKay and Singh 1997, Mullin 
and Snock 1990, Rodriguez et al. 1995, Youakim and Ahdieh 1999). To date, experimental 
models have shown that intravenous injection of endotoxin in rodents (5 µg·kg, 25 µg·kg and 
1 mg·kg) signals a responsive cytokine cascade (TNF-α, IL-1β and IL-6) 10 to 30-fold above 
baseline (Givalois et al. 1994). Administration of endotoxin at 2 ng·kg in healthy human 
subjects resulted in peak circulating endotoxin concentrations ranging from 7 to 13 ng·l, 
followed by marked increases in TNF-α and IL-6, reaching peak concentrations after 60 to 90 
min (68 to 1374 ng·l) and 120 to 150 min (72 to 2820 U·ml), respectively (van Deventer et 
al. 1990), whilst administration at 4 ng·kg in healthy human subjects instigated increases in 





1988). Although these studies provide insight into the mechanistic action of endotoxin, the 
use of animal models limits generalisability. Equally, the small sample sizes used in human 
models (n= 6) limits application to real-life settings and does not accurately reflect the 
general population, and more specifically active populations.  Notably, administration of 
endotoxin via this method does not accurately reflect the mechanisms of intestinal 
permeability (e.g., leaky gut syndrome).  
 
Synthesised and secreted primarily by leukocytes of the innate and adaptive immune system, 
cytokines are soluble immunoregulatory protein and glycoprotein molecules with pleiotropic 
properties, serving as chemical messengers that stimulate maturation, differentiation, and 
proliferation of leukocytes and facilitate cell-to-cell communication in a localised (autocrine, 
paracrine) or systemic (endocrine) manner and do so, at very low concentrations (Suzuki et 
al. 2002). In vivo, cytokines rarely, if ever, act alone. Instead, multiple cytokines which may 
have synergistic or antagonistic properties and (or) induce the synthesis of other cytokines, 
exert their biological effects by binding to highly specific receptors on responding target cells 
which initiates an intracellular signalling cascade, altered gene expression and cellular 
changes (e.g., up-regulation, down-regulation, stimulation or inhibition of cellular processes). 
Cytokines are broadly categorised into pro-inflammatory cytokines (e.g., TNF-α, IFN-γ and 
the interleukins; IL-1β, IL-8, IL-12, IL-18) and anti-inflammatory cytokines (e.g., the 
interleukins; IL-4, IL-6, IL-10, IL-11, IL-13, IL-1ra), which act to counterbalance and restrict 
the degree of the inflammatory response (Lim and Mackinnon 2006, Peake et al. 2015). For 
example, TNF-α and IL-1β concentrations have been reported to increase 2.3-fold and 2.1-
fold respectively, immediately after a competitive marathon race; whilst IL-10 increased 27-
fold and IL-1ra peaked 39-fold 1 h after the race. IL-6, which promotes an anti-inflammatory 





fold (Bethin, Vogt, and Muglia 2000, Ostrowski et al. 1999, Steensberg et al. 2003, Stouthard 
et al. 1995). Similarly, IL-10 (109%) and IL-1ra (212%) increased markedly after a marathon 
race, remaining elevated 1.5 h post-exercise, while significant (but of very low magnitude) 
increases were observed in TNF-α and IL-1β (Nieman et al. 2001); though, considerable 
individual variation in the magnitude of cytokine responses after exercise is reported (Peake 
et al. 2015). 
 
Periods of increased physiological stress augments the release of glucocorticoids hormones 
from the adrenal cortex, namely cortisol, which has marked anti-inflammatory and 
immunosuppressive properties. Indeed, stress hormones appear to promote a shift from T-
helper1 (Th1) lymphocyte cells producing pro-inflammatory cytokines (e.g., TNF-α and IFN-
γ) to T-helper2 (Th2) lymphocyte cell producing anti-inflammatory cytokines (e.g., IL-4, IL-
10 and IL-13) (Elenkov 2004, Elenkov and Chrousos 1999), in addition to inhibiting 
inflammatory signalling pathways such as nuclear factor-kappa B (NF-кB) and subsequent 
pro-inflammatory secretion (D’Acquisto, May, and Ghosh 2002, Hu et al. 2003). However, 
periods of sustained physiological stress may induce HPA axis fatigue, glucocorticoid 
receptor resistance (i.e., diminished sensitivity of leukocytes to glucocorticoids) and 
activation of the inflammatory signalling pathways (e.g., NF-𝜅B) resulting in the up-
regulation of pro-inflammatory cytokines (Cohen et al. 2012, Webster, Tonelli, and Sternberg 
2002). As a result, it is plausible that altered cytokine responses (i.e., continued increased 
pro-inflammatory cytokines leading to an over-exaggerated cytokine-mediated inflammatory 
response) may occur in high-risk situations (e.g., extreme physical exertion such as ultra-
endurance competitions and events) in high-risk individuals (e.g., recreational runners). 
Notably, previous observations suggest the time course for full recovery of altered cytokine 





are considerably delayed (Gomez-Merino et al. 2006, Neubauer, Konig, and Wagner 2008) 
and may play a role in the aetiology of undefined underperformance and chronic fatigue 
syndromes (Morris et al. 2014, Robson 2003). The continuous demand of competition, the 
opportunity for inadequate rest between exercise bouts (i.e., demanding training schedules) 
may promote the clinical manifestations of a systemic inflammatory response, which often 
reflect that of sepsis may ensue and, if left untreated, can lead to organ dysfunction and multi-
organ failure. 
 
At the same time, cytokine-induced (namely IL-6) increases in acute phase proteins such as 
hepatic derived CRP serve to recognise and assist in the removal of pathogens and (or) 
damaged cells by functioning as an opsonin (i.e., coating bacterial surfaces for recognition by 
phagocytes) and complement activator (i.e., amplifies inflammatory responses and 
phagocytosis). CRP can rapidly increase up to 1000-fold during a systemic inflammatory 
response peaking 24 to 48 h after initial exposure to a stress stimulus (Pepys and Hirschfield 
2003, Semple 2006). Increases in CRP of nearly 300% were observed 24 h in athletes (n= 18) 
after a 160 km triathlon (Taylor et al. 1987), whilst a 122% increase in CRP was observed in 
runners (n= 55) 4 h after a marathon race (Siegel et al. 2001).  
 
In summary, loss of intestinal epithelial integrity can promote increases in intestinal 
permeability and an endotoxin-induced cytokine-mediated inflammatory response, which 
may lead to an over-exaggerated response if the stress stimuli is of an extreme nature; for 
example, sustained activities with accompanying physiological stressors such as ultra-
endurance competition. Chapter 6 aimed to track the intestinal permeability of endotoxins 









2.2.1 Prolonged Physical Exertion and Salivary Anti-Microbial Protein Responses 
 
The first reported research investigating the effects of exercise on mucosal immune 
parameters was in cross-country skiers, whereby significantly lower resting S-IgA 
concentrations were observed in elite skiers compared with age-matched controls before 
competition, with further reductions observed after 2-3 h of intensive ski competition 
(Tomasi et al. 1982). It was speculated that following prolonged physical exertion, temporary 
antibody deficiency at the oral-respiratory mucosal surface may lead to an increased 
susceptibility of self-reported bacterial and viral infections. The potential link between 
exercise and infection was originally reported by Peters and Bateman (1983) who conducted 
a survey on the incidence of upper respiratory tract infections (URTI) two weeks after a 56 
km running competition. The authors found that incidence of URTI was significantly greater 
in runners (33%; n= 141) compared with matched controls (15%; n= 124). Subsequent 
studies have since reported similar findings following endurance events (Nieman et al. 1990, 
Nieman et al. 2003, Peters 1990) with increased URTI associated with the degree of exercise 
stress (Nieman 1994). For example, a greater running mileage was correlated with an 
increased incidence of URTI (Heath et al. 1991).  
 
In particular, it has been documented that running exercise, compared with other exercise 
modes, results in greater perturbations to oral respiratory mucosal immunity, contributing to 
increased reports of URS (Matthew et al. 2002, Peters 1990, Peters and Bateman 1983), 





airbourne pathogens. This is of clinical relevance, taking into account that URSI are a 
common medical issue amongst active populations (Cox et al. 2008, Reid et al. 2004, 
Robson-Ansley et al. 2012, Spence et al. 2007). Notably, individuals with selective S-IgA 
deficiency tend to report recurrent sinopulmonary infections (Fried and Bonilla 2009), whilst 
very low saliva rates and oral dryness (xerostomia) is associated with an increased risk of oral 
complications and an increased incidence of URTI such as pharyngitis (Fox et al. 2004, Fox 
et al. 1985). Whilst there is no established ‘cut-off’ value in predetermining URTI risk, an 
absolute S-IgA concentration and S-IgA secretion rate of 40 mg·l-1 and 40 µg·min-1, 
respectively is associated with an increased risk of acquiring an URTI (Fahlman and Engels 
2005, Gleeson et al. 1999).  
 
Over the past thirty years, several reviews have discussed the effects of exercise on mucosal 
immunity (Bishop and Gleeson 2009, Gleeson 2000, Gleeson and Pyne 2000, Mackinnon and 
Hooper 1994, Walsh et al. 2011a). These reviews have reported similar findings, whereby 
depressions in S-IgA (i.e., concentration and secretion rate) have been observed immediately 
after various types of exercise (e.g., sprint, interval and endurance) and during the recovery 
period across many different sports, especially in highly trained athletes (Gleeson et al. 1995, 
Mackinnon and Hooper 1994, Mackinnon, Ginn, and Seymour 1993, Tomasi et al. 1982). 
Indeed, the degree S-IgA depression is invariably related to the volume and intensity of the 
exercise-stress.  For example, significant depressions in S-IgA responses is more consistently 
reported after participation in prolonged (e.g., a marathon) and extreme (e.g., a triathlon and 
ultra-marathon) physical exertion (Gleeson and Pyne 2000, Libicz et al. 2006, Mackinnon 
and Hooper 1994, Nehlsen-Cannarella et al. 2000, Nieman et al. 2006a, Nieman et al. 2003 
Steerenberg et al. 1997). Moreover, it has been suggested that cumulative depressions in S-





Hooper 1994, Tharp and Barnes 1990). For example, pre- and post-session S-IgA levels 
decreased significantly in competitive swimmers during heavy training sessions compared to 
light or moderate training sessions over a three month training period (Tharp and Barnes 
1990). Whilst, competitive runners running for 90 min at 75% VO2max on three consecutive 
days had significantly lower S-IgA secretion rates after each exercise bout (20 to 50%), in 
addition to significantly lower S-IgA secretion rates on the second and third day compared 
with the first day (Mackinnon and Hooper 1994). As such, repetitive bouts of intense exercise 
(e.g., multi-stage ultra-endurance endurance events) without sufficient recovery may 
compromise oral respiratory mucosal immune status to a greater extent if chronic depressions 
occur and S-IgA returning to baseline levels is delayed or impaired. In contrast, moderate, 
physical exertion does not appear to induce significant alterations in S-IgA responses 
(Gleeson and Pyne 2000, Housh et al. 1991, Mackinnon and Hooper 1994, McDowell et al. 
1991). However, inconsistencies in S-IgA responses during the recovery period following 
physical exertion are evident with decreases in S-IgA concentration (Costa et al. 2012, Costa 
et al. 2009, Gleeson et al. 1999, Gleeson et al. 2000), increases in S-IgA concentration 
(Blannin et al. 1998, Laing et al. 2005) and no change in S-IgA concentration (Bishop et al. 
2000, Walsh et al. 1999). Similarly, decreases in S-IgA secretion rate (Laing et al. 2005, 
Mackinnon and Hooper 1994, Walsh et al. 2002), increases in S-IgA secretion rate (Blannin 
et al. 1998), and no change in S-IgA secretion rate (Costa et al. 2012, Costa et al. 2009, 
Walsh et al. 1999) has been previously observed. Indeed, decreases in S-IgA concentration 
and secretion rate have been observed after exhaustive, high-intensity and submaximal 
running exercise (Mackinnon and Hooper 1994, McDowell et al. 1992), whereas increases in 
S-IgA concentration have been reported after marathon competition (Ljungberg et al. 1997) 
and after two 90 min cycling bouts at 60% VO2max (Li and Gleeson 2004). In addition, 





running test to exhaustion (Allgrove et al. 2008) and after longer duration cycle ergometer 
exercise at 55% VO2max for 3 h (Blannin et al. 1998). On the contrary, no change in S-IgA 
concentration was observed after running exercise bouts for durations of 15 to 45 min at 50 to 
80% VO2max (McDowell et al. 1991). Equally, no change in S-IgA concentration or secretion 
rate was observed after a 60 min intermittent exhaustive cycle ergometer exercise (Walsh et 
al. 1999), nor in the last 2 min of a cycling bout at 60% VO2max for 2 h (Bishop et al. 2000). 
Whilst noticeable inconsistencies are apparent between previous exercise studies, the 
influence of extreme physical exertion on S-IgA in addition to other S-AMPs during a multi-
stage ultra-marathon and 24 hour continuous ultra-marathon has yet to be explored.  
 
To date, whilst previous research has suggested that the exercise-induced depressions in S-
IgA likely accounts for the increase prevalence of URSI (Neville, Gleeson, and Folland 
2008), investigation into exercise-induced perturbations of other S-AMPs (e.g., S-α-amylase, 
S-lysozyme and S-lactoferrin) has generally been negligible (Walsh et al. 2011a); and it is 
largely unknown whether changes in these S-AMPs alter susceptibility to URSI (West et al. 
2006). Interestingly, a counteractive effect appears to be present, whereby a decrease or no 
change in one S-AMP (e.g., S-IgA) have been observed alongside simultaneous increases in 
other S-AMPs (e.g., S-α-amylase and S-lysozyme) (Allgrove et al. 2008, Costa et al. 2012). 
Indeed, a prospective observational study that investigated acute (graded exercise test) and 
chronic (five month period) changes in S-AMPs in a cohort of elite rowers (n= 11) observed 
increases in S-lysozyme and S-lactoferrin concentrations (55% and 50%, respectively) after a 
graded exercise test to exhaustion, whilst over a five month period, no significant changes in 
S-lysozyme concentrations were evident compared with sedentary controls. However, 
significantly lower S-lactoferrin concentrations (60%) were observed at baseline and mid-





were observed between groups at the end of the five month period (West et al. 2010). Despite 
the frequent association between prolonged or extreme physical exertion and depressed S-
IgA responses and the diverse responses of other S-AMPs (e.g., S-α-amylase, S-lysozyme 
and S-lactoferrin), which do not necessarily follow the same pattern as S-IgA following 
physical exertion (Allgrove et al. 2008, Costa et al. 2012, West et al. 2010), few studies have 
examined the effects of S-AMP responses during ultra-endurance events. Moreover, to date, 
previous laboratory-controlled studies have implemented exercise protocols lasting ≤2 h 
(Allgrove et al. 2008, Costa et al. 2012, West et al. 2010) which are considerably shorter in 
duration compared to ultra-endurance exercise which typically lasts >4 h. Therefore, whilst 
exercise protocols of shorter duration that entail an overall lower level of physiological stress 
may result in immune perturbations to a lesser extent (i.e., increases and decreases in S-AMP 
responses), it could be speculated that the extreme degree of the exercise-stress associated 
with competitive ultra-endurance events may instead, prompt marked depressions in other S-
AMPs (in addition to S-IgA), thus reducing the overall supply of protective factors at the the 
oral respiratory mucosal surface (Tenovuo 1998). For this reason, individuals partaking in 
such events may be considered a high-risk population group for compromised oral-
respiratory mucosal immune status and contracting sub-clinical or clinically significant 
outcomes following extreme physical exertion (Gleeson et al. 2000).  
 
Whilst substantial biological variation in S-IgA between individuals is reported (Neville, 
Gleeson, and Folland 2008), the inconsistencies in S-IgA responses between studies are likely 
in part, due to variations in the experimental design and methodological approaches of saliva 
collection and S-IgA measurement, making direct comparability between studies difficult. 
For example, timing of the saliva sample (diurnal variation), the exercise protocol 





characteristics of participants (e.g., fitness level and psychological state), expression of S-IgA 
(e.g., absolute concentration, secretion rate, ratio to total protein or osmolality), analytical 
methods used to determine S-IgA concentrations (e.g., technique, calibration, laboratory 
conditions and reproducibility of assay), saliva collection method (e.g., unstimulated, 
stimulated, spitting, swabbing and suction) and the nature or degree of saliva flow stimulus 
(e.g., mechanical, taste and fasting vs. non-fasting) (Bishop and Gleeson 2009, Gleeson and 
Pyne 2000, Hucklebridge, Clow, and Evans 1998, Woof and Kerr 2006). 
 
Unstimulated saliva collection (i.e., passive drool technique) appears to be the most reliable 
and justified method of determining real-time S-AMPs; whereas stimulated saliva collection 
has been shown to alter the volume and composition of saliva resulting in an apparent 
decrease (dilution effect) or increase in secretion rate of salivary biomarkers (i.e., chewing 
stimulates epithelial cell transcytosis of S-IgA) (Proctor and Carpenter 2001). Furthermore, 
the major and minor salivary glands reflect variation in glandular structure and thus 
contribute to salivary secretions in differing quantities. For this reason, whole saliva is 
currently the preferred method of saliva collection.  
 
Indeed, a major source of variation in S-IgA (and other S-AMP) responses is an alteration in 
SFR, which in itself is influenced by multiple confounding factors (e.g., hydration status, age, 
hereditary influences, drugs/medication, diurnal variation, and (or) oral-facial movement) 
(Bosch et al. 1996, Fortes et al. 2012, Kaufman and Lamster 2002, Li and Gleeson 2004, 
Naumova et al. 2012, Walsh et al. 2004a, Walsh et al. 2004b), although not always 
accounted for in previous research studies. Both unstimulated and stimulated saliva collection 
among individuals is highly variable. This large intra- and inter-individual variation in SFR 





for SFR (Brunstrom, Macrae, and Roberts 1997, Dawes, O’Connor, and Aspen 2000). As a 
range, normal values for unstimulated saliva flow have been identified at >100 µl·min 
(average ~300 µl·min), increasing to ≥200 µl·min (maximum of 7000 µl·min) for stimulated 
(Chicharro et al. 1998, Edgar 1990, Humphrey and Williamson 2001). 
 
Another factor that appears to influence SFR is the temperature of the mouth rinse used prior 
to saliva collection. Previous research investigating varying oral temperature stimuli has 
observed enhanced SFR with cooler (0˚C and 8˚C; 700 µl·min) and reduced SFR with 
warmer (37˚C; 540 µl·min) mouth rinse fluid temperatures (Dawes, Connor, and Aspen 
2000). Similar results were reported by Brunstrom, Macrae and Roberts (1997), whereby 
stimuli at 3°C enhanced saliva production compared with 13˚C, 23˚C and 33˚C; whilst 
Pangborn, Chrisp, and Bertolero (1970) observed large variations in parotid saliva flow 
responses among individuals, and greater SFR at extreme mouth rinse water temperatures 
(0°C and 55°C) compared with water temperatures of 22°C and 37°C. These observations 
suggest that varying procedures used to cleanse the mouth before a saliva sample collection 
may affect SFR, possibly due to temperature sensitive muscarinic or purinergic receptor 
activation involved in saliva secretion (Mukaibo et al. 2013).  
 
S-IgA and other S-AMP responses are commonly reported as an absolute concentration 
value, which reflects the current presence of a particular salivary variable per given volume 
on the oral respiratory mucosal surface. Reporting concentration does not, however, take into 
account potential changes in saliva flow induced by external factors (e. g., exercise, hydration 
status and extreme environmental conditions) that may promote a concentrating or diluting 
effect. Therefore, additionally reporting S-AMP responses as a secretion rate provides a 





al. 2012). This is considered a more appropriate method of reporting alterations in S-IgA 
synthesis and translocation during periods of prolonged physical exertion (Blannin et al. 
1998, Bishop and Gleeson 2009). For example, S-IgA secretion rate but not S-IgA 
concentration were reduced in triathletes (n= 42) after a triathlon race (Steerenberg et al. 
1997). Therefore, reporting SFR, S-IgA concentration and secretion rate is possibly the most 
appropriate way of presenting overall S-IgA responses. With this in mind, Chapter 4, 
Chapter 5 and Chapter 8 reported SFR, S-IgA concentration and secretion rate. 
 
A limited number of studies have undertaken pathology testing to differentiate between 
infectious and non-infectious causes of URS episodes in athletes. These studies concluded 
that approximately 5% and 30-40% of URS are of bacterial and viral origin respectively, with 
infections caused by the common respiratory pathogens affecting the general population (e.g., 
Rhinovirus and Influenza infections) (Cox et al. 2008, Spence et al. 2007). On the other hand, 
Spence et al. (2007) reported infectious episodes were higher in athletes (29%; 6 of 21 cases) 
compared to sedentary controls (22%; 2 of 9 cases). In other words, non-infectious episodes 
were higher in controls (78%; 7 of 9 cases) compared with athletes (71%; 15 of 21 cases). 
This study also took place over the summer and autumn months when the risk of contracting 
infectious respiratory illness is likely to be lower.  
 
More recently, it has been suggested that self-reported URTI are not always due to infectious 
aetiology. It is likely that non-infectious clinical conditions (e.g., asthma, allergy, irritation, 
autoimmune disorders, drying of the airways, bronchial hyperresponsiveness) and (or) 
unknown aetiologies such as drying of the airways associated with an increased ventilation 
rate during exercise and (or) airway inflammation induced by mechanical damage to the 





Ansley et al. 2012, Verges et al. 2005) that mimic infectious URS, may account for 30-40% 
of presenting episodes. For example, of the 47% of runners presenting URS after 
participation in the London Marathon, 40% were diagnosed with allergy as defined by the 
validated Allergy Questionnaire for Athletes (AQUA) and elevated specific IgE (Robson-
Ansley et al. 2012). Whilst, the use of a topical anti-inflammatory agent (Difflam throat 
spray) for one week before and two weeks after a half-marathon resulted in a 29% difference 
in symptom severity between the treatment group and placebo (Cox et al. 2010a). 
Collectively, these results suggest that a significant proportion of illness symptoms 
experienced in athletes may be non-infectious or inflammatory in nature, and not caused 
through pathogen aetiology. Notably, earlier studies investigating the link between exercise, 
S-IgA and URTI are primarily based on subjective, self-reported recall measures rather than 
verification through medical diagnosis. Therefore, caution is needed when interpreting results 
from earlier studies.  
 
In summary, S-IgA is the most widely researched biomarker of oral-respiratory mucosal 
immune status within the area of sport and exercise immunology, with depressions in S-IgA 
implicated as a risk factor for URSI in active populations. Salivary biomarkers are affected 
by a number of external factors, which likely accounts for the differences in salivary 
variables reported between previous studies. Given that greater depressions in S-AMPs, in 
particular S-IgA, are observed after prolonged physical exertion, it is plausible that 
participation in extreme physical exertion may exacerbate these depressions further, leading 
to the development of sub-clinical or clinically significant outcomes. In addition to the 
assessment of salivary variables, Chapter 4 and Chapter 5 aimed to determine the incidence 






2.2.2 Prolonged Physical Exertion, Circulatory Endotoxin Concentration and Cytokine 
Profile  
 
An adequate splanchnic blood supply is essential in the maintenance of intestinal epithelial 
integrity. Prolonged physical exertion, particularly running exercise, appears to perturb 
intestinal epithelial integrity through redistributing blood flow to the working muscles and 
peripheral circulation (i.e., aiding thermoregulation), inevitably leading to splanchnic 
ischemia-hypoperfusion and tissue hypoxia (ter Steege and Kolkman 2012, van Wijck et al. 
2012). A recent review by Steege and Kolkman (2012) reported ≤80% reductions in 
splanchnic blood flow with higher intensity and (or) prolonged physical exertion which may 
have particular relevance for active populations partaking in competitive endurance and ultra-
endurance competitions and events. Equally, upon cessation of exercise and restoration of 
splanchnic blood supply, intestinal epithelial integrity can be further exacerbated by 
reperfusion injury (i.e., inflammation and oxidative stress) (van Wijck et al. 2012). Indeed, 
van Wijck et al. (2011) observed hypoperfusion-induced injury to the small intestinal 
epithelium as measured by plasma intestinal fatty acid binding protein (I-FABP) and ileal bile 
acid binding protein (I-BABP) which are considered sensitive markers of enterocyte damage, 
which was correlated with mild increases in intestinal permeability after healthy subjects 
cycled for 60 min at 70% of maximum workload capacity. Additionally, alterations to 
intestinal motility and direct mechanical trauma and (or) injury (i.e., increased repetitive 
jarring associated with prolonged periods of running) and (or) acceleration/deceleration 
forces during running has been shown to induce a greater intestinal burden which can further 
promote irritation to the intestinal mucosa, epithelial damage and (or) dysfunction, thus 
playing a significant role in GI pathology and symptomatic manifestations (Rehrer et al. 





example, a previous laboratory-controlled study showed that running induces over double the 
degree of vibration in the GI region compared with cycling (Rehrer and Meijer 1991). It 
could be speculated that the repetitive jarring and the subsequent ‘churning effect’ induced by 
running, liquefies the contents of the large intestine initiating lower GI symptoms such as 
diarrhoea and abdominal cramps. Indeed, Peters et al. (1999) conducted a self-reported GI 
symptomology questionnaire amongst runners (n= 199), cyclists (n= 197) and triathletes (n= 
210) and found that runners experienced more lower GI symptoms (71%) than cyclists 
(64%), whilst triathletes experienced more lower GI symptoms during running (79%) than 
cycling (45%). These results were reflected in an earlier survey of marathon runners (n=707) 
that showed long-distance running was associated with a high incidence of GI symptoms, 
particularly lower GI; for example, bowel movements and diarrhoea were frequently reported 
(34.9% and 19.2%, respectively) (Keeffe et al. 1984). Equally, these studies used 
retrospective self-reported measures to determine GI symptoms with no control groups for 
comparative purposes. Furthermore, rapid exercise-induced fluid shifts and (or) imbalances 
(e.g., compromised hydration status) may cause further irritation to the intestinal mucosa, 
exacerbating GI symptoms. For example, 80% of those runners who lost >4% body mass 
(BM) after completing a marathon race experienced GI symptoms (Rehrer et al. 1989), 
although other potential confounding factors were not accounted for (e.g., increases in body 
temperature, training status of runners). Equally, 50% of runners participating in a 160 km 
race experienced GI symptoms, although this was unrelated to fluid intake (Glace, Murphy, 
and McHugh 2002). In addition to the assessement of circulatory endotoxin concentrations 
and cytokine profile, Chapter 6 and Chapter 7 aimed to determine the incidence of GI 







In humans, non-invasive non-metabolisable markers of intestinal permeability such as oral 
ingestion and urinary excretion of sucrose, lactulose, 51Cr-labelled 
ethylenediaminetetraacetic (EDTA) acid or the ratio of lactulose to rhamnose or manitol have 
been found to be elevated following exercise (Øktedalen et al. 1992, Pals et al. 1997). Indeed, 
a previous laboratory-controlled study observed significantly greater increases in the mean 
urinary excretion ratio of lactulose to rhamnose (0.107 ± 0.021%) after 60 min of treadmill 
running at 80% VO2max in 22°C compared with treadmill running at rest, 40 and 60% VO2max 
(0.048 ± 0.009, 0.056 ± 0.005 and 0.064 ± 0.010%, respectively) (Pals et al. 1997). However, 
a more widely used method for assessing intestinal permeability following exercise in field 
and laboratory settings is plasma endotoxin and anti-endotoxin antibody concentrations. This 
method is considered practically and logistically advantageous, offering minimal disruption 
to those individuals partaking in intensified training periods and (or) competitive endurance 
and ultra-endurance competitions and events. To date, a number of studies have reported 
variable increases in circulatory endotoxin concentrations following exercise. An early study 
by Brock-Utne et al. (1988) reported increases in plasma LPS concentrations over 100 pg·ml 
in 81% of runners and decreases in plasma anti-endotoxin IgG concentrations after 
completion of a marathon totalling 89.4 km. Similarly, mean plasma LPS concentrations 
increased from 81 to 294 pg·ml after an ultra-distance triathlon, whilst mean plasma anti-
endotoxin IgG concentrations decreased (67.63 to 38.99 µg·ml) (Bosenberg et al. 1988). 
These observations were reflected in a later study by Camus et al. (1997) who observed 
milder increases (7 out of 18 runners) in plasma endotoxin ranging from 5 to 13 pg·ml, with 
one runner having a significantly higher concentration of 72 pg·ml within the first hour of 
recovery after participation in a marathon. Whilst marked decreases in plasma anti-endotoxin 
IgG and IgM concentrations that declined to minimal values in the majority of recreational 





(2000) observed mild increases in plasma endotoxin concentrations (5 to 15 pg·ml) 
immediately after competition (68% of triathletes), 2 h post-competition (19% of triathletes) 
and 16 h post-competition (79% of triathletes), possibly attributed to continued intestinal 
leakage of bacterial endotoxin into the circulation after exercise. Notably, no change in 
plasma anti-endotoxin IgG concentrations were observed immediately after competition, 
although a general decline was observed 2 h post-competition, which significantly declined 
16 h post-competition. Finally, mildly elevated plasma LPS concentrations (31.6%; 1.9 ± 1.9 
pg·ml to 2.5 ± 1.9 pg·ml) were observed in runners after a 21 km half-marathon in warm and 
humid ambient conditions ((approximately 26°C to 27°C and 82 to 84% relative humidity 
(RH)) (Ng et al. 2008). However, none of the above studies included a control group for 
comparative purposes. Whilst the discrepancies between and within study results may in part, 
be attributed to individual variation and the normal fluctuating nature of plasma endotoxin 
concentrations and (or) analytical methods used to determine the presence of endotoxin, 
higher circulating concentrations of endotoxin and anti-endotoxin antibodies have been 
observed in untrained compared with trained individuals (Jeukendrup et al. 2000, Selkirk et 
al. 2008). This gained adaptation in trained individuals is likely attributed to repetitive 
endotoxin challenge and subsequent ‘self-immunisation’ (Bosenberg et al. 1988, Brock-Utne 
et al. 1988).  
 
Via immune mechanisms (e.g., production of cytokines and activation of complement), 
exaggerated circulatory endotoxin concentrations can induce various detrimental 
physiological effects to the host including SIRS; a condition known as a whole body 
inflammatory state. In extreme cases, over-exaggerated immune activation (i.e., innate 
immune cell proliferation and function, and cytokine responses) and increased pro-coagulant 





haemodynamic perturbations with subsequent hypotension, with the end-point being septic 
shock (Hodgin and Moss 2008, van Leeuwen et al. 1994). For example, administration of 
endotoxin at 2 ng·kg in healthy human subjects induced activation of the coagulation 
pathway as evidenced by increases in prothrombin fragments and thrombin-antithrombin 111 
complexes, alongside transient increases in body temperature (oral), pulse rate and decreases 
in blood pressure (van Deventer et al. 1990).  
 
In the mid-late 1990’s, several published studies investigating the effects of exercise on 
cytokine responses began to appear (Nagaraju et al. 1998, Northoff, Weinstock, and Berg 
1994, Ostrowski et al. 1999, Ostrowski et al. 1998). Today, it is known that physical exertion 
induces elevated plasma levels of multiple pro-, anti- and immunomodulatory cytokines, in 
particular muscle derived IL-6, which is the earliest and most prominent (i.e., significantly 
higher concentrations than any other cytokine) cytokine produced upon initiation of exercise 
(Bruunsgaard et al. 1997, Castell et al. 1997, Drenth et al. 1995, Febbraio and Pedersen 2002, 
Nehlsen-Cannarella et al. 1997, Northoff and Berg 1991, Pedersen, Steensberg, and Schjerlin 
2001, Pedersen et al. 1998, Rohde et al 1997, Ullum et al. 1994). For example, IL-6 
concentrations increased up to 100-fold after a marathon race (Ostrowski et al. 1999, 
Ostrowski et al. 1998). The early research consistently reporting a marked increase in IL-6 
following physical exertion instigated further research into exercise-induced cytokine 
responses (Drenth et al. 1995, Sprenger et al. 1992, Ullum et al. 1994). Indeed, a number of 
subsequent studies have since reported increases in circulatory concentrations of both pro-
inflammatory (e.g., IL-1β, TNF-α, IL-6) and anti-inflammatory (e.g., IL-10, IL-6, IL-1ra) 
cytokines after physical exertion (Gleeson et al. 2011b, Ostrowski et al. 1999, Ostrowski et 






 The considerable variation in the magnitude of cytokine responses reported in the current 
literature is likely due to the difference in laboratory-based (exercise mode; e.g., eccentric vs. 
concentric, intensity, duration and Tamb) or field-based (e.g., endurance, ultra-endurance 
exercise and Tamb) protocols (Nieman et al. 2012) and (or) the specificity and sensitivity of 
assays used in earlier studies. Other mechanisms that likely contribute to cytokine release 
include elevated circulatory endotoxin concentrations, in addition to hyperthermia, energy 
imbalance and muscle injury and (or) trauma associated with the exercise-stress (Nieman et 
al. 2014, Pedersen 2000, van de Vyver and Myburgh 2014, Welc and Clanton 2013). 
 
It is well established that moderate physical exertion elicits favourable changes in cytokine 
profile; such as suppression of low-grade inflammation and enhanced anti-inflammatory 
cytokine responses (Peterson and Pedersen 2005, Walsh et al. 2011a). Indeed, the classical 
cytokine response to moderate exercise in thermoneutral conditions (body temperature 
increase <1°C) results in raised circulatory IL-1ra, IL-10, and muscle-derived IL-6 
concentrations; while pro-inflammatory cytokine IL-1β and TNF-α responses are generally 
minimal (Walsh et al. 2011a). For example, 2 h of running at 75% VO2max in 20ºC ambient 
conditions resulted in an approximate 150%, 570% and 1490% increase in IL-1ra, IL-10 and 
IL-6, respectively; while no changes in IL-1β and TNF-α were observed (Costa et al. 2011). 
On the contrary, prolonged physical exertion results in raised circulatory pro-inflammatory 
TNF-α and IL-1β counteracted by raised circulatory anti-inflammatory IL-1ra, IL-10, and IL-
6 concentrations (Camus et al. 1998, Camus et al. 1997, Ostrowski et al. 1999, Ostrowski et 
al. 1998, Suzuki et al. 2002, Walsh et al. 2011a) in part, induced by the augmented increases 
in circulatory stress hormones with known anti-inflammatory properties. Moreover, 
prolonged physical exertion is associated with enhanced bacterial endotoxin translocation 





cytokine profile similar to that of an acute infectious episode (e.g., sepsis, trauma and fever) 
(Bosenberg et al. 1988, Fehrenbach and Schneider 2006, Jeukendrup et al. 2000, Selkirk et 
al. 2008). Therefore, whilst down-regulation of pro-inflammatory cytokines and up-
regulation of anti-inflammatory cytokines initiated by moderate exercise is likely to re-
establish homeostasis; extreme physical exertion (e.g., single- and multi-stage ultra-
endurance endurance events) may lead to an over-exaggerated endotoxin-induced cytokine-
mediated inflammatory response and SIRS (Webster, Tonelli, and Sternberg 2002) which has 
previously been implicated in the aetiology of heat stroke and septic shock (Lim and 
Mackinnon 2006, Opal 2010). 
 
From a practical perspective, single- and multi-stage ultra-endurance events have 
dramatically increased in popularity over the past decade (Knoth et al. 2012), yet research 
into the physiological demands and immune responses to such an extreme sport is limited 
(Murray and Costa 2012). Therefore, to date, the short and long-term effects of such ultra-
endurance exposure on intestinal epithelial integrity and immune responses have not yet been 
established. Furthermore, single- and multi-stage ultra-endurance events which exhibit 
prolonged exposure to other multiple physiological stressors may also have the potential to 
impact upon intestinal epithelial integrity and cytokine responses. For example, a pronounced 
cytokine (i.e., IL-6 and somnogenic cytokines IL-1β, TNF-α, and IFNγ) profile is commonly 
seen after acute periods of sleep deprivation (Dinges et al. 1995, Rogers et al. 2001) and 
compromised energy status (Nieman et al. 1998, Robson 2003). For example, inadequate 
carbohydrate during exercise is associated with higher stress hormone (e.g., cortisol) and 







In summary, endotoxaemia and responsive cytokinaemia have consistently been observed 
after prolonged physical exertion. It is plausible that active populations participating in 
extreme physical exertion (e.g., ultra-endurance competition) are potentially a high-risk 
population group for pronounced acute and long-term GI and immune dysfunction, leading to 
the development of sub-clinical or clinically significant outcomes; including GI symptoms, 
GI diseases, chronic systemic inflammation, autoimmune diseases, chronic fatigue and 
underperformance syndrome. 
 
2.3.1 Exertional-Heat Stress and Salivary Anti-Microbial Protein Responses 
 
Given that hot ambient conditions (i.e., in the absence of exercise-stress) induce the classic 
stress hormone response (e.g., increases in cortisol and catecholamines) and partaking in 
physical exertion in temperate ambient conditions (i.e., in the absence of heat-stress) 
provokes a greater stress hormone response, the combination of exercise plus heat-stress is 
considered a strong stimulus for activation of the HPA and SAM axis, especially if the 
exercise is sustained for prolonged periods and (or) includes repetitive exercise bouts 
(Brenner et al. 1998, Galbo et al. 1979, Laing et al. 2005). Previous studies investigating the 
independent effects of exercise plus heat-stress on stress hormone concentrations have shown 
differential responses compared with exercising in temperate ambient conditions. Brenner et 
al. (1997) observed significant increases in plasma cortisol concentrations in response to 
exercise (two 30 min cycle ergometer exercise at 50% VO2max separated by a 45 min recovery 
interval) in the heat only (40°C and 30% RH), compared with exercise in temperate ambient 
conditions (23°C and 30% RH). Notably, the repetition of exercise in the heat did not 
significantly alter plasma cortisol, although plasma epinephrine and norepinephrine were 





speed requiring 68% VO2max in 21°C, 27°C and 33°C water, increased rectal temperature 
(Tre) in 27°C and 33°C only (0.7 ± 0.1°C and 1.3 ± 0.2°C, respectively), whilst plasma 
cortisol (27°C and 33°C water only) and noradrenaline (33°C water only) concentrations 
increased in the warmer water temperatures (Galbo et al. 1979). More recently, Laing et al. 
(2005) reported greater increases in plasma cortisol after a 2 h cycling bout at 62% VO2max in 
hot ambient conditions (30.3°C and 76% RH) compared with temperate ambient conditions 
(20.4°C and 60% RH). Whilst robust methods were applied these laboratory-controlled 
studies provide insight into stress hormone responses at differing temperatures, the 
application to real-life ultra-endurance exercise models is limited. 
 
In relation to oral-respiratory mucosal immunity, salivary variables are influenced by the 
SAM axis, whereby increases in sympathetic nervous system activity and subsequent 
vasoconstriction of the blood vessels supplying the salivary glands has been shown to inhibit 
SFR; the primary mechanism most commonly proposed to explain depressions in salivary 
variables (e.g., smaller volume of viscous saliva and subsequent reductions in S-AMP 
secretion rates). Previously, Li and Gleeson (2005) suggested that there may be a threshold 
level of sympathetic nervous system activation to constrict salivary glandular vessels, which 
may in part, explain the inconsistencies between studies investigating exercise and alterations 
in SFR. Additionally, sympathetic (and parasympathetic to a lesser extent) nervous system 
activity has been shown to increase the movement of S-IgA into saliva (i.e., increased S-IgA 
secretion rate), which can be maintained over an extended period of time (>2 h) (Carpenter et 
al. 1998, Carpenter et al. 2000). Equally, in the absence of nerve stimulation, S-IgA was 
shown to gradually accumulate within a glandular compartment (Carpenter et al. 1998). 
These results suggest that IgA is continuously being synthesised, of which secretion increases 





system activity); whilst during periods of less demand, excess IgA may be drained into the 
lymphatic vessels.  However, such extensively stimulated glands resulted in reduced levels of 
S-IgA (i.e., 77% of S-IgA levels in unstimulated control glands), suggesting that excessive 
stimulation may decrease S-IgA secretion rate (Bishop and Gleeson 2009), Indeed, a trend for 
decreased S-IgA secretion was observed with consecutive, increasing doses of isoprenaline 
(beta-adrenoceptor agonist) and methacholine (cholinergic agonist) (Proctor et al. 2003). 
Therefore, sympathetic nervous system activation during short duration, high intensity 
exercise may increase transcytosis of S-IgA into saliva; whereas, longer duration, lower 
intensity exercise may deplete the IgA pool available for transcytosis (i.e., excessive 
stimulation). For that reason, the different modes of exercise protocols implemented in 
previously published studies and (or) the interaction between different stimulatory 
mechanisms and their receptors may in part, explain the discrepancies between studies 
investigating the S-IgA response to physical exertion.  
 
Similarly, the HPA axis and subsequent increases in cortisol concentrations are thought to 
play a significant role in inhibiting S-IgA transcytosis (Hucklebridge, Clow, and Evans 
1998). Indeed, Wira et al. (1990) observed decreased S-IgA concentrations in rodents 
following glucocorticoid (dexamethasone) administration, whilst glucocorticoid 
administration in vivo has been shown to rapidly inhibit transepithelial transport (i.e., 
translocation) of S-IgA, possibly reflective of suppression in B-lymphocyte cell maturation, 
differentiation and proliferation, thus accounting for the decreases in S-IgA concentration and 
secretion rate consistently reported following prolonged physical exertion (Sabbadini and 
Berczi 1995, Saxon et al. 1978). Notably, whilst glucocorticoid administration has also been 
reported to dampen Ig responses (i.e., decreases in Ig synthesis) (Saxon et al. 1978), it is 





physical exertion is due to changes in the transepithelial transport mechanism, as opposed to 
B-lymphocyte cell Ig synthesis and production, which requires many hours to days 
(Hucklebridge, Clow, and Evans 1998). Other possible mechanisms attributable to the 
frequently reported depressions in S-IgA is through alterations in tSC production (Woof and 
Mestecky 2005), the contribution of different salivary glands and different stimuli activating 
specific glands which may play a role in altered responses of S-AMPs (Noble 2000); or 
indirectly through SAM axis-induced alterations in SFR and composition (Carpenter et al. 
2000, Carpenter et al. 1998, Chicharro et al. 1998, Teeuw et al. 2004, Tenovuo 1998). 
Indeed, sympathetic activation alters saliva composition and elicits a high protein content 
secretion; therefore EHS may promote a greater secretion of S-α-amylase and S-lysozyme 
into the saliva (Bishop et al. 2000; Chatterton et al. 1996). For example, sympathetic 
stimulation in anesthetised rodents substantially increased amylase and total protein secretion 
430- and 490-fold, respectively, compared with S-IgA (2.7-fold) (Carpenter et al. 2000).  
 
Exercising in a hypohydrated state is associated with an amplified stress hormone response, 
compared to a blunted stress hormone response in a euhydrated state. Previously, 
significantly elevated plasma cortisol have been observed after a 2 h cycling bout at 65% 
VO2max with no fluid intake (670 ± 63 nmol·l) compared with fluid intake (592 ± 62 nmol·l) 
before and during exercise (Bishop et al. 2004); highlighting the importance of maintaining 
euhydration in the attenuation of stress hormone responses which may subsequently alter 
salivary variables. Equally, compromised hydration status per se and subsequent salivary 
gland hypofunction is another mechanism proposed to explain the depressions in salivary 
variables following physical exertion, particularly when performed in hot ambient conditions. 
Indeed, the main constituent of saliva is water (97-99.5%) and the level of salivary output is 





salivary acinar cells; thus a copious blood flow to the salivary glands ensures an adequate 
saliva flow. Water movement from the plasma through the salivary acinar cells into the 
salivary ducts to form primary saliva, is driven osmotically in response to trans-acinar sodium 
gradients. However, progressive dehydration increases the extracellular sodium concentration 
(and plasma osmolality; POsmol). As such, a greater sodium concentration would have to be 
generated across the salivary acinar cell in order to drive fluid into the acinar lumen, possibly 
accounting for the reduced volume of viscous saliva and changes in saliva composition (Ship 
and Fischer 1997). Previously, Ship and Fischer (1997) reported an approximate 90% 
decrease in SFR compared with baseline after a 24 h period without food and fluid. More 
recently, laboratory-controlled studies have shown that a 48 h period of fluid restriction 
resulting in 3.2% BM loss was associated with a 64% decrease in SFR and a non-significant 
decrease in S-IgA secretion rate (19%). However, fluid and energy restriction combined 
resulting in 3.6% BM loss was associated with a 54% decrease in SFR and a significant 
decrease in S-IgA secretion rate (39%). Notably, the alterations in salivary variables were 
independent of alterations in cortisol, which did not change throughout the 48 h period 
(Oliver et al. 2007). This was further reflected in a study by Allgrove et al. (2008) who 
observed increases in S-IgA secretion rate (50%) after a short duration incremental exercise 
test to exhaustion and no change in S-IgA secretion rate after 50% or 75% VO2max trials, 
despite no change in S-cortisol on all three trials. Collectively, these results suggest that 
irrespective of stress hormone responses, S-IgA regulation ((e.g., transcytosis and (or) 
synthesis)) can be impaired via other mechanisms (e.g., hydration status); as such, fluid 
availability per se to offset fluid losses appears to play a significant role in the maintenance 
of salivary variables (Oliver et al. 2007, Walsh et al. 2004a). Given that salivary variables 
normalised upon rehydration, these results support the notion that maintaining a euhydrated 





ultra-endurance events) is an effective strategy in preventing decreases in SFR and 
subsequent alterations in S-AMP secretions after prolonged physical exertion (Oliver et al. 
2008, Walsh et al. 2004a, Walsh et al. 2004b). In Chapter 4, Chapter 5 and Chapter 8, 
baseline hydration status of participants was assessed via BM and POsmol.  
 
Further studies have shown that exercise-heat induced dehydration resulting >3% BM loss 
resulted in a 67% decrease in SFR and accompanying decreases in S-α-amylase and 
lysozyme secretion rates (44% and 46%, respectively), although S-IgA secretion rate 
remained unchanged (Fortes et al. 2012). However, irrespective of ambient conditions, when 
adequate provision of fluids is available during periods of prolonged physical exertion, 
salivary variables may be perturbed to a lesser extent. For example, no differences in SFR, S-
IgA concentration or secretion rate were observed in response to two separate cycling bouts 
of 2 h at 62% VO2max performed in a hot environment (30.3°C and 76% RH) compared with a 
thermoneutral environment (20.4°C and 60% RH) when water was provided ad libitum 
(Laing et al. 2005); suggesting that regular fluid intake during EHS assists in the maintenance 
of SFR and subsequent S-AMP secretions. It has also been proposed recently that 
maintaining euhydration may be an important strategy for keeping upper respiratory mucosal 
passages moist, attenuating the potential surface irritation and inflammation associated with 
URS and exercise-induced asthma (Anderson and Kipperlen 2008, Anderson and Daviskas 
2000). 
 
In summary, amplified increases in stress hormone release and compromised hydration status 
are known key factors influencing SFR. Whilst extreme physical exertion in hot ambient 
conditions may provoke greater perturbations in salivary variables; to date, the influence of 





examining the effects of S-AMP responses during repetitive bouts of extreme physical 
exertion in the heat.  
 
2.3.2 Exertional-Heat Stress, Circulatory Endotoxin Concentration and Cytokine 
Profile 
 
Exercise heat-induced thermal alterations can exacerbate GI tract functionality whereby the 
thermal effect of direct heat (hyperthermia) on epithelial cells is associated with increases in 
intestinal permeability in animal models (Hall et al. 2001, Oliver et al. 2012, Shapiro et al. 
1986). For example, high levels of hyperthermia (41.5-42.0°C) in sedated rats promoted 
increases in intestinal permeability as measured by Flurescein isothiocyanate (FITC)-dextran 
molecule (4000 Da), as well as hyperthermia-induced epithelial damage ((e.g., sloughing 
(shedding) of the epithelium, cellular swelling and vacuolization)) as assessed by histological 
analysis (Lambert et al. 2002). Such results suggest that the intestinal epithelium is 
responsive to changes in temperature. This was further reflected in a recent laboratory-
controlled study whereby an average increase of 54% in LPS after a 60 min run at 70% 
VO2max in hot ambient conditions (33°C and 50% RH) was observed, while no significant 
changes in LPS were observed in temperate ambient conditions (22°C and 62% RH); 
suggesting that exercising in hot ambient conditions may exacerbate intestinal epithelial 
integrity and promote translocation of larger quantities of bacterial endotoxins into the portal 
and systemic circulation (Yeh, Law, and Lim 2013). Such findings are supported by in vitro 
studies observing increases in tight junction permeability with exposure to temperatures of 
37°C to 41°C (Dokladny, Moseley, and Ma 2006). Several field-based studies have 
consistently shown increases in plasma endotoxin concentrations after endurance events 





Jeukendrup et al. 2000, Ng et al. 2008), although environmental conditions (e.g., Tamb and 
RH) in the majority of studies were not reported. It is therefore difficult to establish whether 
the increases in endotoxin translocation were in part, due to environmental stressors or other 
influencing factors. 
 
However, given that a comparably high Tcore  (>40°C) has been observed in both patients 
with heatstroke and in healthy active populations (Maron, Wagner, and Horvath 1977, 
Shapiro and Seidman 1990), hyperthermia-induced epithelial damage is implied as a pre-
requisite, facilitating but not triggering the pathological manifestations of heat stroke by 
promoting endotoxin translocation (Lim and Mackinnon 2006). Indeed, a 100-fold range 
difference in plasma endotoxin neutralising capacity between individuals has been observed 
(Warren et al. 1985), suggesting that the onset of heatstroke may be dependent on an 
individual’s endotoxin clearance capacity (i.e., threshold for endotoxin leakage). Such results 
were reflected in a laboratory-controlled study investigating that effects of heat-stress 
induced endotoxaemia in trained and untrained subjects before and after walking at 4.5 km·h 
(2% elevation) in a climatic chamber (40°C and 30% RH) wearing protective clothing until 
exhaustion. Untrained subjects had significantly greater increases in plasma endotoxin 
concentrations at exhaustion (14.5 pg·ml) compared with trained subjects (8.08 pg·ml), and a 
lower tolerance for thermal strain (Tre: 39.1°C ± 0.1°C and 39.7 ± 0.1°C in untrained and 
trained, respectively) (Selkirk et al. 2008).  
 
Prolonged physical exertion is an independent contributing factor of compromised intestinal 
epithelial integrity through exercise-induced splanchnic ischemia-hypoperfusion and tissue 
hypoxia (ter Steege et al. 2012). The addition of heat-stress (e.g., ambient conditions >30ºC), 





enhanced thermoregulatory strain, increased body water losses (e.g., sweating loses 
exceeding fluid intake) with accompanying hypovolaemia, and promotion of a progressive 
dehydrated state which collectively has the potential to further promote splanchnic 
hypoperfusion and disrupt intestinal epithelial integrity further (Lambert 2009, Wendt, van 
Loon, and Lichtenbelt 2007, van Wijck et al. 2011). For example, a study by Lambert et al. 
(2008) found that 60 min treadmill running at 70% VO2max without fluid intake resulting in 
1.5% BM loss significantly increased gastroduodenal and intestinal permeability as assessed 
by urinary sucrose excretion and the lactulose to rhamnose excretion ratio, compared to 
resting conditions. Additionally, epidemiological data on heat illness hospitalisations (n= 
5246) for the U.S Army from 1980 to 2002 found that dehydration was associated with 17% 
of the heat stroke cases documented (Carter et al. 2005), suggesting that the inability to 
maintain fluid balance during periods of EHS can modify an individual sensitivity and (or) 
accelerate pathological conditions such as exertional-heat stroke.  
 
To date, a number of studies have observed augmented increases in stress hormone (Brenner 
et al. 1998, Galbo et al. 1979, Laing et al. 2005) and cytokine (Cosio-Lima et al. 2011, Peake 
et al. 2008, Rhind et al. 2004, Satarifard et al. 2012, Starkie et al. 2005) responses during 
physical exertion in hot ambient conditions compared with more temperate ambient 
conditions. Indeed, the impact of changes in Tre induced by EHS and the influence on stress 
hormone and cytokine responses was investigated by Rhind et al. (2004) who found that a 40 
min cycle at 65% VO2max in hot water immersion (39°C) provoked an amplified increase in 
plasma cortisol (80%), epinephrine (>500%), norepinephrine (>350%) and cytokine 
responses (e.g., >90%, >400%, 150% and 150% in TNF-α, IL-6, IL-12 and IL-1ra, 
respectively) compared with cold water immersion (18°C). Interestingly, cold immersion 





responses, which in part, may explain the pathophysiology of exertional-heat illness in active 
populations exercising in hot ambient conditions.    
 
Whilst the classical cytokine response to moderate, physical exertion in thermoneutral 
conditions results in raised circulatory concentrations of anti-inflammatory cytokines and 
minimal changes in pro-inflammatory cytokines (Costa et al. 2014, Walsh et al. 2011a), 
prolonged physical exertion promotes augmented increases in circulatory concentrations of 
pro-inflammatory cytokines counteracted by anti-inflammatory cytokines (Camus et al. 1997, 
Camus et al. 1998, Nieman et al. 2001, Ostrowski et al. 1999, Ostrowski et al. 1998, Suzuki 
et al. 2002, Walsh et al. 2011a). Previous laboratory-controlled studies have consistently 
observed greater cytokine responses (e.g., IL-6, TNF-α, IL-1ra, and IL-10) in hot (32-39°C) 
conditions, compared with more temperate (15-22°C) conditions (Cosio-Lima et al. 2011, 
Peake et al. 2008, Rhind et al. 2004, Satarifard et al. 2012, Starkie et al. 2005); although the 
degree of impact from intestinal originated bacterial endotoxins was not confirmed. Such 
observations indicate that heat-stress appears to play a role in the degree of systemic 
cytokinaemia observed after physical exertion. Moreover, systemic endotoxin and cytokine 
responses have also been associated with symptomatic manifestations of GI symptoms 
(Jeukendrup et al. 2000, Lambert 2008, van Leeuwen et al. 1994) commonly associated with 
prolonged exposure to physical exertion and EHS (Øktedalen et al. 1992, Peters et al. 1999, 
Pfeiffer et al. 2012, Rehrer and Meijer 1991). 
 
During EHS, a persistent endotoxin-induced cytokine-mediated inflammatory response 
appears to be a key feature in the aetiology of exertional-heat illnesses (i.e., exertional-heat 
stroke) with fatalities being acknowledged and resulting SIRS. Indeed, episodes of clinical 





inflammatory response syndrome) in military, occupation and sporting populations 
(Armstrong et al. 2007, Hunt, Parker, and Stewart 2013, Nag, Nag, and Ashtekar 2007, Rav-
Acha et al. 2004, van Leeuwen et al. 1994, Xiang et al. 2014). For example, from 1992-2002, 
diagnosed cases of heat stroke (n= 134) were reported in military personnel during infantry 
training in hot ambient conditions. Of these, mortality incidence of heat stroke (n= 6) was 
reported to be due septic shock, in which SIRS is a key feature (O’Connor et al. 2010, Rav-
Acha et al. 2004). A persistent endotoxin-induced cytokine-mediated inflammatory response 
may be further exacerbated by repetitive bouts of extreme physical exertion (e.g., multi-stage 
ultra-marathon events) with insufficient recovery. This is associated with unexplained 
underperformance syndrome, possibly caused by excessive cytokine release instigating a 
chronic systemic inflammatory state and ‘cytokine sickness’ (Robson 2003), chronic fatigue 
syndrome and (or) accumulative perturbations in immune function. 
 
From a practical perspective, competing in multi-stage ultra-endurance competition exposes 
active populations to consecutive days of EHS. This population may thus be pre-disposed to 
sub-clinical (e.g., GI symptoms) and clinical (e.g., exertional-heat illnesses and sepsis) 
manifestations potentially originating from loss of intestinal epithelial integrity. Indeed, mild 
endotoxaemia, cytokinaemia, and GI symptoms have been reported after marathon (Camus et 
al. 1997) and Ironman triathlon (Jeukendrup et al. 2000) events, which were also associated 
with decrements in overall performance (Pfeiffer et al. 2012). 
 
To date, exercise immunology research in ultra-endurance sports is limited (Murray and 
Costa 2012), with no research exploring and tracking intestinal permeability of endotoxins 
and cytokine profile during multi-stage ultra-marathon competition. Besides the consecutive 





previously been acknowledged as predisposing factors in the aetiology of fatal incidence of 
heat stroke and SIRS (Armstrong et al. 2007, O’Connor et al. 2010, Rav-Acha et al. 2004, 
Walsh et al. 2011b). These include inadequate recovery opportunities, sleep deprivation, and 
acute periods of compromised hydration and (or) nutritional status (Costa et al. 2013a, Costa 
et al. 2013b). Moreover, the predominant characteristics of those individuals generally 
observed (e.g., recreationally active population, not acclimatised to ambient conditions, 
training status suboptimal for degree of physical exertion required, high body fat, high 
motivation, and situation of compromised immune status) are also reported to be aetiological 
predisposing factors (Walsh et al. 2011b). 
 
In summary, previous findings support the notion that prolonged and (or) extreme physical 
exertion in hot ambient conditions poses a greater threat to intestinal epithelial integrity, 
leading to increases in intestinal permeability, an endotoxin-induced cytokine-mediated 
inflammatory response and subsequent sub-clinical or clinically significant episodes with 
fatal outcomes being reported. Notably, extreme physical exertion such as competitive ultra-
endurance events meet all of the above requirements for SIRS (Suzuki et al. 2000, Suzuki et 
al. 1999), while chronic altered cytokine responses may promote undefined 
underperformance and chronic fatigue syndromes. 
 
2.4.1 Probiotics and Intestinal Integrity 
 
The GI tract is colonised by a plethora of microorganisms (~1000 species) which have the 
potential to promote either beneficial or harmful effects on GI integrity, function, and overall 
health (Gareau, Sherman, and Walker 2010, Holzapfel et al. 1998, Murguía-Peniche et al. 





relatively sparse in the stomach and duodenum (e.g., x 101 to x 103), gradually increasing to x 
104 to x 107 in the jejunum and ileum, and achieving concentrations of up to 1012 cells per 
gram (dry weight) (35-50% of the volume of colonic contents) in the large intestine (O’Hara 
and Shanahan 2006). Colonic microflora interact with the intestinal epithelium, stimulating 
immunomodulatory effects. These interactions represent a functionally paradoxical 
relationship whereby some defence mechanisms (e.g., mucus membranes, secretion of AMPs 
such as IgA, lysozyme, proteases and defensins) aim to prevent penetration of pathogens and 
inflammation, whilst others (e.g., structured lymphoid sites such as Peyer’s patches and 
lymphoid follicles) aim to sample bacteria in the intestinal lumen to initiate adaptive immune 
responses (Sansonetti 2004). Indeed, enterocytes bear pattern-recognition receptors (PPRs) 
such as the membrane-associated Toll-like receptors (TLRs) which interact with pathogen-
associated molecular patterns (PAMPs) present on colonic microflora (and pathogens) 
(Akira, Takeda, and Kaisho 2001). In the majority of cases, ligand recognition by PPRs 
induce the production of pro-inflammatory cytokines. For example, the major ligand for 
endotoxin is TLR-4; this interaction activates enterocytes, triggering an intracellular cellular 
cascade and release the transcription NF-кB leading to the subsequent transcription and 
expression of localised pro-inflammatory cytokines which is appropriately downregulated by 
anti-inflammatory cytokines in order to prevent chronic inflammation of the intestinal 
epithelium (Walker 2008). 
 
All individuals have the predominant genera of colonic microflora (e.g., Bacteroides, 
Eubacterium, Bifidobacterium and Peptostreptococcus species) detectable in faeces. 
However, there is considerable inter-individual variation in the species composition and 
diversity, which can fluctuate under particular circumstances (e.g., antibiotic therapy and 





serves to maintain homeostasis of the mucosal epithelium and modulate innate and adaptive 
immune responses via a number of specific metabolic, immunological and structural 
functions. Indeed, colonic microflora can de novo synthesise vitamins (e.g., vitamin K and 
most B vitamins) (Conly et al. 1994, Hill 1997, LeBlanc et al. 2013) and promote 
micronutrient absorption (e.g., calcium, magnesium, and iron) (Miyazawa et al. 1996, 
Younes et al. 2001). The major metabolic function of colonic microflora is the fermentation 
of substrates (i.e., non-digestible dietary carbohydrates; e.g., resistant starches, cellulose, 
pectins and gums) to generate readily absorbed short-chain fatty acids (SCFAs); in particular 
butyrate, acetate and propionate. SCFAs provides the major energy source for colonic 
microbial growth and intestinal epithelial cells (i.e., proliferation and differentiation; Frankel 
et al. 1994), in addition to involvement in cellular processes such as modulation of 
inflammation and oxidative stress (e.g., exerting anti-carcinogenic and anti-inflammatory 
activity via inhibition of pro-inflammatory cytokines such as IFN-γ) (Hamer et al. 2008, Inan 
et al. 2000, Lührs et al. 2002, Segain et al. 2000, Vinolo et al. 2011a, Vinolo et al. 2011b), 
and enhancement of intestinal epithelial integrity via regulating the assembly of tight junction 
proteins (Peng et al. 2009). 
 
Furthermore, complex interactions between colonic microflora and the intestinal epithelium 
which harbours MALT and intra-epithelial lymphocytes appears to promote mucosal immune 
modelling and competency. For example, undeveloped mucosal immunity (e.g., hypoplastic 
Peyer’s patches containing few germinal centres and reduced numbers of plasma cells) in 
germ-free animal models has previously been observed (Cash and Hooper 2005, Macpherson 
and Harris 2004), suggesting that colonic microflora is necessary for optimal immune 
functioning and the driving force behind adaptive immune development in the GI tract. 





surface of the intestinal epithelium. For example, exogenous microorganisms with pathogenic 
properties may have difficulty colonising and becoming established within the GI tract since 
they have to directly compete with the colonic microflora for space, nutrients and attachment 
sites (Canny and McCormick 2008, Kamada et al. 2013).  
 
Probiotics are defined as viable non-pathogenic microorganisms that, when administered in 
adequate amounts, confer a health benefit to the host (WHO/FAO 2002), of which the most 
commonly studied and traditionally used probiotic species in fermented dairy products 
belong to the Lactobacillus and Bifidobacterium anaerobic species. These species are known 
to colonise the GI tract in the majority of humans. The major functional effects of probiotics 
firstly refer to their ability to alter the composition of the colonic microflora (e.g., altering the 
ratio of pathogenic to non-pathogenic bacteria by increasing numbers and (or) activity of 
non-pathogenic bacteria) and promote re-establishment of balanced microflora and 
homeostasis; for example, Bifidobacterium has been shown to inhibit the activity of gram-
positive and gram-negative bacteria (Gibson and Wang 1994). Secondly, to interfere with and 
prevent pathogen adherence (i.e. displacing pathogens), colonisation and overgrowth by 
competitively adhering to epithelial cells (i.e., binding to and occupying adhesion receptor 
sites) (Altenhoefer et al. 2004). Thirdly, to stimulate selected aspects of innate and adaptive 
immune function (e.g., pro- and anti-inflammatory cytokine production, IgA and mucin 
secretion) (Otte and Podolsky 2004, Salminen, Isolauri, and Salminen 1996, Qiao et al. 
2002); for example, Bifidobacterium and Lactobacillus have been shown to initiate 
production of AMPs which express adhesive properties (Servin 2004), in addition to other 
metabolic molecules (e.g., SCFAs); and fourthly, to enhance tight junction stability (Otte and 
Podolsky 2004, Seth et al. 2008). Additionally, novel mechanisms of action by which 





activated receptor gamma (PPARγ), a nuclear receptor that is expressed largely in the colon 
that regulates intestinal inflammation (i.e., interferes with inflammatory signalling pathways) 
through inhibition of NF-кβ. For example, studies in vitro have reported up-regulation of 
PPARγ expression ((messenger ribonucleic acid (mRNA) and protein levels)) and supressed 
pro-inflammatory cytokine responses (e.g., TNF-α) with L.casei and L.GG Saccharomyces 
boulardii probiotic strains (Eun et al. 2007, Isolauri et al. 2001, Majamaa and Isolauri 1997). 
Collectively, these functional effects of probiotics may assist in the maintenance of intestinal 
epithelial integrity, preventing increases in intestinal permeability, translocation of bacterial 
endotoxins and a resultant cytokine-mediated inflammatory response. The use of probiotics in 
reducing intestinal permeability and endotoxin leakage has been substantiated in animal 
(Isolauri et al. 1993) and human studies (Salimen et al. 1996), subsequently leading to 
probiotic research within the last decade diversifying into the area of sport and exercise 
immunology (Clancy et al. 2006, Cox et al. 2010b, Kekkonen et al. 2007, Shing et al. 2013); 
although, to date, the efficacy of probiotic supplementation in general healthy population 
groups is limited, including active populations. Therefore, Chapter 8 and Chapter 9 aimed 
to determine the influence of probiotic supplementation on selected immune variables in an 
active population group.  
 
Research has attempted to address the mechanistic action of probiotics with a number of 
studies reporting improvements in intestinal epithelial integrity, immunological parameters 
and (or) clinical outcomes in vitro, in vivo and in a limited number of human studies 
(Kekkonen et al. 2007, Liu and Rhoads 2013, Mack et al. 2003, Mattar et al. 2002, Möndel et 
al. 2009, Schlee et al. 2008, Wehkamp et al. 2004). However, valid conclusions about the 
health benefits of probiotics have yet to be made due to the inconsistencies in reported 





approaches employed. For example, the use of different probiotic strains (e.g., bioavailability 
and level of activity), probiotic dose provided, criteria used to define an illness episode (i.e., 
URSI or GI episode) duration of treatment (i.e., supplementation) period, route of 
administration (e.g., yogurt, beverage, liquid form, freeze-dried tablet form and mucosal 
spray), differences in patient characteristics (e.g., severity of the clinical condition, present 
microflora composition, current immunological state and age) and subjective data 
interpretation. Recent meta-analysis and systematic reviews of randomised controlled trials 
have yielded inconsistent results (Hempel et al. 2012, Hoveyda et al. 2009, McFarland and 
Dublin 2008), potentially questioning the clinical relevance of probiotics. Additionally, major 
concerns exist around the effectiveness of commercially available probiotics since the 
effectiveness of a particular probiotic strain is dependent upon whether it is resistant and 
viable to industrial handling, processing and preparation methods. For example, liquid-form 
fermented dairy products containing probiotics have a relatively short shelf life in their active 
form and bacterial damage may occur through the pasteurization or centrifugation process 
and (or) the use of additives and preservatives (Marteau 2001). Whilst the process of freeze-
drying powdered probiotics (e.g., tablet form) may cause bacterial damage, resulting in poor 
colonisation and survival in the GI tract and (or) upon water absorption whereby bacteria may 
become activated, then cease (Sekhon and Jairath 2010). Furthermore, previous research has 
indicated that commercially available probiotics in the UK may lack the number of 
microbiota otherwise stated (Hamilton-Miller, Shah, and Smith 1996), possibly due to the 
practicalities surrounding handling, processing, preparing, storage and transportation of the 
probiotic product. Finally, given that the GI tract provides a multifaceted and hostile 
environment to many microorganisms, it could be questioned as to whether ingested 






Given that probiotics have been shown to modulate various innate and adaptive aspects of 
immune function (Delcenserie et al. 2008, Isolauri et al. 2001), it is theoretically plausible 
that ingestion of large volumes of probiotics may create excessive stimulation, aggravation 
and (or) inflammation of the mucosal immune system in the GI tract leading to systemic 
infections and detrimental metabolic activities (Marteau 2001). Moreover, clinical studies 
using probiotics have reported substantial inter-individual variation whereby some 
individuals have had favourable outcomes whilst others have not (responders vs. non-
responders) (Reid et al. 2010). The limited understanding of the mechanistic action of 
probiotics is a major disadvantage when attempting to address whether a particular probiotic 
strain is likely to induce immuno-enhancing or immuno-suppressing effects which may be 
considered protective or harmful (e.g., pathogenic, toxic) to the host. It is possible that under 
certain conditions and (or) in certain individuals, probiotics may fail to maintain intestinal 
epithelial integrity and promote translocation of large molecular weight molecules such as 
endotoxins or induce infections themselves (Sanders et al. 2010). For example, in ‘high-risk’ 
individuals (e.g., untrained, illness-prone, history of GI-related issues) that participate in 
extreme exercise in extreme environmental conditions, amplified disturbances to intestinal 
epithelial integrity may increase the risk of clinically significant episodes including sepsis. 
 
The general consensus is that probiotics are safe in healthy population groups (Boyle, 
Robins-Browne, and Tang 2006) and side effects (if any) tend to be mild, with large doses 
failing to exhibit any toxicity (Ahmed et al. 2007, Holzapfel et al. 1998, Larsen et al. 2006, 
Sekhon and Jairath 2010). To date, research investigating the dose-response of probiotic 
supplementation (typical dosages: x 1010 CFU·100ml-1·day-1) and the ‘ideal’ dose to induce a 
definitive pharmaceutical effect on S-AMP responses is absent. Adverse probiotic effects are 





weak experimental designs lacking rigour and power (e.g., small participant numbers) are 
implemented (Dunne et al. 2001).   
 
In summary, whilst limited studies have shown that probiotic supplementation may provide 
some immunological benefit, the mechanisms of action of probiotics are yet to be fully 
elucidated, whilst their efficacy in attenuating and (or) preventing illness requires further 
exploration. The potential use of probiotics in clinical health conditions (e.g., irritable bowel 
syndrome) has since generated interest in other sub-groups (e.g., active populations). 
However, very few studies in active populations have investigated probiotic supplementation 
on immunological parameters and (or) clinical illness symptoms; thus overall results have 
yielded insufficient evidence to provide recommendations in active populations. Chapter 8 
and Chapter 9 aimed to explore the use of probiotic supplementation as a potential 
nutritional strategy in active population groups. 
 
2.4.2 Probiotics, Salivary Anti-Microbial Protein Responses and Physical Exertion 
 
With the considerable personal and economic investment in training and competition, it is 
crucial for active populations to maintain host defence, thus minimising the risk of clinically 
significant outcomes (e.g., URSI) that may negatively affect exercise performance. Although 
considered medically harmless in sedentary populations, sub-clinical or clinically significant 
outcomes in athletes may result in competing at a sub-optimal level or missing the event 
completely (West et al. 2009). Therefore, the immunostimulating properties of probiotics 
may induce a small worthwhile effect on host defence and possibly a favourable option 
amongst active populations to minimise perturbations to oral respiratory mucosal immunity. 





tract, exerting a desirable influence at other mucosal sites (e.g., URT) and prevent common 
cold or Influenza symptoms. For example, a systematic review of randomised controlled trials 
showed that probiotics may be a more favourable option over placebo in attenuating the 
incidence, severity and duration of acute URTI in healthy population groups (Berggren et al. 
2011, Hao et al. 2011), and in sub-groups of the population, including the elderly and 
children (Leyer et al. 2009, Makino et al. 2010). Additionally, it has been suggested that 
probiotics may exert their therapeutic effects in the oral respiratory pathway through direct 
contact, interaction and adherence to the mucosal epithelium (Stamatova and Meurman 
2009). Although athletes are not considered immunocompromised, the transient depressions 
in salivary variables following physical exertion may justify their use as a nutritional adjunct 
pre and (or) during periods of intensified training and (or) competitive events (Gleeson et al. 
2011a, West et al. 2009). For example, practical barriers to consistently meeting nutritional 
and (or) hydration requirements during prolonged physical exertion commonly exist (Costa et 
al. 2013a, Costa et al. 2013b). Consequently, probiotics may have particular relevance for 
active populations partaking in prolonged physical exertion, especially when performed in 
hot ambient conditions when oral-respiratory mucosal immune status is more likely to be 
compromised compared with exertional stress in temperate conditions.  
 
Currently, a limited number of studies have investigated the influence of probiotic 
supplementation amongst highly trained athletes on oral-respiratory mucosal immunity with 
conflicting results. Recently, significantly higher S-IgA concentrations were observed in 
active individuals during and after four months of winter training after consuming a 
fermented milk drink containing L. casei Shirota (two 65ml bottles containing 6.5 x 109 CFU 
each). In this study, participants were randomised to probiotic or placebo. Whilst no 





S-IgA concentration was significantly higher at eight and sixteen weeks in the probiotic 
group compared with placebo. This was further reflected in a lower mean number of URTI 
symptom weeks in the probiotic group (1.9 ± 1.5) compared to placebo (3.5 ± 2.0), and a 
lower mean number of URTI episodes in the probiotic group (1.2 ± 1.0) compared to placebo 
(2.1 ± 1.2) (Gleeson et al. 2011a). However, S-IgA secretion rates were not reported. Given 
that reporting concentration values alone do not take into account potential changes in saliva 
flow rate, these results are limited in their interpretation. Conversely, a study involving elite 
male distance runners (n= 20) over a four month period of winter training observed no 
significant changes in S-IgA concentration after ingestion of a freeze-dried probiotic powder 
capsule containing 1.2 x 1010 CFU·day. Still, less than half the number of URT and LRT 
episodes were reported in the probiotic group (n= 4) compared with placebo (n= 9) and the 
number of total illness days was significantly less (30 illness days vs. 72 illness days in 
probiotic and placebo, respectively), although the mean URT and LRT episode duration did 
not differ between groups (Cox et al. 2010b). Furthermore, three weeks of military training 
followed by a five day combat course did not induce changes in S-IgA concentration between 
probiotic (a fermented milk drink containing L. casei strain DN-114 001) and placebo at any 
of the four saliva sampling time points; although S-IgA concentration was significantly lower 
after the five day combat course in placebo, whereas S-IgA concentrations did not change 
over time throughout the study period in the probiotic group. However, medical examinations 
assessing URT and LRT infections confirmed that no differences were observed in those 
subjects who presented at least one infection during the study period (46%; n=11 vs. n=13; 
57% in probiotic and placebo, respectively). Moreover, no differences were observed in RTI 
incidence (0.8 ± 0.2 vs. 0.6 ± 0.1 in probiotic and placebo, respectively), nor in the duration 
of symptoms (5.5 ± 1.6 vs. 6.1 ± 1.7 in probiotic and placebo, respectively) between the 





period, the majority of participants in the probiotic group experienced rhinopharyngitis 
(70%), whereas diagnosed symptoms in the placebo group were more evenly distributed (e.g., 
40% rhinopharyngitis, 20% bronchitis and 17% tonsillitis) These findings suggested that 
infections were predominantly confined to the nasopharyngeal area and that probiotic 
supplementation may have prevented the spread of infection beyond the respiratory tract 
(Tiollier et al. 2007). Similarly, S-IgA secretion rate was not reported. 
 
A further randomised, double-blind intervention study investigating probiotic 
supplementation (2 x 65ml milk drink containing a total of 4.0 x 1010 of Lactobacillus 
rhamnosus GG (LGG) or 2 capsules containing a total of 1 x 1010 LGG)) during a three 
month training period prior to a marathon race reported no differences in number of healthy 
days (79.0 vs. 73.4 days in probiotic and placebo, respectively). Additionally, no differences 
were observed in the number of participants with a self-reported URTI episode (46% vs. 37% 
in probiotic and placebo, respectively), in the duration of those individuals who reported an 
URTI (6.3 days vs. 7.9 days in probiotic and placebo, respectively), nor in the two week 
follow-up period after the marathon between groups (Kekkonen et al. 2007). On the contrary, 
powered-form single-strain probiotic supplementation (Bifidobacterium animalis subsp. lactis 
Bl-04, 2.0 × 109 CFU·day) for one-hundred and fifty days in healthy active individuals was 
associated with a significant reduction (27%) in URTI episode risk, and a non-significant 
reduction (19%) with powdered-form multi-strain probiotic supplementation (Lactobacillus 
acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07, 5 × 109 CFU·day) 
compared with placebo (West et al. 2014). Moreover, multi-strain probiotic supplementation 
(L. gasseri PA 16/8, B. longum SP 07/3, B. bifidum MF 20/5) over a three month training 
period significantly decreased the mean duration of self-reported common cold episodes, 





episodes in the probiotic and placebo group, respectively) (de Vrese et al. 2005). Finally, a 
randomised controlled trial involving eleven weeks of probiotic supplementation (minimum 
of 1 × 109 Lactobacillus fermentum) in competitive cyclists observed no differences in S-IgA, 
S-lysozyme or S-lactoferrin concentrations between probiotic and placebo (West et al. 2011). 
The authors reported large within- and between-subject variability in the AMPs measured and 
ambiguity of clinical outcomes (self-reported URTI) (West et al. 2011). Notably, with the 
more recent development of a ‘non-infectious’ hypothesis, it could be speculated that the 
previous positive impacts of probiotic supplementation may target inflammation suppression 
rather than prevention and (or) attenuation of pathogen infection via anti-inflammatory 
mechanisms such as the upregulation of anti-inflammatory cytokines, IgA and mucin 
production. 
 
Collectively, results suggest that probiotic supplementation in active populations may induce 
favourable changes in S-IgA. However, all probiotic studies, with the exception of one, have 
solely reported S-IgA responses in the assessment of oral-respiratory mucosal immune status. 
Given the protective properties of other S-AMPs, probiotic studies to date are currently 
limited in their interpretation of the exerted influence on oral-respiratory mucosal immune 
status. Moreover, the majority of studies establish the existence of an URTI through self-
reported measures, without determining the causality of the URTI (e.g., pathogen presence 
through medical diagnosis). This is considered important to identify for the tailoring of a 
treatment plan which differs depending on whether the URTI is infectious or non-infectious. 
Additionally, S-IgA secretion rate has not been reported in any of the aforementioned studies, 
which is surprising given the exercise-induced changes on SFR. To date, research 
investigating the influence of probiotic supplementation on S-AMP responses during EHS 





Although S-IgA does not appear to be affected by exercise (≤2 h) in environmental extremes 
in laboratory-controlled studies (Housh et al. 1991, Laing et al. 2005, Walsh et al. 2002), 
extreme physical exertion (e.g., single- or multi-stage ultra marathon events) in addition to 
heat-stress with accompanying physiological stressors is likely to perturb oral-respiratory 
mucosal immune status to a greater extent.  
 
Given that probiotics are ingested orally and inevitably come into direct contact with oral 
mucosal surfaces, another mechanism in which probiotics may induce health-promoting 
effects is directly through modification of the oral microbial ecology. Analogically to the GI 
tract, it is plausible that adherence to mucosal surfaces, competition for adhesion receptors 
and (or) modification of the pellicle may favourably impact upon enhancing host defence. To 
date, studies have shown that probiotics may affect the oral ecology (e.g., preventing 
adherence of other microorganisms, modifying protein composition of the salivary pellicle) 
through temporary colonisation (Haukioja et al. 2008). Equally, colonisation potential and 
binding efficacy to the oral mucosa appears to be strain-specific (Haukioja et al. 2006), whilst 
unaltered S-IgA concentrations have been reported after three weeks of probiotic 
supplementation (Kekkonen et al. 2007, Paineau et al. 2008).  
 
In summary, previous research suggests that probiotic supplementation may play a role in 
attenuating and (or) preventing URSI during periods of compromised oral-respiratory 
mucosal immune status. Given that prolonged physical exertion is associated with significant 
depressions in S-IgA and an increased susceptibility to URSI; and probiotics have the 
potential to stimulate aspects of the immune system beyond the GI tract, probiotic 
supplementation in the weeks leading up to competitive endurance and ultra-endurance 





counteract the depressions in oral-respiratory mucosal immune status. However, to date, the 
efficacy of probiotics on salivary immune variables in active populations is extremely 
limited. 
 
2.4.3 Probiotics, Endotoxaemia and Physical Exertion 
 
Despite unsubstantiated claims, commercially available probiotics (e.g., L.casei) products 
dominate the global gut-health market (Cummings et al. 2004), increasing in popularity 
amongst active populations; with reported focus on prevention-management of GI related 
symptoms (e.g., traveller’s diarrhoea) (Sazawal et al. 2006, Tillett and Loosemore 2009). It 
has been suggested that probiotics may play a beneficial role in the maintenance of gut-
barrier function in active populations, potentially counteracting the disturbances to intestinal 
epithelial integrity and preventing or attenuating the manifestation of GI symptoms.  
 
Probiotics have been shown to exert protective effects and contribute to intestinal epithelial 
integrity through a number of different mechanisms. Firstly, by inhibiting pathogenic activity 
through production of anti-microbial substances and preventing pathogenic colonisation and 
translocation of the intestinal epithelium through competitive adherence for cell surface 
receptors. Indeed, studies in vitro and in vivo have shown up-regulation of mucin and β-
defensin gene expression in intestinal epithelial cells, augmenting mucus and β-defensin 
secretion (Mack et al. 2003, Mattar et al. 2002, Möndel et al. 2009, Otte and Podolsky 2004, 
Schlee et al. 2008, Wehkamp et al. 2004) and production of substances such as SCFAs, 
hydrogen peroxide, nitric oxide and bacteriocins (Atassi and Servin 2010, Chenoll et al. 
2010, Corr, Hill, and Gahan 2009). Secondly, through stimulation of innate and acquired 





cells ((e.g., IL-8), anti-inflammatory cytokines (e.g., IL-10) from dendritic cells and S-IgA 
(Hart et al. 2004, Liu and Rhoads 2013, Vizoso Pinto et al. 2007); and thirdly, through 
regulation and stabilisation of the intestinal epithelial cell barrier (i.e., modulating 
homeostasis). For example, secretion of probiotic proteins (e.g., p75 and p40) with apparent 
anti-inflammatory effects which activate Akt (i.e., protein kinase B1). Akt protects intestinal 
epithelial cells from apoptosis (Otte and Podolsky 2004, Seth et al. 2008).  
 
A systematic review of randomised controlled trials on the impact of probiotics on GI health 
has demonstrated favourable effects of probiotic bacteria (e.g., L.casei) on markers of 
intestinal epithelial integrity; albeit within inflammatory gut diseases (Moayyedi et al. 2010). 
In animal models, multi- and single-strain probiotic supplementation has been shown to be 
effective in maintaining intestinal epithelial integrity in animals with sepsis, colitis and 
alcohol-induced intestinal integrity and liver injury (Ewaschuk et al. 2007, Mennigen et al. 
2009, Wang et al. 2012). While in human models, single-strain probiotics have also been 
shown to induce favourable changes on tight junction and intestinal epithelium integrity 
(Anderson et al. 2010, Resta-Lenert and Barrett 2006, Ukena et al. 2007, Qin et al. 2009). 
For example, Karczewski et al. (2010) observed increases in the expression of tight junction 
proteins (zonula occludens and occludin) after probiotic administration (Lactobaccilus 
plantarum) through an intraduodenal feeding catheter. Indeed, a recent randomised controlled 
trial investigated the influence of a multi-strain probiotic supplementation (Bifidobacterium 
bifidum W23, Bifidobacterium lactis W51, Enterococcus faecium W54, Lactobacillus 
acidophilis W22, Lactobacillus brevis W63, Lactococcus lactis W58) containing 1010 
CFU·day on tight junction competency and intestinal permeability in endurance trained males 
(n= 23) by measuring faecal concentrations of zonulin (a surrogate marker of impaired 





study showed that zonulin, a protein synthesised by intestinal epithelial cells that modulates 
the permeability of intercellular tight junctions whereby increased concentrations indicate 
increased intestinal permeability, significantly decreased in faeces after fourteen weeks in the 
probiotic group (>20%; p= 0.019) compared with placebo and; although failing to reach 
significance (p= 0.054), reduced concentrations of TNF-α compared to placebo after fourteen 
weeks. The authors concluded that probiotic supplementation can initiate improvements in 
intestinal epithelial integrity and reduce intestinal permeability (Lamprecht et al. 2012). 
However, this study focused solely on zonulin. The inclusion of a wider range of biochemical 
and stool markers would have allowed for a deeper mechanistic insight, in addition to a more 
comprehensive overview of intestinal permeability. Moreover, Christensen et al. (2006) 
established that as dosage of probiotic supplementation (e.g., Bifidobacterium animalis ssp. 
lactis x 1010 vs. x 1011 CFU·day-1) increases, the proportion of bacteria specific positive 
subjects also increases (i.e., 40% vs. 90%, respectively). A further randomised controlled trial 
involving eleven weeks of probiotic supplementation (minimum of 1 × 109 Lactobacillus 
fermentum) in competitive cyclists reported attenuated exercise-induced changes in pro- and 
anti-inflammatory cytokines (IL-1ra, IL-6, IL-8, IL-10, IFN-γ and TNF-α) when adjusted for 
mean training load, although no significant differences in resting cytokine concentrations 
from pre- to post-supplementation were observed between groups, with no associations with 
illness symptoms. Notably, the number and duration of mild GI symptoms were 2-fold 
greater in the probiotic group, possibly reflecting the introduction of additional bacterial 
species and subsequent adaptive changes in the GI tract; although severity of GI symptoms 







To knowledge, only one study has investigated the influence of probiotics on circulatory LPS 
concentrations and cytokine profile following exercise. In contrast to results reported by 
Lamprecht et al. (2012), Shing et al. (2013) demonstrated that despite 4 weeks of multi-strain 
probiotic (Lactobaccilus, Bifidobacterium, Streptococcus) supplementation (i.e., modest dose 
of 4.510 CFU·day-1),  no significant differences in pre- and post-exercise (incremental run to 
fatigue at 80% ventilatory threshold in hot ambient conditions; 35°C and 40% RH) 
circulatory plasma LPS concentrations, or the ratio of urinary lactulose to rhamnose were 
observed between probiotic and placebo in male runners (n= 10). Similarly, no significant 
differences in cytokine profile (IL-6, TNF-α, IL-1ra and IL-10) were observed between 
groups (Shing et al. 2013). These outcomes were however in response to short duration, high 
intensity exercise, with relatively short heat exposure time (<40 min at 35˚C), and modest 
rises in Tcore (38.1˚C). Whilst perturbations to intestinal epithelial integrity are more likely to 
be amplified with longer duration exercise and the duration of the exercise implemented in 
this study does not reflect endurance populations, Chapter 9 aimed to determine the 
influence of probiotic supplementation during a 2 h bout of EHS. 
Notably, in an in vitro human colonic microbiota model, daily administration of some 
specific probiotics strains belonging to the Lactobacillus and Bifidobacterium species for 
fourteen days have been shown to reduce concentrations of gut-derived LPS which was 
positively and significantly correlated with cytokine production (e.g., TNF-α and IL-1β) 
(Rodes et al. 2013). These results suggest that the pro-inflammatory cytokine tone can be 
attenuated if intestinal epithelial integrity can be maintained through probiotic use. Indeed, it 
has been suggested that attenuating cytokine responses such as IL-6 during exercise may 
reduce susceptibility to unexplained underperformance syndrome (Robson 2003). Moreover, 
given the potential for an endotoxin-induced cytokine-mediated inflammatory response 





probiotic supplementation in the weeks leading up to endurance and ultra-endurance events 
may be justified. Despite this, no research exists examining the effects of probiotics during 
prolonged physical exertion in the heat (Brock-Utne et al. 1988, Bosenberg et al. 1988, 
Camus et al. 1998, Camus et al. 1997, Jeukendrup et al. 2000, Ng et al. 2009). It is plausible 
that using probiotics as a preventative measure to counteract disturbances to intestinal 
epithelial integrity may also attenuate or prevent symptomatic manifestations of GI 
symptoms in active populations, although this has yet to be substantiated.  
 
To date, a limited number of studies have assessed the efficacy of probiotic supplementation 
on GI symptoms amongst active population groups, with inconclusive results. For example, 
probiotic supplementation (2 x 65ml milk drink containing a total of 4.0 x 1010 of 
Lactobacillus rhamnosus GG (LGG) or 2 capsules containing a total of 1 x 1010 LGG)) 
during a three month training period prior to a marathon race was shown to reduce the 
duration of GI symptoms by 33% compared with placebo, and by 57% in the two week 
follow-up period after the marathon compared with placebo. However, no differences in the 
frequency of GI symptom episodes were observed during the training period nor in the two 
week follow-up period after the marathon between groups (Kekkonen et al. 2007). 
 
In summary, previous research has suggested that probiotic supplementation may enhance 
gut-barrier function. However, to date, the efficacy of probiotics in counteracting 
disturbances to intestinal epithelial integrity (e.g., increases in intestinal permeability and a 
subsequent endotoxin-induced cytokine-mediated inflammatory response) in active 
populations is extremely limited. Whilst the impact of probiotic supplementation during 
prolonged physical exertion, especially in hot ambient conditions when intestinal epithelium 





2.5.1 Thesis Aims 
 
The presented literature suggests that participating in prolonged or extreme physical exertion 
with or without heat-stress, but with accompanying physiological stressors has the potential 
to perturb oral-respiratory mucosal immunity, potentially increasing the risk of URSI. 
Additionally, prolonged or extreme physical exertion with or without heat-stress is associated 
with disturbances to intestinal epithelial integrity and a systemic endotoxin-induced cytokine-
mediated inflammatory response which is a key feature in the aetiology of exertional-heat 
illnesses. While chronic altered cytokine responses may play a role in the aetiology of 
undefined underperformance and chronic fatigue syndromes (Morris et al. 2014, Robson 
2003). It is plausible that participating in extreme physical exertion (e.g., single- or multi-
stage ultra-marathon events) with or without heat-stress, but with accompanying 
physiological stressors, may amplify and (or) instigate cumulative perturbations to oral 
respiratory mucosal immunity and (or) intestinal epithelial integrity. Furthermore, the 
presented literature suggests that probiotics may have a role to play in preventing 
perturbations to oral respiratory mucosal immunity, support in the maintenance of intestinal 
epithelial integrity and attenuate and (or) prevent sub-clinical or clinically significant 
episodes in active population groups. Although research investigating the potential use of 
probiotic supplementation during prolonged physical exertion is extremely limited, the 
presence of other key factors (e.g., amplified circulatory stress hormone release and 
compromised hydration status) associated with prolonged physical exertion plus heat-stress 
may further justify the use of probiotics in these higher-risk situations. 
 
With this information in mind, the broad aims of the studies contained within this thesis were 





24 h continuous over-night ultra-marathon in temperate ambient conditions on S-AMP 
responses, stress hormone response and incidence of URS; 2. the effects of a multi-stage 
ultra-marathon in hot ambient conditions, and a 24 h continuous over-night ultra-marathon in 
temperate ambient conditions on circulatory endotoxin concentration, cytokine profile and 
incidence of GI symptoms; and finally, 3. acute high dose supplementation of L. casei on S-
AMP responses, circulatory endotoxin concentration and cytokine profile in response to EHS. 
 
It was hypothesised that: 1. a multi-stage ultra-marathon performed in hot ambient conditions 
would depress salivary variables, leading to an increased reports of URS in ultra-endurance 
runners (UER); 2. a 24 h continuous overnight ultra-marathon performed in temperate 
ambient conditions would depress salivary variables, leading to an increased reports of URS 
in UER; 3. a multi-stage ultra-marathon performed in hot ambient conditions would initiate 
progressive increases in endotoxaemia, mirrored by a cytokinaemic response which 
correlated with GI symptoms in UER; 4. a 24 h continuous overnight ultra-marathon 
performed in temperate ambient conditions would initiate pronounced increases in 
endotoxaemia, mirrored by a cytokinaemic response which correlated with GI symptoms in 
UER; and finally, 5. enhanced S-AMP responses would be seen after one week of 
supplementation of L.casei, after EHS, and during the recovery period compared with 
placebo; additionally, decreases in circulatory endotoxin concentrations and cytokine profile 












3.1 Ethical Approval  
 
Prior to the commencement of each study, approval was received from the Local Ethics 
Committee (Coventry University) that conformed to the 2008 Helsinki Declaration for 
Human Research Ethics. All participants were made fully aware of the nature and purpose of 
each study, and the risks and benefits were fully explained, both verbally and in a written 
format via participant information forms (Appendix B). Participants gave written informed 
consent (Appendix B) freely and voluntarily; and completed a health screen questionnaire 
(Appendix C) prior to the commencement of each study. Each participant was made fully 
aware that they were able to withdraw from any study at any time, and without reason. Each 
study had individual inclusion and exclusion criteria. Participants were only eligible to 
initiate and complete the study if they met and fulfilled this criteria.  
 
3.2 Preliminary Measures 
 
Height was measured by a wall-mounted stadiometer. BM was determined using calibrated 
electronic scales (BF510, Omron Healthcare, Ukyo-ku, Kyoto, Japan) placed on a hard 
levelled surface. Waist and hip circumferences were measured using a standard clinical tape 
measure by trained researchers, in accordance with International Standards for ISAK 
international standards for anthropometric assessment (ISAK 2001). BM and circumference 
measures were used when conducting multi-frequency bioelectrical impedance analysis 






3.3 Dietary and Hydration Analysis 
 
Total energy and water intake through foods and fluids were determined and analysed 
through Dietplan6 dietary analysis software (v6.60, Forestfield Software, Horsham, West 
Sussex, UK) by a trained dietetic researcher. To improve the validity of the dietary analysis, 
all the nutritional information gathered from food-beverage packages during the interview 
procedure was entered into the dietary analysis software program. In addition, to improve the 
reliability of the dietary analysis, all the completed dietary interview logs were blindly 
analysed by a 2nd trained dietetic researcher. The coefficient of variation (CV) for the energy, 
macronutrients, and water variables analysed are individually reported within each study 
chapter. 
 
Exercise-induced BM change (pre- to post-exercise BM difference) was determined from 
pre- and post-stage BM values (Chapters 4 to 9). Pre- and post-exercise POsmol was 
determined from 50 μl lithium heparin plasma samples in duplicate by freezepoint 
osmometry (Osmomat 030, Gonotec, Germany), as previously recommended (Seifarth et al. 
2004) (Chapters 4 to 9). For Chapters 4 to 7, POsmol was determined once samples had been 
frozen and thawed, as described in Section 3.6, whilst for Chapters 8 and 9, POsmol was 
determined immediately after sample collection. 
 
3.4 Tympanic and Rectal Temperature Measurements 
 
To determine tympanic temperature (Ttymp) (Chapter 6 and Chapter 7) participants were 
asked to position their head in the Frankfort plane and avoid head movement until Ttymp 





(Braun Thermoscan, Kronberg, Germany); the right auricle was then gently pulled up and 
back before the sensor was insertion into the right external auditory canal for five seconds, 
without touching the tympanic membrane. 
 
To monitor body temperature during EHS (Chapter 9), participants inserted a thermocouple 
12 cm beyond the external anal sphincter (Tre); CorTemp Core Body Temperature Sensor, 
Florida, USA). 
 
3.5 Saliva Sample Collection and Analysis 
  
Prior to saliva collection, participants were asked to thoroughly rinse the mouth with plain 
water (15–25°C) and swallow in order to fully empty contents of the mouth. Participants 
were then asked to lean forward and passively drool into the universal tube with minimal 
orofacial movements. Unstimulated whole saliva samples were collected by a dribbling 
method into pre-weighed 30 ml universal tubes (HR 120-EC, A & D instruments, Tokyo, 
Japan). Saliva volume was measured by weighing the universal tube immediately after 
collection to the nearest milligram. By assuming saliva density to be 1.00 g·ml (Cole and 
Eastoe 1988), SFR in µl·min was determined by dividing the volume of saliva by the 
collection time. Aliquots of saliva were pipetted into Eppendorf tubes and stored frozen 
initially at -20°C prior to transferring to -80°C storage after completion of the experimental 
procedure (Chapter 4 and Chapter 5). Aliquots of saliva were pipetted into Eppendorf tubes 
and stored frozen at -80°C storage after completion of the EHS protocol (Chapter 8). 
 
After thawing and gentle mixing by vortex, 50 µl of the saliva sample was used to determine 





(Chapter 4). After thawing and centrifuging at 5000g for 2 min, S-IgA (Salimetrics Europe, 
Suffolk, UK), S-lysozyme (Bioquote, York, UK), and S-cortisol (Salimetrics Europe) 
concentrations were determined by enzyme linked immunosorbent assay (ELISA), and the S-
α-amylase concentration was determined by an enzyme reaction assay kit (Salimetrics 
Europe). To account for stress-induced changes in SFR, the secretion rates for S-AMPs (and 




S-IgA concentrations (Salimetrics Europe, Suffolk, UK) were determined by ELISA using an 
indirect competitive immunoassay as per manufacturer’s instructions. Using a 1:5 dilution, 25 
µl of sample was diluted in 100 µl of S-IgA diluent. 10 µl of standards, controls and samples 
were added to tubes containing 4ml of S-IgA diluent. 50 µl of diluted antibody-enzyme 
conjugate was then added to the tubes containing 4 ml of S-IgA diluent. All tubes were gently 
inverted and incubated for 90 min at room temperature (20°C). 50 µl from each tube was 
pipetted in duplicate, into each well on the microtitre plate. The plate was covered and 
incubated at room temperature with continuous mixing at 500 rpm for 90 min. After plate 
washing, 50 µl of TMB substrate solution was added to each well and placed on a microtitre 
plate shaker for 5 min at 500 rpm and incubated in the dark at room temperature for an 
additional 40 min. 50 µl of stop solution was then added to each well and placed on the 
microtitre plate shaker for 3 min at 500 rpm, followed by reading at optical density (OD) 450 
nm. Concentration was calculated by plotting the absorbance against standards in a linear 
regression curve. The CV’s for S-IgA were <3.4% for studies included in this thesis 







S-lysozyme concentrations (Bioquote, York, UK) were determined by a sandwich ELISA 
assay as per manufacturer’s instructions. Using a 1:4000 dilution, 10 µl of sample was diluted 
in 390 µl (step 1), and 10 µl in 990 µl (step 2) with Phosphate-saline buffer into tubes. 50 µl 
of standards, controls and samples were pipetted in duplicate, into each well on the microtitre 
plate. The plate was covered and incubated at room temperature for 60 min. After plate 
washing, 100 µl of the lysozyme antiserum was added to each well. Once more, the plate was 
covered and incubated at room temperature for 60 min. After plate washing, 100 µl of the 
diluted Donkey anti-Goat IgG Peroxidase was added to each well. Again, the plate was 
covered and incubated at room temperature for 60 min. After plate washing, 100 µl of 
substrate mix (TMB solution and Hydrogen Peroxide solution) was added to each well and 
incubated at room temperature for 15 min. 100 µl of Stop solution was added to each well, 
followed by reading at 450 nm. Concentration was calculated by plotting the absorbance 
against standards in a linear regression curve. The CV’s for S-lysozyme were <3.6% for 
studies included in this thesis (Chapter 4, Chapter 5 and Chapter 8). 
 
S-α-amylase 
S-α-amylase concentrations (Salimetrics Europe, Suffolk, UK) were determined by enzyme 
reaction assay kit as per manufacturer’s instructions. Using a 1:10 dilution, 10 µl of sample 
was diluted in 90 µl of α-amylase diluent with a final dilution of 1:200. 8 µl of controls and 
samples were pipetted in duplicate, into each well on the microtitre plate. 320 µl of pre-
heated (37°C) α-amylase substrate solution was added to each well, followed by reading at 
exactly 1 and 3 min. The 1 min readings are subtracted from the 3 min readings and 
multiplied by the conversion factor. The CV’s for S-α-amylase were <4.2% for studies 






S-cortisol concentrations (Salimetrics Europe, Suffolk, UK) were determined by ELISA 
using an indirect competitive immunoassay as per manufacturer’s instructions. 25 µl of 
standards, controls and samples were pipetted in duplicate, into each well on the microtitre 
plate. A 1:1600 dilution of the conjugate was made by adding 15 µl of the conjugate to a tube 
containing 24 ml of assay diluent, followed by gentle inverting. 200 µl of the conjugate were 
pipetted into each well and the plate was placed onto a microtitre plate shaker at 500 rpm for 
5 min. After 4 plate washes, 200 µl of TMB solution was added to each well. The plate was 
placed back onto the microtitre plate shaker at 500 rpm for 5 min, and incubated in the dark 
at room temperature for an additional 25 min. 50 µl of Stop solution was added to each well, 
placed on the microtitre plate shaker at 500 rpm for 3 min, followed by reading at 450 nm. 
Concentration was calculated by plotting the OD against standards in a linear regression 
curve. The CV’s for S-cortisol were <4.1% for studies included in this thesis (Chapter 4, 
Chapter 5 and Chapter 8). 
 
All salivary variables analysed were individually run on the same day, with standards and 
controls on each plate, and each participant assayed on the same plate. 
 
3.6 Blood Sample Collection and Analysis 
 
Whole blood samples were collected by venepuncture without venostasis from an antecubital 
vein using a 21G butterfly syringe into one lithium heparin (6 ml, 1.5 IU·ml heparin; Becton 
Dickinson, Oxford, UK) and one K3EDTA (6 ml, 1.6 mg·ml of K3EDTA; Becton Dickinson, 
Oxford, UK) vacutainer tube. Blood samples were immediately centrifuged at 3000 rpm for 





to transferring to -80°C storage after completion of the experimental procedure (Chapter 6 
and Chapter 7). Plasma was aliquoted into Eppendorf tubes and stored frozen at -80°C 
storage after completion of the EHS protocol (Chapter 9). 
 
Whole blood haemoglobin concentration and haematocrit were used to estimate changes in 
plasma volume (Pv) relative to pre-Stage 1 (Chapter 6), pre-competition (Chapter 7) and to 
baseline (Chapter 9). Haemoglobin concentration and hematocrit content of K3EDTA blood 
samples (100 µl) were determined using an automated cell counter (Coulter ACT Diff, 
Beckham Coulter, USA) immediately after sample collection (Chapter 6). Whilst, 
haemoglobin concentration was determined using a haemoglobin analyser (HemoCue Hb 
201+ Analyzer, California, USA) and hematocrit was determined by capillary method in 
triplicate using lithium heparin blood samples and a microhematocrit reader immediately 
after sample collection (Chapter 7 and Chapter 9). All blood parameters were corrected for 
changes in Pv (Dill and Costill 1974).  
 
Endotoxin 
Gram-negative bacterial endotoxin concentration (HIT302, Hycult Biotech, Uden, 
Netherlands) was determined by limulus amebocyte lysate (LAL) chromogenic endpoint 
assay using K3EDTA plasma as per manufacturer’s instructions. 20 μl of sample was diluted 
in 380 μl of endotoxin-free water, and then incubated at 75°C for 10 min. Once at room 
temperature, 50 μl of standards, blank, positive control, and samples were added to plate 
wells in duplicate. To enhance assay validity, background plate reading without LAL reagent 
was performed at OD 405nm. 50 µl LAL reagent was then added. Plate was covered and 
incubated at 22ºC for 30 min, followed by reading at OD 405 nm. Concentration was 





eliminating background error. The CV’s for endotoxin were ≤5.5% for studies included in 
this thesis (Chapter 6, Chapter 7 and Chapter 9). 
 
Cytokine Profile 
Circulatory concentrations of IL-6, TNF-α, IL-1β, IFN-γ, IL-1ra and IL-10 (Invitrogen, 
Carlsbad, US) were determined by ELISA using K3EDTA plasma as per manufactures 
instructions (Chapter 6). Prior to analysis, wells on the microtitre plate were coated with 100 
µl of diluted coating antibody (10 µl of coating antibody and 9.99 µl of coating buffer). 
Plates were covered and incubated for 12-18 h at 4°C. After plate washing, 300 µl of Assay 
Buffer was added to each well. The microtitre plate was incubated at room temperature for 60 
min. 100 µl of diluted standards and samples were pipetted in duplicate, into each well on the 
microtitre plate, followed by 50 µl of detection antibody. The plate was placed onto a 
microtitre plate shaker at 700 rpm and incubated for 120 min. After 5 plate washes, 100 µl of 
the streptavidin-HRP solution was added to each well. The plate was placed back onto the 
microtitre plate shaker at 700 rpm and incubated for 30 min. After 5 washes, 100 µl of TMB 
substrate was added to each well, placed onto the microtitre plate shaker at 700 rpm and 
incubated for 30 min, followed by 100 µl of Stop Solution and reading at 450 nm. 
Concentration was calculated by plotting the absorbance against standards in a linear 
regression curve.  
 
Circulatory concentrations of IL-6, TNF-α, IL-1β, IFN-γ, IL-8 and IL-10 (human pro-
inflammatory 7-plex ultra-sensitive kit (K15008C-1), MesoDiscovery, Gaithersburg, MD, 
USA) were determined by a sandwich ELISA assay using K3EDTA plasma as per 
manufactures instructions (Chapter 7 and Chapter 9). 25 µl of diluent was added to each 





room temperature for 30 min. 25 µl of standards and samples were pipetted in duplicate, into 
each well on the MSD plate. The plate was covered, placed onto the microtitre plate shaker 
(700rpm) and incubated at room temperature for 120 min. After 3 plate washes, 25 µl of the 
Detection Antibody Solution was added to each well. Once more, the plate was covered, 
placed onto the microtitre plate shaker (700rpm) and incubated at room temperature for 120 
min. After 3 plate washes, 150 µl of Read Buffer T was added to each well, followed by 
analysis using a SECTOR imager (SECTOR imager 2400, MesoScale Discovery, Rockville, 
MD, USA). The CV’s for cytokines were ≤5.5% (Chapter 6) and ≤14.7% (Chapter 7 and 
Chapter 9) for studies included in this thesis. 
 
C-reactive protein  
Circulatory concentrations of CRP (eBioscience, Hatfield, UK) were determined by ELISA 
as per manufacturer’s instructions. Using a 1:4000 dilution, 10 µl of sample was diluted in 
390 µl (step 1), and 10 µl in 990 µl (step 2) with wash buffer into tubes. 100 µl of standards 
and samples were pipetted in duplicate, into each well on the microtitre plate. The plate was 
covered and incubated at room temperature for 120 min. After 5 plate washes, 100 µl of 
diluted HRP-conjugate was added to each well. Once more, the plate was covered and 
incubated at room temperature for 60 min. After 5 plate washes, 100 µl of the TMB substrate 
solution was added to each well and left for 5-10 min, followed by reading at 450 nm. 
Concentration was calculated by plotting the absorbance against standards in a linear 
regression curve. The CV’s for CRP were ≤5.5% (Chapter 6) and ≤14.7% (Chapter 7 and 
Chapter 9) for studies included in this thesis. 
 
All plasma variables analysed were individually run on the same day, with standards and 





3.7 Assessment of Upper Respiratory Symptoms and Gastrointestinal Symptoms 
 
The assessment of illness symptoms in Chapter 4 and Chapter 5 (URS) and in Chapter 6 
and Chapter 7 (GI symptoms) was included to explore whether alterations in physiological 
variables (e.g., S-AMP concentration, circulatory endotoxin concentrations and cytokine 
profile) resulted in the manifestation of clinically significant outcomes. 
 
The Wisconsin Upper Respiratory Symptom Survey (WURSS) was used to assess illness 
symptoms during and daily for four weeks after the competition in Chapter 4 and Chapter 
5. In the absence of a medical diagnosis, the WURSS is considered a useful, validated tool 
for measuring symptoms (Barrett et al. 2009, Spence et al. 2007). 
 
A standardised questionnaire assessing GI symptoms during endurance events (Pfeiffer et al. 
2009, Pfeiffer et al. 2012) was adapted for use in Chapter 6 and Chapter 7 to measure GI 
symptoms and severity.  
 
3.8 Statistical Analysis 
 
The primary outcomes of this thesis were SFR, S-IgA, S-α-amylase, S-lysozyme 
concentration and secretion rate, S-cortisol concentration and appearance rate, circulatory 
endotoxin concentration, circulatory cytokine profile (IL-6, TNF-α, IL-1β, IFN-γ, IL-8, IL-
1ra and IL-10) and circulatory CRP concentration. Given the variation in methodological 
design and experimental protocols between presented studies in this thesis, statistical analysis 





were self-reported illness symptoms, specifically URS and GI symptoms. Illness symptoms 
were assessed as described in Section 3.7.  
 
For Chapter 4 and Chapter 6, 23 out of 69 (33%) and 19 out of 69 (28%) UER entering 
multi-stage ultra-marathon volunteered to participate in the study, respectively. For Chapter 
5 and Chapter 7, 25 out of 48 (52%) and 17 out of 48 (35%) UER entering the 24 h ultra-
marathon volunteered to participate in the study. Previous field-based studies exploring the 
effects S-AMPs and URSI have used sample sizes between 14 and 38 participants (Gleeson et 
al. 1999, Neville et al. 2008, Pacque et al. 2007, Peters et al. 2010), whilst previous field-
based studies exploring the effects of circulatory endotoxin concentrations and cytokine 
profile have used sample sizes between 18 and 29 participants (Bosenberg et al. 1988, Camus 
et al. 1998, Jeukendrup et al. 2000, Nieman et al. 2006). 
 
For Chapter 8 and Chapter 9, n= 8 endurance runners volunteered to participate in the 
study. Previous data examining the effects of heat-stress and nutritional interventions on 
physiological variables have used sample sizes between 6 and 10 participants (Costa et al. 














Salivary Anti-Microbial Protein Responses During Multi-stage Ultra-Marathon 
Competition Conducted in Hot Ambient Conditions. 
Gill, S. K., Teixeira, A., Rosado, F., Hankey, J., Scheer, V., Robson-Ansley, P., and Costa, R. J. S. (2013) 
‘Salivary Antimicrobial Protein Responses During Multi-Stage Ultra-Marathon Competition Conducted in Hot 
Environmental Conditions’. Applied Physiology, Nutrition, and Metabolism 38 (9), 977-987 
 
4.1 Summary: Prolonged physical exertion is commonly reported to depress oral-respiratory 
immune status and increase the incidence of URS. This novel investigation aimed to 
determine the S-AMP responses and hydration status of UER (n= 23) and a control group 
(CON, n= 12) during a 230 km multi-stage ultra-marathon conducted in hot ambient 
conditions (32–40°C). BM was measured and unstimulated saliva and venous blood samples 
were taken before and after each stage of the ultra-marathon. Ad libitum fluid intake was 
permitted throughout each race day. URS were monitored during and until four weeks after 
race completion. Samples were analysed for S-IgA, S-lysozyme, S-α-amylase, and S-cortisol, 
as well as for POsmol and SOsmol. Mean exercise-induced BM loss over the five stages ranged 
from 1.3% to 2.4%. Overall mean pre- and post-stage POsmol measurements in the UER were 
279 ± 14 mOsmol·kg−1 and 293 ± 15 mOsmol·kg−1, respectively. Decreases in SFR (overall 
change 22%) and post-stage increases in SOsmol (36%) were observed in the UER during the 
ultra-marathon. Reduced S-IgA (32%) (p <0.001 vs. pre-stage S-IgA), enhanced S-α-amylase 
(187%) (p <0.001 vs. pre-stage S-α-amylase), and no change in S-lysozyme secretion rates 
were observed in the UER throughout the ultra-marathon. Only 1 UER reported URS during 
and one month after competition. Observed depressions in S-IgA secretion rates were offset 
by favourable increases in S-α-amylase and unchanged S-lysozyme responses in the majority 
of runners during the competition. Ensuring euhydration throughout a multi-stage ultra-








Reported episodes of URS are often attributed to the commonly observed transient decreases 
in S-IgA responses (Costa et al. 2009, Gleeson et al. 2000, Neville et al. 2008). Such a 
response has been suggested as creating an “open window”, whereby viruses and (or) bacteria 
may gain a hold on oral-respiratory mucosal surfaces (Nieman 1994).  
 
Because of the nature of multi-stage ultra-marathon events, UER are a high-risk population 
group for contracting sub-clinical or clinically significant illnesses and (or) infections during, 
and in the month after, competition (Gleeson et al. 2000). The presence of URS per se may 
have both clinical and performance significance for UER participating in a multi-stage ultra-
endurance competition, because symptom aggravation and discomfort leading to negative 
effects on nutrition and hydration status (e.g., loss of appetite, food–fluid disinterest, and (or) 
pain when eating or drinking) may ultimately result in withdrawal from competition and (or) 
in medical intervention.  
 
With this in mind, the aims of the current study were to determine the S-AMP responses and 
hydration status of UER during a multi-stage ultra-marathon competition in hot ambient 
conditions, in which ad libitum fluid intake was permitted throughout each race day. 
Additionally, URS during the race and daily for four weeks after race completion were 
monitored. It was hypothesized that the water intake habits of UER would not be sufficient to 
consistently maintain baseline euhydration levels throughout the competition, and 
subsequently, depressed salivary variables (i.e., SFR and S-AMP responses) would be 






4.3 Methods  
 
Setting. The study was conducted during the 2011 Al Andalus Ultimate Trail 
(www.alandalus-ut.com), held during the 2nd week of July, in the region of Loja, Spain. The 
multi-stage ultra-marathon was conducted over five stages (five days) totalling a distance of 
230 km (Stage 1: 37 km, Stage 2: 48 km, Stage 3: 38 km, Stage 4: 69 km, and Stage 5: 38 
km, respectively), and performed on a variety of terrains; predominantly off-road trails and 
paths, but also included steep and narrow mountain passes, and occasional road. Mean 
running intensity was (mean ± SD) 7.2 ± 0.9 METs (SenseWear 7.0, BodyMedia Inc., 
Pittsburgh, PA, USA). Sleeping arrangements from Stages 1 to 5 included a combination of 
outdoor tent and village sports hall accommodation (mean sleep duration per  night was 7 h 
54 min ± 0 h 37 min) (Pittsburgh Sleep Diary) (Monk et al. 1994). Moreover, the run course 
was routed over an altitude ranging between 473 to 1443 m above sea level (Garmin 
International, Olathe, Kansas, US). Average daytime maximum Tamb during the running 
stages ranged between 32-40C, with maximum daytime RH also ranging between 32-40% 
(Garmin International, Olathe, Kansas, US).  
 
Participants. After ethical approval, a convenience sampling observational cohort was 
studied, whereby 23 out of 69 UER who entered this ultra-marathon competition volunteered 
to participate in the study [UER (Male n= 16, Female n= 7): age 41 ± 9 y, height 1.75 ± 0.06 
m, BM 70.0 ± 9.0 kg, body fat mass 16 ± 4%]. For comparative purposes, 12 matched 
individuals who accompanied the UER along the ultra-marathon course, but did not compete 
(absence of exercise stress), volunteered to participate in the study as part of the CON group 
[(Male n= 5, Female n= 7): age 35 ± 13 y, height 1.67 ± 0.09 m, BM 69.9 ± 16.2 kg, body fat 





32% of participants resided in countries with hot ambient conditions similar to those of the 
race location (≥30°C Tamb) at the time of competition; whilst the remaining 68% of 
participants resided in countries with cold or thermoneutral ambient conditions (≤20°C). No 
participant reported any incidence of illness and/or infection in the twelve weeks leading up 
to the ultra-marathon.  
 
Study design and data collection. Following participant recruitment and informed consent, 
preliminary measures were taken to determine participant characteristics (Section 3.2). The 
current ultra-marathon was semi self-sufficient, whereby participants (including CON) 
planned and provided their own foods and fluids (except plain water) along the five days of 
competition. Participants’ equipment and sustenance was transported to each stage section by 
the race organisation. Only plain water was provided by the race organisers ad libitum during 
the rest phase throughout competition. Additionally, aid stations along the running phase of 
competition were situated approximately 10 km apart, and only provided plain water, fruit 
(oranges and watermelon), and electrolyte supplementation (Elete electrolyte add-in, Mineral 
Resources International, South Ogden, Utah, US). Participants were advised to adhere to their 
programmed habitual dietary practices throughout the entire competition.  
 
Each day, for five consecutive days, running stages commenced at either 08:00 or 09:00 h. 
Within the hour prior to the start of each running stage, pre-stage measurements were 
determined and samples collected. BM measurements were taken, as previously described 
(Section 3.2). Participants were then required to sit in an upright position for 10 min before 
whole blood and 2 min saliva samples were collected, as previously described (Section 3.5 
and 3.6). All measurement techniques and samples were consistently conducted and 





facility. BM was re-measured in those participants who needed to urinate prior to the stage 
start. Immediately post-stage and before any foods or fluids could be consumed, BM was 
measured, followed by blood and saliva sampling, as previously described (Section 3.5 and 
3.6). For consistency, the order, positioning and technique of measurements and sampling 
were similar pre- and post-stage for all stages, and were taken by the same trained researcher 
throughout. 
 
At the end of each competition day (20:00 to 22:00 h) on Stages 1 to 4, trained dietetic 
researchers conducted a standardised structured interview (dietary recall interview technique) 
on participants to ascertain total daily food and fluid ingestion. To avoid inter-observer 
variations, each trained researcher conducted the interview on the same participant 
throughout the entire ultra-marathon. Participants also completed an URS log (Wisconsin 
Upper Respiratory Symptom Survey, St. Madison, WI, USA) during this period and each day 
for four weeks following race completion.  
 
Dietary analysis and hydration status. Dietary analysis and hydration status were determined 
as previously described in Section 3.3. The mean CV for energy, macronutrient, and water 
variables analysed was 1.3%, 2.3%, and 0.7%, respectively. The CV for POsmol was 3.5%. 
 
Saliva sample analysis. Unstimulated whole saliva samples were analysed as previously 
described in Section 3.5. In CON, salivary variables were determined on pre-Stages 1, 3 and 
5 only.  
 
A CON group was included to allow for comparability between resting values (UER vs. 





5). Since the CON group did not compete (absence of exercise stress) and the focus of 
Chapter 4 and Chapter 6 was not to determine the time effect of salivary or plasma 
variables in CON, respectively; collecting samples post-stages of competition was not 
justified.  
 
Data analysis. Data in text (overall mean value unless otherwise specified) and tables are 
presented as mean ± standard deviation (SD). For clarity, the data in figures are presented as 
mean ± SEM, unless otherwise specified. Because of pronounced diurnal variation in cortisol 
responses (Shephard and Shek 1997), statistical analysis was performed between stages for 
pre- and post-stage time points only. A one-way analysis of variance (ANOVA) was applied 
to determine differences in variables between stages, whereas a two-way ANOVA was 
applied to determine differences between groups (UER vs. CON), and between pre- and post-
stage values within stages (SPSS v.20, Illinois, US). Significant main effects were analysed 
using a post hoc Tukey's honestly significant difference test. All data were checked for 
normal distribution by calculating skewness and kurtosis co-efficients. When the data 
violated the assumption of normality, they were log transformed, and the transformed data 
were used in the analysis. For comparative purposes, an independent sample t-test with non-
parametric verification was used to assess differences in post-stage salivary anti-microbial 
protein responses between euhydrated (EH) runners (mean ≤1.5% exercise-induced BM loss) 
and hypohydrated (HH) runners (mean >3.0% exercise-induced BM loss). The acceptance 









4.4 Results  
 
Energy, macronutrient, and water ingestion. Total daily energy intake did not vary 
significantly among stages in UER (15.0 ± 3.3 MJ·day−1; 12% protein, 61% carbohydrates, 
27% fat) and CON (11.6 ± 4.8 MJ·day−1; 10% protein, 67% carbohydrates, 23% fat). 
Compared with CON, the total daily energy intake was higher in UER on Stages 1 to 3 (p< 
0.001). Total daily water intake through foods and fluids did not vary significantly among 
stages in UER (7383 ± 1578 ml·day−1) and CON (3301 ± 163 ml·day−1). Compared with 
CON, the total daily water intake through foods and fluids was higher in UER on all stages 
(p< 0.001).Total and rate of water intake through foods and fluids during running did not 
differ among stages in UER (4030 ± 1307 ml and 731 ± 226 ml·h−1, respectively). 
 
Body mass. No significant changes in pre-stage BM in UER (pre-Stage 1, 71.4 ± 9.2 kg to 
pre-Stage 5, 70.7 ± 9.0 kg) and CON (pre-Stage 1, 68.9 ± 16.2 kg to pre-Stage 5, 69.1 ± 16.9 
kg) were observed during the ultra-marathon. However, as expected, BM loss did occur from 
pre- to post-stage (p< 0.001) in UER on all stages, with no significant differences among 













Figure 4.1: Exercise induced body mass loss of ultra-endurance runners participating in a 
230 km multi-stage ultra-marathon competition conducted in a hot ambient environment. 




Plasma osmolality. Pre-stage POsmol was significantly higher on Stage 2 compared with Stage 
4 only in UER (p= 0.045) (Figure 4.2) but did not differ among stages in CON (pre-stage, 
278 ± 12 mOsmol·kg−1). Pre-stage POsmol did not differ between UER and CON within stages 
throughout the ultra-marathon. Post-stage POsmol did not differ among stages in UER. Post-











Figure 4.2: Changes in plasma osmolality of ultra-endurance runners participating in a 230 
km multi-stage ultra-marathon competition conducted in a hot ambient environment. Data are 
presented as mean and range (n= 23). a, Normal clinical reference range (280–300 
mOsmol·kg−1) (Fischbach and Dunning 2004; Thomas et al. 2008). †, p< 0.01 vs. pre-stage; 




Saliva flow rate and saliva osmolality. The pre- and post-stage SFR did not significantly 
differ among stages in UER and CON (Table 4.1). Compared with pre-stage values, 
decreases in the SFR (p= 0.002) occurred after Stages 1 to 4 (37%, 34%, 20%, and 31%, 
respectively). Before Stage 3, the SFR was higher in UER than in CON (p< 0.001). An 18% 
lower post-stage SFR was evident in HH runners compared with EH runners (p= 0.095). 
SOsmol was higher (p< 0.001) before Stage 5 (53%) compared with before Stage 1 in UER, but 
did not change significantly in CON (Table 4.1). No significant changes in post-stage SOsmol 
were observed in UER throughout the ultra-marathon. Compared with pre-stage values, 





respectively). No differences in SOsmol were observed between UER and CON throughout the 
ultra-marathon. A 26% higher post-stage SOsmol was evident in HH runners compared with 











Table 4.1: Changes in saliva flow rate and osmolality of ultra-endurance runners participating in a 230 km multi-stage ultra-marathon 













 Pre Post Pre Post Pre Post Pre Post Pre Post 
 
Saliva flow rate (μl·min-1)     
   
UER 651 ± 579 412 ± 249* 523 ± 330 343 ± 292† 535 ± 319‡ 430 ± 291* 601 ± 350 415 ± 247† 414 ± 318 473 ± 331 
 
CON 458 ± 198    353 ± 153    365 ± 297  
 
Saliva osmolality (mOsmolkg-1)      
  
UER 45 ± 12 65 ± 36* 47 ± 19 63 ± 24* 49 ± 15 59 ± 15* 50 ± 11 68 ± 25* 69 ± 28§ 67 ± 31 
 
CON 44 ± 12    53 ± 15    57 ± 28  
 






S-IgA responses. The pre- and post-stage S-IgA concentration did not alter significantly 
throughout the ultra-marathon in UER and CON (Table 4.2; Figure 4.3A). Similarly, no 
significant pre- to post-stage changes in S-IgA concentration were observed throughout the 
ultra-marathon in UER. Compared with CON, the UER S-IgA concentration was lower at 
baseline (before Stage 1) (p< 0.001). The pre- and post-stage S-IgA secretion rate did not 
alter significantly throughout the ultra-marathon in UER and CON (Table 4.2; Figure 4.3B). 
Compared with pre-stage values, decreases in the S-IgA secretion rate (p= 0.001) occurred 
after Stages 2 to 5 (35%, 36%, 23%, and 33%, respectively) in UER. No significant 
differences in the S-IgA secretion rate were observed between UER and CON throughout the 
ultra-marathon. The post-stage S-IgA concentration (p= 0.026) and secretion rate (p= 0.05) 



















Figure 4.3: Changes in salivary IgA concentration (A) and secretion rate (B) of ultra-
endurance runners participating in a 230 km multi-stage ultra-marathon competition 
conducted in a hot ambient environment. Data are presented as mean (squares; n= 23) and 










S-α-amylase responses. The pre- and post-stage S-α-amylase concentration did not alter 
significantly throughout the ultramarathon in UER and CON (Table 4.2; Figure 4.4A). 
Compared with pre-stage values, increases in the S-α-amylase concentration (p< 0.001) 
occurred on all stages (194%, 573%, 257%, 87%, and 28%, respectively) in UER. The S-α-
amylase concentration was significantly lower in UER compared with CON before Stage 3 
(p= 0.002). The pre- and post-stage S-α-amylase secretion rate did not change significantly 
throughout the ultra-marathon in UER and CON (Table 4.2; Figure 4.4B). Compared with 
pre-stage values, increases in the S-α-amylase secretion rate (p< 0.001) occurred on Stages 1, 
2, 3, and 5 (106%, 380%, 195%, and 68%, respectively) in UER. No significant differences in 
the S-α-amylase secretion rate were observed between UER and CON throughout the ultra-
marathon. No differences in the post-stage S-α-amylase concentration and secretion rate were 


















Figure 4.4: Changes in salivary α-amylase concentration (A) and secretion rate (B) of ultra-
endurance runners participating in a 230 km multi-stage ultra-marathon competition 
conducted in a hot ambient environment. Data are presented as mean (squares; n= 23) and 











S-lysozyme responses. The pre- and post-stage S-lysozyme concentration did not alter 
significantly throughout the ultra-marathon in UER and CON (Table 4.2; Figure 4.5A). 
Compared with pre-stage values, increases in the S-lysozyme concentration (p= 0.002) 
occurred on Stages 1 to 4 (33%, 180%, 60%, and 100%, respectively) in UER. No significant 
differences in the S-lysozyme concentration were observed between UER and CON 
throughout the ultra-marathon. The pre- and post-stage S-lysozyme secretion rate did not 
alter significantly throughout the ultra-marathon in UER and CON (Table 4.2; Figure 4.5B). 
Similarly, no significant changes in the pre- to post-stage S-lysozyme secretion rate were 
observed in UER during the ultra-marathon competition. No significant differences in the S-
lysozyme secretion rate were observed between UER and CON throughout the ultra-
marathon. The post-stage S-lysozyme concentration (p= 0.004) was 70% lower in HH 
runners compared with EH runners. A 56% lower post-stage S-lysozyme secretion rate was 

















Figure 4.5: Changes in salivary lysozyme concentration (A) and secretion rate (B) of ultra-
endurance runners participating in a 230 km multi-stage ultra-marathon competition 
conducted in a hot ambient environment. Data are presented as mean (squares; n= 23) and 








Table 4.2: Salivary anti-microbial protein responses of ultra-endurance runners participating in a 230 km multi-stage ultra-marathon competition 













 Pre Post Pre Post Pre Post Pre Post Pre Post 
 
Salivary IgA concentration (μgml-1) 
 
UER 203 ± 115‡ 253 ± 150 274 ± 183 246 ± 167 253 ± 173 229 ± 146 192 ± 123 230 ± 162 316 ± 184 190 ± 124 
 
CON 364 ± 118    447 ± 124    487 ± 166  
 
Salivary IgA secretion rate (μgmin-1) 
 
UER 105 ± 64 88 ± 57 123 ± 87 80 ± 77* 134 ± 129 86 ± 78* 111 ± 89 85 ± 59* 120 ± 104 80 ± 78* 
           
CON 158 ± 61    157 ± 84    176 ± 93  
 
Salivary α-amylase concentration (Uml-1) 
 
UER 49 ± 58 144 ± 120† 22 ± 27 148 ± 126† 42 ± 59‡ 149 ± 117* 60 ± 49 113 ± 102* 75 ± 89 96 ± 82* 
           
CON 56 ± 19    58 ± 10    39 ± 51 
 
 
Salivary α-amylase secretion rate (Umin-1) 
 
UER 33 ± 48 68 ± 58* 10 ± 11 48 ± 55† 19 ± 30 56 ± 54† 39 ± 43 39 ± 33 25 ± 31 42 ± 37* 
 







Salivary lysozyme concentration (μgml-1) 
 
UER 5.7 ± 5.2 7.9 ± 7.6* 5.4 ± 4.2 13.8 ± 18.8* 5.4 ± 4.5 7.9 ± 7.2* 8.1 ± 8.6 16.5 ± 18.6† 7.4 ± 7.8 10.4 ± 10.6 
           
CON 3.4 ± 1.8    4.4 ± 1.7    8.9 ± 4.7  
 
Salivary lysozyme secretion rate (μgmin-1) 
 
UER 3.5 ± 4.0 3.0 ± 2.5 3.3 ± 3.4 3.6 ± 5.0 2.8 ± 2.7 3.0 ± 2.9 4.0 ± 3.5 4.9 ± 4.6 2.8 ± 2.6 4 .1 ± 4.0 
 
CON 1.3 ± 0.5    1.7 ± 0.6    4.2 ± 4.3 
 
 





S-cortisol responses. The pre-stage S-cortisol concentration did not alter significantly 
throughout the ultra-marathon competition in UER and CON (Table 4.3). The post-stage S-
cortisol concentration was lower (54%) on Stage 3 compared with Stage 1 in UER (p= 
0.006). The S-cortisol concentration was higher (p< 0.001) before Stages 1 and 3 in UER 
compared with CON. The pre-stage S-cortisol appearance rate did not alter significantly 
throughout the ultra-marathon competition in UER and CON (Table 4.3). The post-stage S-
cortisol appearance rate was lower on Stages 2 and 3 (36% and 50%, respectively) compared 
with Stage 1 in UER (p= 0.006). The S-cortisol appearance rate was higher (p< 0.001) before 
Stages 1 and 3 in UER compared with CON. 
 
Upper respiratory symptoms. Only 1 runner reported URS during and four weeks after the 
ultra-marathon competition. The initial symptoms were reported on Stage 3 and continued, 
varying in severity, until seven days after the ultra-marathon competition. Over the five 
stages, the runner presented a mean exercise-induced BM loss of 3.2%, a pre-stage mean 
POsmol of 288 mOsmol·kg
−1, and a post-stage mean POsmol of 305 mOsmol·kg
−1. The runner 
also presented a pre- to post-stage decrease in SFR (25%), a decrease in S-IgA (21%), no 
change in S-lysozyme, and an increase in S-amylase secretion rates (30%). No URS were 

















Table 4.3: Salivary cortisol responses of ultra-endurance runners participating in a 230 km multi-stage ultra-marathon competition conducted in 













 Pre Post Pre Post Pre Post Pre Post Pre Post 
 
Salivary cortisol concentration (μgml-1) 
 
UER 66 ± 28‖ 63 ± 37 65 ± 26 48 ± 28 59 ± 24‖ 29 ± 17¶ 60 ± 29 51 ± 31 51 ± 33 42 ± 27 
 
CON 30 ± 16    25 ± 11    36 ± 18 
 
 
Salivary cortisol appearance rate (μgmin-1) 
 
          
UER 39 ± 29† 22 ±18 34 ± 26 14 ±15¶ 31 ± 25† 11 ± 8¶ 38 ± 27 23 ± 19 27 ± 25 20 ± 21 
 
CON 15 ± 7    12 ± 6    9 ± 8  
 







The novel outcomes of this field-based investigation suggest that the UER were able to 
maintain oral-respiratory mucosal surface immune integrity, possibly through their effective 
hydration strategies. Moreover, a counteractive effect appears to be present in the majority of 
runners, whereby the observed post-stage decreases in S-IgA responses were counterbalanced 
by increases in S-α-amylase and S-lysozyme responses. The observed maintenance of oral-
respiratory mucosal immune integrity may have reduced the likelihood of URS. 
 
The overall average total water intake in the runners through foods and fluids was 7.4 l·day−1, 
whereas the overall average rate of water intake during running was 731 ml·h−1, resulting in 
an average exercise-induced BM loss of 2.0% and a post-stage POsmol of 293 mOsmol·kg
−1. 
Because exercise-induced BM loss and post-stage POsmol indicative of hypohydration were 
observed in only 33% of UER (Fischbach and Dunning 2004, Sawka et al. 2007, Thomas et 
al. 2008) and because they returned to baseline values prior to the onset of the next day's 
stage, the fluid intake habits of the majority of UER appear to have been sufficient to 
maintain euhydration throughout the current ultra-marathon. Taking into account the 
influence of hydration status on SFR (Oliver et al. 2008, Walsh et al. 2004a, Walsh et al. 
2004b), the maintenance of euhydration may have contributed to the prevention of substantial 
depressions in the SFR. 
 
In the current study, the pre- to post-stage reduction in SFR ranged from 20-37%. In relation 
to S-AMP responses, a consistent post-stage decrease in the S-IgA secretion rate was 
observed (32%), whereas S-α-amylase and S-lysozyme increased or remained unchanged. 





reductions in post-stage S-IgA secretion rates) were compensated for by increases in S-α-
amylase (91% of UER showed increases in post-stage S-α-amylase secretion rates) and S-
lysozyme (57% of UER showed increases in post-stage S-lysozyme secretion rates) responses 
during the competition. Of the 43% of UER that showed decreased post-stage S-lysozyme 
secretion rates, 88% demonstrated increased post-stage S-α-amylase secretion rates. Given 
that saliva secretions are under neuroendocrine control (Carpenter et al. 2000, Carpenter et al. 
1998, Chicharro et al. 1998; Teeuw et al. 2004, Tenovuo 1998), the increased circulating 
stress hormone concentrations associated with exercise-heat stress may have influenced the 
small fluctuations in S-AMPs observed during the ultra-marathon.  
 
The novel findings in the current study indicated that a low prevalence (n= 1) of URS during 
and up to four weeks after a 230 km multi-stage ultra-marathon competition are not in 
accordance with the findings of symptomology reports of other field-based, prolonged 
running studies that showed a high incidence of URT illness symptoms (Heath et al. 1991, 
Linde 1987, Nieman et al. 1990, Peters 1990, Peters and Bateman 1983). Additionally, the 
multi-stage ultra-marathon took place during the summer months and therefore the risk of 
contracting an illness of viral aetiology (e.g., the common cold) is less likely compared to if 
the multi-stage ultra-marathon took place during the winter months. 
 
In regards to limitations, the sample of UER recruited to take part in the study was not 
randomised and therefore the potential for self-selection bias was not eliminated. This can 
potentially lead to a sample not being representative of the population studied, which in this 
case are UER. Additionally, the control group had different characteristics to the sampled 
cohort of UER, thus applying a statistical correction method during analysis would have 





In conclusion, S-AMP responses appear to be maintained throughout multi-stage ultra-
marathon competition irrespective of exposure to environmental extremes and other 
accompanying physiological stressors known to perturb immune function and hydration. 
Regardless of neuroendocrine regulation, maintaining euhydration through the maintenance 
of the saliva flow rate may play a fundamental role in protecting the oral respiratory mucosal 
surface, thereby ensuring an adequate presence of S-AMPs and preventing oral-respiratory 
surface drying and associated inflammatory responses. The observed unfavourable reductions 
in S-IgA responses were offset by favourable increases in the S-α-amylase and S-lysozyme 
responses. This is further reflected by the low prevalence of URS reported during and up to 





















Salivary Anti-Microbial Protein Responses During a 24 h Ultra-Marathon in Temperate 
Ambient Conditions. 
Gill, S. K., Teixeira, A. M., Rosado, F., Hankey, J., Wright, A., Marczak, S., Murray, A., and Costa, R. J. S. 
(2014) ‘The Impact of a 24-h Ultra-Marathon on Salivary Antimicrobial Protein Responses’. International 
Journal of Sports Medicine 35 (11), 966-971 
 
5.1 Summary: Depressed oral-respiratory mucosal immunity and increased incidence of 
URS are commonly reported after bouts of prolonged physical exertion. The current study 
observed the impact of a 24 h continuous overnight ultra-marathon competition (distance 
range: 122-208 km; Tamb range: 0-20°C) on S-AMP responses and incidence of URS. BM, 
unstimulated saliva and venous blood samples were taken from UER (n=25) and CON 
(n=17), before and immediately after competition. URS were assessed during and until four 
weeks after event completion. Samples were analysed for S-IgA, S-lysozyme, S-α-amylase, 
and S-cortisol in addition to POsmol. Decreased SFR (overall mean change 36%; p< 0.001 vs. 
pre-competition), S-IgA (overall mean change 33%; p< 0.001 vs. pre-competition) and S-
lysozyme (overall mean change 41%; p= 0.015 vs. pre-competition) secretion rates, and 
increased S-α-amylase secretion rates (overall mean change 92%; p< 0.001 vs. pre-
competition) and S-cortisol responses (overall mean change 71%; p< 0.001 vs. pre-
competition) were observed post-competition in UER; with no changes being observed in 
CON. No incidences of URS were reported by participants. A 24 h continuous overnight 
ultra-marathon resulted in the depression of some S-AMP responses, but no incidences of 
URS were evident during or following competition. S-AMP synergism, effective 
management of non-infectious episodes, maintaining euhydration, and (or) favourable 









Taking into account the extreme nature of ultra-endurance events, oral-respiratory mucosal 
immune status may be compromised to a greater extent compared with shorter bouts of 
endurance exercise reporting high incidence of URS (Linde 1987, Nieman et al. 1990). To 
date, the impact of a 24 h continuous ultra-marathon on oral-respiratory mucosal immunity 
has not been determined. The unique characteristics of ultra-endurance running events expose 
participants to a combination of physiological stressors known to perturb oral-respiratory 
immune status, through neuroendocrine (i.e., stress hormones) regulated salivary activity and 
hydration status. Both of these mechanisms have been shown to contribute towards depressed 
SFR and S-AMP responses (Chicharro et al. 1998, Costa et al. 2010, Fortes et al. 2012, 
Oliver et al. 2007, Teeuw et al. 2004, Tenovuo 1998). Even though previous laboratory-
controlled studies have reported modest alterations in SFR and S-IgA responses at rest or in 
response to physical exertion after an acute period of sleep deprivation with and without 
energy-nutrient restriction (Costa et al. 2010, Costa et al. 2008, Costa et al. 2005, Oliver et 
al. 2007); exposure to cold Tamb (0°C) resulted in a 36% and 24% decrease in S-IgA 
concentration and secretion rate, respectively (Costa et al. 2010). This is on the contrary to 
heat exposure, in which there is general consensus that S-AMP (i.e., S-IgA) perturbations are 
no greater when exercising in hot Tamb (>30°C) compared with thermoneutral ambient 
conditions (Laing et al. 2005, Walsh and Whitham 2006). It therefore appears that both 
neuroendocrine (i.e., stress hormones) responses and hydration status are potentially two key 
factors influencing oral-respiratory mucosal immune status under conditions of physical 






With this in mind, the current study aimed to determine S-AMP responses of UER before and 
immediately after a 24 h continuous overnight ultra-marathon competition, in which 
participants were also exposed to a period of cold ambient conditions and energy inadequacy. 
Additionally, in order to assess the possible impact of S-AMPs (or other immune) responses 
to the ultra-marathon upon URS susceptibility, URS were recorded during the event and 
monitored daily until four weeks after completion of the event. It was hypothesized that 
depressed salivary variables (i.e., saliva flow and S-AMP responses) would be evident 






















5.3 Methods  
 
Setting and participants. The study was conducted during the 2011 and 2012 Glenmore24 
Trail Race (www.glenmore24.com), held during the first week of September, in the 
Cairngorms National Park, Scottish Highlands, UK (Tamb range: 0-20°C, RH range: 54-82%). 
The 24 h continuous ultra-marathon was conducted on a 6 km looped-course on a variety of 
terrains; including off-road trails, paths, and grassland. Distance covered by participants 
ranged between 122-208 km at an estimated average intensity of 7.2 ± 1.2 METs (SenseWear 
7.0, Bodymedia, PA, Pittsburgh, USA), and in an altitude averaging 342 m above sea level. 
After ethical approval, a convenience sampling observational cohort was studied; whereby 25 
out of 48 UER entering the event volunteered to participate in the study (male n= 19, female 
n= 6: age 39 ± 7 y, height 177 ± 8 cm, BM 78 ± 11 kg). Additionally, 17 individuals who did 
not compete (absence of exercise stress), volunteered to participate in the study as part of the 
CON group (male n= 6, female n= 11: age 32 ± 11 y, height 170 ± 10 cm, BM 69 ± 13 kg), 
for comparative purposes. All participants reported no illness and (or) infection in the twelve 
weeks leading up to the ultra-marathon.  
 
Study design and data collection. Within the hour prior to commencement of competition 
(11:00-12:00 h), BM measurements were taken, as previously described (Section 3.2). 
Participants were then required to sit in an upright position for 10 min before whole blood 
and 2 min saliva samples were collected, as previously described (Section 3.5 and Section 
3.6), for all participants (UER and CON). BM was re-measured in those participants who 
needed to urinate prior to the start of competition. Immediately after competition (12:00 h the 
following day) and before any foods or fluids could be consumed, BM was measured, 





All measurements and samples were collected for all participants (UER and CON) within 1 h 
after completing the ultra-marathon (12:00-13:00 h). Also, within 1 h following competition, 
trained dietetic researchers conducted a standardised structured interview on participants to 
ascertain total foods and fluids ingested during the ultra-marathon. Participants were also 
educated and instructed to complete a validated URS log (Wisconsin Upper Respiratory 
Symptom Survey, St. Madison, WI, USA) for the ultra-marathon period and daily until four 
weeks after event completion.   
 
Dietary analysis and hydration status. Dietary analysis and hydration status were determined 
as previously described in Section 3.3. Energy expenditure was measured by a triaxial 
accelerometer, which also included measurements of heat flux, skin temperature and galvanic 
skin responses (SenseWear 7.0, Bodymedia, PA, Pittsburgh, USA). Pre- and post-competition 
POsmol was determined as previously described in Section 3.3. The mean CV for energy, 
macronutrient, and water variables analysed was 0.8%, 1.4%, and 0.5%, respectively. The 
CV for POsmol was 3.5%. 
 
Saliva sample analysis. Unstimulated whole saliva samples were analysed for S-IgA, S-α-
amylase, S-lysozyme, and S-cortisol as previously described in Section 3.5.  
 
Data analysis. Data in text are presented as mean ± SD. For clarity, data in figures are 
presented as mean ± SEM. Due to the commonly large individual variation in salivary 
variables (S-AMP responses) (Gleeson and Pyne 2000, Walsh et al. 2011a), data are 
presented as mean and 95% confidence interval (CI) for mean (lower and upper boundary). 
Data were processed and analysed in SPSS for Windows (SPSS v.17.0.2, Illinois, US). 





test) were performed prior to analysis. Where data violated the assumption of normality, data 
were log transformed, and the transformed data was analysed using parametric statistics, 
verified against non-parametric equivalents where appropriate. Paired-sample t-tests were 
applied to determine pre- to post-competition variable differences; while independent-sample 
t-tests were applied for group (UER vs. CON) and sub-group comparisons (pre- to post-
competition variable changes for running distance (<160 km vs.  ≥160 km)) (Pacque et al. 
2007, Peters and Bateman 1983) and hydration status (EH (≤1.5% exercise-induced BM loss) 
vs. HH (>3.0% exercise-induced BM loss)) (Fortes et al. 2012). The acceptance level of 
significance was set at p< 0.05. Descriptive statistics were used to explore URS (percentage 






















Energy balance and hydration status. Total energy intake and energy expenditure over the 24 
h period was 20 ± 11 MJ and 55 ± 11 MJ for UER, and 12 ± 1 MJ and 14 ± 5 MJ for CON, 
respectively. Total fluid ingestion over the 24 h period was 9.1 ± 4.0 l for UER, and 2.1 ± 0.4 
l for CON. While rate of fluid ingestion was 378 ± 164 ml·h-1 for UER. Significant BM loss 
occurred pre- to post-competition (p= 0.001) in UER (pre-competition: 78.2 ± 11.5 kg, post-
competition: 77.0 ± 11.7 kg; 1.6 ± 2.0%). No significant changes in POsmol were observed pre- 
to post-competition in UER (pre-competition: 285 ± 11 mOsmol·kg-1, post-competition: 287 
± 10 mOsmol∙kg-1) and remained within normal clinical reference range (280-300 
mOsmol∙kg-1) (Thomas et al. 2008). Compared with CON, POsmol pre- and post-competition 
was lower in UER (p= 0.05 and p< 0.001, respectively). 
 
Saliva flow rate and salivary anti-microbial protein responses. Decreased SFR (overall mean 
change: 36%; p= 0.001 vs. pre-competition) was observed post-competition in 88% of 
sampled UER, with no significant change in CON evident (Figure 5.1). No significant 












Figure 5.1: Saliva flow rate in ultra-endurance runners before and immediately after a 24 h 
continuous overnight ultra-marathon competition. Mean ± SEM: UER (closed squares; n= 




A pre- to post-competition increase in S-IgA concentration (overall mean change: 34%) was 
observed in UER (p= 0.077; Table 5.1), but failed to reach significance. Decreased S-IgA 
secretion rate (overall mean change: 33%; p< 0.001 vs. pre-competition) was observed post-
competition in 84% of sampled UER. No significant differences in pre- to post-competition 
S-IgA concentration and secretion rate were observed in CON, nor observed for sub-group 
comparisons.  
 
Increased S--amylase concentration (overall mean change: 85%) was observed post-
competition in UER (p= 0.001 vs. pre-competition; Table 5.1). Similarly, increased S--
amylase secretion rate (overall mean change: 92%) was observed post-competition in 90% of 





competition S--amylase concentration and secretion rate were observed in CON, nor 
observed for sub-group comparisons.  
 
A pre- to post-competition increase in S-lysozyme concentration (overall mean change: 98%) 
was observed in UER (p= 0.085; Table 5.1), but failed to reach significance. Decreased S-
lysozyme secretion rate (overall mean change: 41%) was observed post-competition in 73% 
of sampled UER (p= 0.015 vs. pre-competition). No significant differences in pre- to post-
competition S-lysozyme concentration and secretion rate were observed in CON, nor 





















Table 5.1: Salivary antimicrobial protein responses in ultra-endurance runners before and 







Salivary IgA concentration (μgml-1) 
 
UER 193 (136-249) 258 (166-350)† 
 
CON 202 (104-298) 204 (74-332) 
 
Salivary IgA secretion rate (μgmin-1) 
 
UER 91 (52-130) 61 (36-85)** 
 
CON 95 (44-144) 74 (30-117) 
 
Salivary α-amylase concentration (Uml-1) 
 
UER 35 (17-55) 70 (45-99)**aa 
 
CON 34 (19-48) 27 (16-37) 
 
Salivary α-amylase secretion rate (Umin-1) 
 
UER 17 (8-24) 33 (15-46)**aa 
 
CON 12 (5-19) 11 (6-16) 
 
Salivary lysozyme concentration (μgml-1) 
 
UER 4.9 (2.6-7.6) 9.7 (2.9-15.9)‡a  
 
CON 4.8 (3.1-7.2) 3.2 (1.6-5.2) 
 
Salivary lysozyme secretion rate (μgmin-1) 
 
UER 3.4 (2.0-5.0)a 2.0 (0.7-3.3)**b 
 
CON 1.4 (0.6-2.2) 1.0 (0.4-1.5) 
 
Mean and 95% CI (lower and upper bound): UER (n= 25) and CON (n= 17). ** p< 0.01 vs. 
pre-competition, † p= 0.077 and ‡ p= 0.085 vs. pre-competition, a p< 0.05 and aa p< 0.01 vs. 





Salivary cortisol responses. Increased S-cortisol concentration (overall mean change: 71%; 
p< 0.001 vs. pre-competition) was observed post-competition in UER (Figure 5.2). A 66% 
increase in pre- to post-competition S-cortisol appearance rate was observed in UER, but 
failed to reach significance (p= 0.164). No significant differences in pre- to post-competition 
S-cortisol concentration and appearance rate were observed in CON, nor observed for sub-
























Figure 5.2: Salivary cortisol concentration (A) and appearance rate (B) in ultra-endurance 
runners before and immediately after a 24 h continuous overnight ultra-marathon 
competition. Mean ± SEM: UER (closed squares; n= 25) and CON (open squares; n= 17). ** 









Upper respiratory symptoms. In accordance with the Wisconsin Upper Respiratory Symptom 
Survey, no (0%) URS per se were reported by UER and CON during the ultra-marathon. 
However, sub-symptoms were acknowledged by UER, whereby n= 1 UER reported fever, n= 
2 UER reported cold-flu like symptoms, and n= 4 UER reported headache during the event. 
Additionally, no (0%) URS and sub-symptoms were reported by UER and CON in the four 


























In accordance with the hypothesis, irrespective of distance covered, results show reductions 
in S-IgA and S-lysozyme secretion rates post-competition; whereas in contrast to the 
hypothesis S-α-amylase responses increased. Despite exposure to multiple physiological 
stressors and unfavorable reductions in some S-AMP responses, a novel finding was that no 
URS were reported by UER during and four weeks following the ultra-marathon.  
 
Compared with the current study, greater depressions in S-AMP responses (i.e., S-IgA), have 
previously been observed after 82 km (50%) and 160 km (57%) ultra-marathons (Nieman et 
al. 2003, Pacque et al. 2007), although hydration status was not accounted for in these 
studies. Given that the majority of previous studies have solely reported S-IgA responses 
after exercise-stress, collectively determining S-AMPs may provide a clearer interpretation of 
oral-respiratory mucosal immune status (Costa et al. 2012). For example, the increased S-
IgA, S-α-amylase, and S-lysozyme concentrations post-competition likely reflected a 
concentrating effect of reduced SFR (Costa et al. 2012, Costa et al. 2009). Whereas, even 
though reduced secretion rates of S-IgA and S-lysozyme were observed post-competition, a 
compensatory level of mucosal protection may have been provided (increased S-α-amylase 
secretion rate), irrespective of distance covered. 
 
In the current study, amplified S-cortisol concentrations post-competition, suggesting raised 
HPA activation, possibly attributed to the combination of extreme physical exertion and 
energy inadequacy (Costa et al. 2005), and not necessarily sleep deprivation (Costa et al. 
2010), likely played a significant role in the modest depressions in salivary variables 






Contrary to previous field-based studies, showing high incidence of URS after prolonged 
running (Heath et al. 1991, Linde 1987, Nieman et al. 1990, Peters and Bateman 1983), 
commonly attributed to the reductions in S-IgA responses (Costa et al. 2005, Gleeson and 
Pyne 2000, Neville, Gleeson, and Folland 2008), more recent ultra-marathon studies have 
reported minimal incidence of URS (Pacque et al. 2007). In agreement with these studies, 
despite the extreme physical exertion and exposure to multiple physiological stressors known 
to perturb immune function (Walsh et al. 2011a, Walsh and Whitham 2006), low incidences 
of URS were reported during and up to four weeks following competition (Chapter 4).  
 
In conclusion, a 24 h continuous overnight ultra-marathon resulted in the modest depressions 
of some S-AMP responses, but no incidences of URS were evident during or following 
competition. Given that S-AMPs work synergistically to protect the URT against pathogen 
adhesion, replication, and invasion; the counteractive effect observed in S-AMP responses 
















Circulatory Endotoxin Concentrations and Cytokine Profile During a Multi-Stage 
Ultra-Marathon Competition Conducted in Hot Ambient Conditions. 
Gill, S. K., Teixeira, A., Rama, L., Rosado, F., Hankey, J., Scheer, V., Hemmings, K., Ansley-Robson, P., and 
Costa, R. J. S. (2015) ‘Circulatory Endotoxin Concentration and Cytokine Profile in Response to Exertional-
Heat Stress During a Multi-Stage Ultra-Marathon Competition’. Exercise Immunology Review 21, 114-128 
 
6.1 Summary: Exertional-heat stress has the potential to disturb intestinal integrity, leading 
to enhanced permeability of enteric pathogenic microorganisms and associated clinical 
manifestations. The study aimed to determine circulatory endotoxin concentration and 
cytokine profile of UER (n= 19) and a control group (CON, n= 12) during a 230 km multi-
stage ultra-marathon (mean ± SD: 27 h 38 min ± 3 h 55 min) conducted in hot ambient 
conditions (32-40ºC) and to explore the relationship between these responses with severe GI 
symptoms and perceptive thermal tolerance rating. BM and Ttymp were measured, and venous 
blood samples were taken before (pre-stage) and immediately after (post-stage) each stage of 
the ultra-marathon. Samples were analysed for gram-negative bacterial endotoxin, CRP, 
cytokine profile (IL-6, IL-1β, TNF-α, IFN-γ, IL-10, and IL-1ra), and POsmol. GI symptoms 
and perceptive thermal tolerance rating were also monitored throughout competition. Mean 
exercise-induced BM loss over the five stages ranged 1.0% to 2.5%. Pre- and post-stage 
POsmol in UER ranged 277-282 mOsmol·kg and 286-297 mOsmol·kg, respectively. Pre-stage 
concentrations of endotoxin (peak: 21% at Stage 5), CRP (889% at Stage 3), IL-6 (152% at 
Stage 2), IL-1β (95% at Stage 5), TNF-α (168% at Stage 5), IFN-γ (102% at Stage 5), IL-10 
(1271% at Stage 3), and IL-1ra (106% at Stage 5) increased as the ultra-marathon progressed 
in UER; while no changes in CON were observed (except for IL-1β; 71%). Pre- to post-stage 
increases were observed for endotoxin (peak: 22% at Stage 3), CRP (25% at Stage 1), IL-6 
(238% at Stage 1), IL-1β (64% at Stage 1), TNF-α (101% at Stage 1), IFN-γ (39% at Stage 





UER reported at least one severe GI symptom (including 33% of sampled UER reporting 
nausea) during competition, while no GI symptoms were reported by CON. Multi-stage ultra-
marathon competition in the heat resulted in a modest circulatory endotoxaemia accompanied 
by a pronounced pro-inflammatory cytokinaemia by post-Stage 1, both of which were 
sustained throughout competition at rest (pre-stage) and after stage completion. 
Compensatory anti-inflammatory responses and other external factors (i.e., training status, 
cooling strategies, heat acclimatization, nutrition and hydration) may have contributed 
























Perturbations to intestinal epithelial integrity during EHS have been linked to increased 
intestinal permeability of gram-negative bacterial endotoxins, leading to endotoxaemia and 
responsive cytokinaemia (Camus et al. 1998, Camus et al. 1997). Endotoxin-induced 
cytokinaemia has previously been implicated in the aetiology of heat-related illness (Lim and 
Mackinnon 2006, Opal 2010). Taking into account that previous research has predominantly 
focused on single bouts of prolonged physical exertion with and without heat-stress, to date, 
it is still unclear the extent to which consecutive days of EHS may impact on circulatory 
endotoxin and cytokine responses along the duration of exposure.  
 
With this in mind, the aims of the current study were to: 1) determine circulatory endotoxin 
concentration and cytokine profile of UER throughout a five days (five stages) multi-stage 
ultra-marathon competition conducted in hot ambient conditions; 2) determine the 
relationship between these responses with those individuals reporting severe GI symptoms, 
and perceptive thermal tolerance rating; and 3) determine if gender, fitness level, and 
hydration status influence responses. Taking into account the nature of the event, it was 
hypothesised that a progressive endotoxaemia would be seen along the ultra-marathon, and a 
cytokinaemic response would mirror the endotoxaemia. It was also hypothesised that 
correlations between circulatory responses with severe GI symptoms (positive) and 
perceptive thermal tolerance rating (negative) would be seen. Additionally, it was 
hypothesised that no difference in responses would be seen between genders, faster runners 
with higher fitness levels would show lower responses, and a state of hypohydration would 






6.3 Methods  
 
Setting. The study was conducted during the 2011 Al Andalus Ultimate Trail 
(www.alandalus-ut.com), held during the 2nd week of July, in the region of Loja, Spain. The 
multi-stage ultra-marathon was conducted over five stages (five days) totalling a distance of 
230 km (Stage 1: 37 km, Stage 2: 48 km, Stage 3: 38 km, Stage 4: 69 km, and Stage 5: 38 
km, respectively), and performed on a variety of terrains; predominantly off-road trails and 
paths, but also included steep and narrow mountain passes, and occasional road. Mean 
running intensity was (mean ± SD) 7.5 ± 0.5 METs (SenseWear 7.0, BodyMedia Inc., 
Pittsburgh, PA, USA). Sleeping arrangements from Stages 1 to 5 included a combination of 
outdoor tent and village sports hall accommodation (mean sleep duration per night was 8 h 18 
min ± 1 h 22 min) (Pittsburgh Sleep Diary) (Monk et al. 1994). Moreover, the run course was 
routed over an altitude ranging between 473 to 1443 m above sea level (Garmin International, 
Olathe, Kansas, US). Average daytime maximum Tamb during the running stages ranged 
between 32-40C, with maximum daytime RH also ranging between 32-40% (Garmin 
International, Olathe, Kansas, US). 
 
Participants. After ethical approval, a convenience sampling observational cohort was 
studied, whereby 19 out of 69 UER who entered this ultra-marathon competition volunteered 
to participate in the study [UER (Male n= 13, Female n= 6): age 45 ± 6 y, height 1.71 ± 0.05 
m, BM 69.0 ± 7.0 kg, body fat mass 17.5 ± 4%]. For comparative purposes, 12 matched 
individuals who accompanied the UER along the ultra-marathon course, but did not compete 
(absence of exercise stress), volunteered to participate in the study as part of the CON group 
[(Male n= 5, Female n= 7): age 35 ± 13 y, height 1.67 ± 0.09 m, BM 69.9 ± 16.2 kg, body fat 





2 of participants resided in countries with hot ambient conditions similar to those of the race 
location (≥30°C Tamb) at the time of competition; the remaining participants resided in 
countries with cold or thermoneutral ambient conditions (≤20°C). No participant reported any 
incidence of illness and (or) infection in the twelve weeks leading up to the ultra-marathon.  
 
Oral anti-inflammatory agents. The use of non-steroidal anti-inflammatory drugs (NSAIDs) 
and other anti-inflammatory agents amongst UER included: paracetamol (500-1000mg), 
ibuprofen (400mg), cocodamol (500-1000mg), Celebrex (200mg), and fish oils (1-2 
capsules). Anti-inflammatory agent use by UER ranged from n= 2 on Stage 1 to n= 6 on 
Stage 5. Of the total number of participants, n= 13 did not use any form of oral anti-
inflammatory agents throughout the ultra-marathon.  
 
Study design and data collection. Following participant recruitment and informed consent, 
preliminary measures were taken to determine participant characteristics (Section 3.2). The 
current ultra-marathon was semi self-sufficient, whereby participants (including CON) 
planned and provided their own foods and fluids (except plain water) along the five days of 
competition. Participants’ equipment and sustenance was transported to each stage section by 
the race organisation. Only plain water was provided by the race organisers ad libitum during 
the rest phase throughout competition. Additionally, aid stations along the running phase of 
competition were situated approximately 10 km apart, and only provided plain water, fruit 
(oranges and watermelon), and electrolyte supplementation (Elete electrolyte add-in, Mineral 
Resources International, South Ogden, Utah, US). Participants were advised to adhere to their 






Each day, for five consecutive days, running stages commenced at either 08:00 or 09:00 h. 
Within the hour prior to the start of each running stage, pre-stage measurements were 
determined and samples collected. BM measurements were taken, as previously described 
(Section 3.2). Participants were then required to sit in an upright position for 10 min before 
Ttymp was determined, as previously described (Section 3.4) and whole blood samples 
collected, as previously described (Section 3.6). All measurement techniques and samples 
were consistently conducted and collected in a large partitioned research field tent (four 
sections, 3 m x 3 m) or sports hall facility. BM was re-measured in those participants who 
needed to urinate prior to the stage start. Immediately post-stage and before any foods or 
fluids could be consumed, BM was measured, followed by blood sampling, as previously 
described (Section 3.6). For consistency, the order, positioning and technique of 
measurements and sampling were similar pre- and post-stage for all stages, and were taken by 
the same trained researcher throughout.  
 
At the end of each competition day (20:00 to 22:00 h) on Stages 1 to 4, trained dietetic 
researchers conducted a standardised structured interview (dietary recall interview technique) 
on participants to ascertain total daily food and fluid ingestion. To avoid inter-observer 
variations, each trained researcher conducted the interview on the same participant 
throughout the entire ultra-marathon. Severe GI symptoms (Pfeiffer et al. 2012) and thermal 
tolerance rating through a Likert scale (-3 very poor to +3 very good, with 0 being a neutral 
response) (Hollies and Goldman 1977: 107) were also explored at this time through a 
research-generated symptomology tool. Exertional heat illness symptoms were verified by a 






Dietary analysis and hydration status. Dietary analysis and hydration status were determined 
as previously described in Section 3.3. The mean CV for energy, macronutrient, and water 
variables analysed was 1.3%, 2.3%, and 0.7%, respectively. The CV for POsmol was 3.5%.  
Blood sample analysis.  Whole blood samples were analysed for circulatory concentrations of 
CRP, cytokines (IL-6, TNF-α, IL-1β, IFN-γ, IL-10, and IL-1ra) and gram-negative bacterial 
endotoxin, as previously described in Section 3.6. In CON, blood-borne indices were 
determined on pre-Stages 1, 3 and 5 only. 
  
Data analysis. Data in text (overall mean value otherwise specified) and tables are presented 
as mean ± SD. Due to commonly large individual variation in immunological responses to 
exercise (Walsh et al. 2011), data in figures are presented as mean and individual participant 
responses. A one-way ANOVA was applied to determine differences in variables between 
stages. Whereas, a two-way ANOVA was applied to determine differences between groups 
[UER vs CON, genders (total and BM corrected values), oral anti-inflammatory agent 
administration, running speed (slow runners (SR, n= 11), who completed the entire distance 
of the ultra-marathon using a mixture of walking and running (overall mean speed <8 km·h), 
and fast runners (FR, n= 8), who completed the majority of the ultra-marathon distance 
running (overall mean speed ≥8 km·h))], and between pre- and post-stage values within 
stages (SPSS v.20, Illinois, US). All data were checked for normal distribution by calculating 
skewness and kurtosis co-efficients. Where data violated the assumption of normality, data 
were log transformed, and the transformed data was used in analysis. Significant main effects 
were analysed using post hoc Tukey’s HSD tests. For comparative purposes, an independent-
sample t-test with nonparametric verification was used to assess post-stage endotoxin and 
cytokine responses between hydration status (euhydrated (EH) runners (mean ≤1.5% 





BM loss)). Pearson’s coefficient correlation analysis was used to assess associations between 
endotoxin with CRP and cytokine profile. Spearman’s rank correlation analysis was used to 
assess associations between blood-borne variables with self-reported GI symptoms and 
perceptive thermal tolerance rating. Individual participant ratios between IL-1β and TNF-α 
with IL-10 were calculated to determine the pro- to anti-inflammatory cytokines balance. The 











Energy, macronutrient, and water ingestion. No difference in daily energy (16.0 ± 3.0 
MJ·day) and macronutrient [protein: 1.5 ± 0.4 g·kgBM·day (12% of energy intake), 
carbohydrate: 7.5 ± 1.6 g·kgBM·day (62% of energy intake), fat: 1.4 ± 0.5 g·kgBM·day 
(26% of energy intake)] intakes were seen between stages in UER and CON (11.4 ± 4.4 
MJ·day; 10% protein, 67% carbohydrate, 23% fat). Total daily energy intake was higher in 
UER on Stage 1 and Stage 4 compared with CON (p< 0.001).  Overall rate of carbohydrate 
intake during running was 28 ± 12 g·h in UER, with no difference seen between stages. No 
difference in total daily water intake through foods and fluids was seen between stages in 
UER (7.3 ± 1.7 l·day) and CON (3.3 ± 0.2 l·day). Total daily water intake through foods and 
fluids was higher in UER on all stages compared with CON (p< 0.001). Total and rate of 
water intake through foods and fluids during running did not differ between stages in UER 
(4.2 ± 1.5 l, 775 ± 248 ml·h; respectively). 
 
Body Mass, plasma osmolality, and plasma volume change. Pre- and post-stage BM did not 
significantly alter throughout competition in UER (pre-Stage 1: 71.7 ± 9.5 kg to pre-Stage 5: 
71.2 ± 9.2 kg; and post-Stage 1: 69.8 ± 8.9 kg to post-Stage 5: 69.6 ± 9.5 kg) and CON (pre-
Stage 1: 67.4 ± 15.0 kg to pre-Stage 5: 67.0 ± 14.8 kg). Stage 1 (2.5%) resulted in a greater 
exercise-induced BM loss compared with Stages 2 to 5 in UER (2.0%, 1.0%, 2.2%, and 
2.2%, respectively; p< 0.001). Pre-stage (range: 277 to 282 mOsmol·kg) and post-stage 
(range: 286 to 297 mOsmol·kg) POsmol did not differ between stages in UER.  Pre-stage POsmol 
did not differ from CON throughout the ultra-marathon. Pre- to post-stage increases in POsmol 
(p< 0.001) were observed on all stages in UER. Relative to pre-Stage 1, resting pre-stage PV 





2.0%) in UER; while no significant change in PV was observed in CON, relative to pre-Stage 
1. UER presented greater PV change at pre-Stages 3 and 5 compared with CON (p< 0.001). 
 
Tympanic temperature. Ttymp was within normal range pre- (overall mean: 36.3 ± 0.4°C) and 
post-stage (overall mean: 37.0 ± 0.3°C) in UER. Pre-stage Ttymp gradually decreased (p< 
0.001) in UER as the ultra-marathon progressed (pre-Stage 1: 36.5°C and pre-Stage 5: 
36.0°C). No change in pre-stage Ttymp (36.7 ± 0.5°C) was observed for CON throughout the 
ultra-marathon. Pre- to post-stage increases (0.7°C; p< 0.001) in Ttymp were also observed in 
UER throughout the ultra-marathon. No differences in Ttymp were observed for sub-group 
comparisons (gender, running speed, and hydration status). 
 
Circulatory gram-negative bacterial endotoxin concentration. Pre-stage circulatory 
endotoxin concentration gradually increased (p< 0.001) in UER as the ultra-marathon 
progressed (Table 6.1, Figure 6.1A), peaking at Stage 5 (21%). No change in pre-stage 
circulatory endotoxin concentration was observed between Stages 1, 3, and 5 for CON. Pre- 
to post-stage increases (p= 0.002) in circulatory endotoxin concentration were also observed 
in UER throughout the ultra-marathon (Table 6.1, Figure 6.1B). No differences in 
circulatory endotoxin concentration were observed for sub-group comparisons (oral anti-








Table 6.1: Circulatory gram-negative bacterial endotoxin concentration, C-reactive protein concentrations, and plasma cytokine profile of a 














Post Pre Post Pre Post Pre Post Pre Post 
           
Gram-negative endotoxin (EU/ml)           
UER 2.8 ± 0.3 3.2 ± 0.8§ 3.0 ± 0.4 3.1 ± 0.5 2.9 ± 0.4 3.5 ± 0.8** 3.3 ± 0.5†† 3.6 ± 0.6* 3.4 ± 0.5†† 3.6 ± 0.9 
CON 3.0 ± 0.2    3.0 ± 0.4    3.1 ± 0.5  
C-reactive protein (µg/ml)           
UER 1.1 ± 1.7 1.6 ± 2.4 7.4 ± 5.3†† 8.8 ± 5.4 10.0 ± 5.7††aa 9.6 ± 5.9 9.2 ± 5.9†† 10.0 ± 6.7* 8.8 ± 5.6††aa 11.0 ± 6.4* 
CON 1.4 ± 0.7    1.3 ± 0.8    1.3 ± 0.8  
IL-6 (pg/ml)           
UER 8.2 ± 4.5 27.9 ± 23.4** 20.8 ± 18.5†† 20.7 ± 14.8 20.7 ± 16.8††aa 25.3 ± 24.3** 19.2 ± 14.1†† 21.7 ± 12.6** 18.2 ± 11.6††aa 23.4 ± 13.1** 
CON 7.5 ± 2.5    5.5 ± 7.1    6.5 ± 5.7  
IL-1β (pg/ml)           
UER 0.6 ± 0.3 1.0 ± 0.3** 1.1 ± 0.4†† 1.1 ± 0.4 1.2 ± 0.4†† 1.2 ± 0.4 1.1 ± 0.3†† 1.4 ± 0.4** 1.2 ± 0.4†† 1.4 ± 0.4* 
CON 0.7 ± 0.2    1.2 ± 0.2†    1.3 ± 0.5††  






UER 3.1 ± 2.9 6.3 ± 5.0** 6.1 ± 4.5†† 6.6 ± 3.7 6.9 ± 4.4††aa 6.1 ± 3.8* 6.5 ± 4.2†† 8.1 ± 4.3** 7.1 ± 3.8††aa 8.3 ± 5.0 
CON 1.3 ± 0.4    1.8 ± 0.7    2.3 ± 0.7  
IFN-γ (IU/ml)           
UER 9.3 ± 5.5 12.9 ± 6.0** 15.2 ± 6.8 16.9 ± 5.7 16.7 ± 6.7† 15.2 ± 5.2 16.2 ± 7.2† 19.9 ± 8.3** 18.8 ± 10.0†† 22.7 ± 9.9** 
CON 16.8 ± 5.5    14.3 ± 2.0    16.8 ± 5.1  
IL-10 (pg/ml)           
UER 0.7 ± 0.6 7.9 ± 10.1** 7.0 ± 10.8†† 7.9 ± 9.1 9.0 ± 10.2††aa 8.0 ± 9.4 9.0 ± 12.2†† 9.3 ± 10.1 8.2 ± 11.2††aa 10.9 ± 15.0* 
CON 0.6 ± 0.1    1.4 ± 0.3    1.4 ± 0.7  
IL-1ra (pg/ml)           
UER 22.9 ± 8.0 70.3 ± 28.1** 39.8 ± 12.4†† 61.0 ± 39.8** 45.5 ± 20.6††aa 53.9 ± 19.0* 37.9 ± 14.7†† 56.3 ± 30.4** 47.1 ± 22.4††aa 63.2 ± 28.1** 
CON 23.4 ± 7.3    36.4 ± 9.2    33.1 ± 9.3  
Mean ± SD: ultra-endurance runners (UER, n= 19) and control group (CON, n= 12). †† p< 0.01 and † p< 0.05 vs pre-Stage 1, ** p< 0.01 and * p< 









Figure 6.1: Individual changes in pre-stage resting (A) and pre- to post-stage (B) circulatory 
gram-negative endotoxin concentration of ultra-endurance runners participating in a 230 km 
multi-stage ultra-marathon competition conducted in a hot ambient environment. Individual 











Plasma C-reactive protein concentration. Pre-stage plasma CRP concentration increased (p< 
0.001) by Stage 2 in UER, and remained elevated thereafter (Table 6.1, Figure 6.2A), 
peaking at Stage 3 (889%). No change in pre-stage plasma CRP concentration was observed 
between Stages 1, 3, and 5 for CON, and levels were lower than UER pre-Stages 3 and 5 (p< 
0.001). Pre- to post-stage increases (p< 0.05) in plasma CRP concentration were also 
observed in UER throughout the ultra-marathon (Table 6.1, Figure 6.2B). Plasma CRP 
concentration was observed to be higher (p< 0.001) in males (pre-stage: 8.9 ± 3.6 µg·ml, 
post-stage: 10.1 ± 4.0 µg·ml) compared with females (pre-stage: 4.2 ± 2.6 µg·ml, post-stage: 
4.3 ± 2.5 µg·ml) throughout the ultra-marathon. This difference was also observed when 




















Figure 6.2: Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma C-
reactive protein concentration of ultra-endurance runners participating in a 230 km multi-
stage ultra-marathon competition conducted in a hot ambient environment. Individual ultra-
endurance runner responses (●; n= 19). Additional individual responses outside the figure 
range for pre- to post-stage changes: Stage 1, n= 1 at 1827%; Stage 2, n= 1 at 429% and n= 1 









Plasma interleukin-6 concentration. Pre-stage plasma IL-6 concentration increased (p< 
0.001) by Stage 2 (152%) in UER, and remained elevated thereafter (Table 6.1, Figure 
6.3A). No change in pre-stage plasma IL-6 concentration was observed between Stages 1, 3, 
and 5 for CON, and levels were lower than UER pre-Stages 3 and 5 (p< 0.001). Pre- to post-
stage increases (p< 0.001) in plasma IL-6 concentration were also observed in UER (Table 
6.1, Figure 6.3B). Post-stage plasma IL-6 concentration was observed to be higher (p= 
0.054) in males (26.7 ± 20.5 pg·ml) compared with females (17.6 ± 5.7 pg·ml) throughout the 
ultra-marathon. However, when corrected for BM no substantial difference was observed. 
There was also a tendency for higher (p= 0.094) pre-stage plasma IL-6 concentration in SR 
(20.4 ± 15.2 pg·ml) compared with FR (13.3 ± 5.4 pg·ml) throughout the ultra-marathon. 
Additionally, dehydration status had a tendency to promote higher (42%, p= 0.068) post-
stage plasma IL-6 concentrations compared with a euhydrated status. No differences in other 


















Figure 6.3: Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
interleukin-6 concentration of ultra-endurance runners participating in a 230 km multi-stage 
ultra-marathon competition conducted in a hot ambient environment. Individual ultra-
endurance runner responses (●; n= 19). Additional individual responses outside the figure 










Plasma interleukin-1β concentration. Pre-stage plasma IL-1β concentration increased (p< 
0.001) by Stage 2 in UER (Table 6.1, Figure 6.4A) and remained elevated thereafter, 
peaking at Stage 5 (95%). While unexpected increases were also observed for CON (p< 
0.001), whereby plasma IL-1β concentration increased by Stage 3 and remained elevated 
thereafter. Pre- to post-stage increases (p= 0.001) in plasma IL-1β concentration were also 
observed in UER (Table 6.1, Figure 6.4B). Pre- and post-stage plasma IL-1β concentration 
was observed to be lower (p= 0.014) in males (pre-stage: 1.0 ± 0.2 pg·ml, post-stage: 1.1 ± 
0.2 pg·ml) compared with females (pre-stage: 1.2 ± 0.4 pg·ml, post-stage: 1.3 ± 0.4 pg·ml) 
throughout the ultra-marathon. However, when corrected for BM no substantial difference 
was observed. There was a tendency for higher (p= 0.054) pre-stage plasma IL-1β 
concentration in SR (1.1 ± 0.2 pg·ml) compared with FR (0.9 ± 0.5 pg·ml) throughout the 


















Figure 6.4: Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
interleukin-1β concentration of ultra-endurance runners participating in a 230 km multi-stage 
ultra-marathon competition conducted in a hot ambient environment. Individual ultra-











Plasma tumour necrosis factor-α concentration. Pre-stage plasma TNF-α concentration 
increased (p< 0.001) at Stage 2 in UER (Table 6.1, Figure 6.5A) and remained elevated 
thereafter, peaking at Stage 5 (168%). No change in pre-stage plasma TNF-α concentration 
was observed between Stages 1, 3, and 5 for CON, and levels were lower than UER pre-
Stages 3 and 5 (p< 0.001). Pre- to post-stage increases (p= 0.007) in plasma TNF-α 
concentration were also observed in UER (Table 6.1, Figure 6.5B). Pre- and post-stage 
plasma TNF-α concentration was observed to be lower (p< 0.001) in males (pre-stage: 4.8 ± 
1.8 pg·ml, post-stage: 6.1 ± 2.8 pg·ml) compared with females (pre-stage: 8.4 ± 6.1 pg·ml, 
post-stage: 9.3 ± 6.1 pg·ml) throughout the ultra-marathon. This difference was also observed 
when corrected for BM (pre-stage: p< 0.001, post-stage: p= 0.001). Pre-stage plasma TNF-α 
concentration was observed to be higher (p= 0.016) in SR (6.9 ± 1.8 pg·ml) compared with 
FR (4.7 ± 6.1 pg·ml) throughout the ultra-marathon. No differences in other sub-group 

















Figure 6.5: Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
tumour necrosis factor-α concentration of ultra-endurance runners participating in a 230 km 
multi-stage ultra-marathon competition conducted in a hot ambient environment. Individual 











Plasma interferon-γ concentration. Pre-stage plasma IFN-γ concentration increased (p= 
0.008) at Stage 3 in UER (Table 6.1, Figure 6.6A), peaking at Stage 5 (102%). No change in 
pre-stage plasma IFN-γ concentration was observed for CON. Pre- to post-stage increases (p= 
0.021) in plasma IFN-γ concentration were also observed in UER (Table 6.1, Figure 6.6B). 
Pre-stage plasma IFN-γ concentration was observed to be higher (p= 0.016) in SR (16.7 ± 6.4 
IU·ml) compared with FR (13.2 ± 9.2 IU·ml) throughout the ultra-marathon. No differences 






















Figure 6.6: Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
interferon-γ concentration of ultra-endurance runners participating in a 230 km multi-stage 
ultra-marathon competition conducted in a hot ambient environment. Individual ultra-
endurance runner responses (●; n= 19). Additional individual responses outside the figure 










Plasma interleukin-10 concentration. Pre-stage plasma IL-10 concentration increased (p< 
0.001) by Stage 2 in UER, and remained elevated thereafter (Table 6.1, Figure 6.7A), 
peaking at Stage 3 (1271%). No change in pre-stage plasma IL-10 concentration was 
observed between Stages 1, 3, and 5 for CON, and levels were lower than UER pre-Stages 3 
and 5 (p< 0.001). Pre- to post-stage increases (p= 0.003) in plasma IL-10 concentration were 
also observed in UER (Table 6.1, Figure 6.7B). Pre- and post-stage plasma IL-10 
concentration was observed to be lower (p< 0.001) in males (pre-stage: 4.1 ± 4.1 pg·ml, post-
stage: 6.3 ± 7.6 pg·ml) compared with females (pre-stage: 12.6 ± 13.6 pg·ml, post-stage: 14.2 
± 14.3 pg·ml) throughout the ultra-marathon. This difference was also observed when 
corrected for body mass (pre-stage: p< 0.001, post-stage: p= 0.001). No differences in other 



















Figure 6.7: Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
interleukin-10 concentration of ultra-endurance runners participating in a 230 km multi-stage 
ultra-marathon competition conducted in a hot ambient environment. Individual ultra-
endurance runner responses (●; n= 19). Additional individual responses outside the figure 
range for pre- to post-stage changes: Stage 1, n= 1 at 2305%, n= 1 at 3781%, n= 1 at 4761%, 









Plasma interleukin-1 receptor antagonist concentration. Pre-stage plasma IL-1ra 
concentration gradually increased (p< 0.001) in UER as the ultra-marathon progressed (Table 
6.1, Figure 6.8A), peaking at Stage 5 (106%). No change in pre-stage plasma IL-1ra 
concentration was observed between Stages 1, 3, and 5 for CON, and levels were lower than 
UER pre-Stages 3 and 5 (p< 0.001). Pre- to post-stage increases (p< 0.001) in plasma IL-1ra 
concentration were also observed in UER throughout the ultra-marathon (Table 6.1, Figure 























Figure 6.8: Individual changes in pre-stage resting (A) and pre- to post-stage (B) plasma 
interleukin-1ra concentration of ultra-endurance runners participating in a 230 km multi-stage 
ultra-marathon competition conducted in a hot ambient environment. Individual ultra-
endurance runner responses (●; n= 19). Additional individual responses outside the figure 










Pro-inflammatory to anti-inflammatory cytokine ratio. Pre-stage IL-1β: IL-10 and TNF-α: 
IL-10 ratios decreased in UER (p= 0.041 and p< 0.001, respectively) as the ultra-marathon 
progressed, with the lowest ratios seen at pre-Stage 4. Ratios in UER did not differ from 
CON pre-Stages 3 and 5. Only pre- to post-stage decreases in IL-1β: IL-10 ratio were 
observed in UER (p= 0.05), with the largest decrease occurring on Stage 1. No differences in 
sub-group comparisons were observed for IL-1β: IL-10 and TNF-α: IL-10 ratios. 
 
Gastrointestinal symptoms and thermal tolerance rating. GI symptoms were a common 
feature amongst UER sampled for endotoxin and cytokine responses; with 58% reporting at 
least one severe GI symptom (including 33% of sampled UER reporting nausea) during 
competition, while no GI symptoms were reported by CON. No difference in the reported 
rates of severe GI symptoms was observed between stages in UER. Perceptive thermal 
tolerance rating in UER improved as the ultra-marathon progressed (p= 0.005), with no 
change in CON. Additionally, no heat related symptoms or illnesses were observed in UER 
and CON throughout the ultra-marathon.  
 
Correlation analysis. Small but significant positive correlations were observed between pre-
stage circulatory gram-negative bacterial endotoxin concentration with pre-stage plasma CRP 
(r2= 0.343, p= 0.001), IL-6 (r2= 0.246, p= 0.019), IL-1β (r2= 0.305, p= 0.003), TNF-α (r2= 
0.370, p< 0.001), IFN-γ (r2= 0.282, p= 0.007), IL-10 (r2= 0.309, p= 0.003), and IL-1ra (r2= 
0.268, p= 0.011) concentrations; and between post-stage circulatory endotoxin concentration 
with post-stage plasma CRP concentration (r2= 0.213, p= 0.043). No correlations were 
observed between circulatory gram-negative bacterial endotoxin concentration and plasma 
cytokine concentrations with severe GI symptoms (including nausea). A strong relationship 





0.665, p< 0.001), whereby lower perceptive tolerance rating to heat was associated with 
greater reports of severe GI symptoms in UER. However, no correlations were observed 
between circulatory gram-negative bacterial endotoxin concentration and plasma cytokine 











Findings confirm that consecutive days of EHS resulted in a modest rise in both resting and 
post-stage circulatory gram-negative bacterial endotoxin concentration. Despite overnight 
recovery between stages, results show that pyrogenic pro-inflammatory cytokines (i.e., IL-1β, 
TNF-α, and IFN-γ) increased in response to EHS and remained elevated at rest throughout 
competition. These responses however were counteracted by anti-inflammatory cytokines 
(IL-10 and IL-1ra) which predominated throughout competition. Although the characteristics 
and magnitude of cytokine responses observed were similar to that of an acute infectious 
episode and in accordance with the aetiology of exertional-heat illnesses (i.e., exertional-heat 
stroke and SIRS), no diagnosis of heat related symptoms or illnesses by a qualified Sports 
Physician were established in UER along the ultra-marathon. Severe GI symptoms reported 
by UER were generally high; but in contrast to our hypothesis, no relationship between 
severe GI symptoms with circulatory gram-negative endotoxin concentration and cytokine 
profile were observed.   
 
In the current study, plasma CRP concentrations of UER increased by Stage 2 and remained 
elevated thereafter. Interestingly, on this occasion, males showed high plasma CRP 
concentration throughout competition compared with females, suggesting greater general 
inflammatory presence in males.  
 
The current ultra-marathon resulted in modest increases in post-stage circulatory endotoxin 
concentrations throughout competition (i.e., 30 pg·ml average increase from pre- to post-
stage, with the highest increase observed at 92 pg·ml). However, a novel finding was the 





increase from Stage 1 to 5, with 32% of runners had concentrations >100 pg·ml and the 
highest increase observed at 130 pg·ml). While, observed increases in resting pre-stage and 
pre- to post-stage plasma IL-6, IL-1β, TNFα, and IFN-γ concentrations remained elevated 
throughout competition; while no change in CON was observed (except for IL-1β). The 
cytokine profile of the current study mirrors that of an acute infectious episode. The current 
ultra-marathon also resulted in substantial increases in resting pre-stage and pre- to post-stage 
anti-inflammatory cytokines that remained elevated thereafter to a similar degree as 
compensatory anti-inflammatory syndrome (Adib-Conquy and Cavaillon 2009, Shubin, 
Monaghan, and Ayala 2011). 
 
Perceptive thermal comfort rating improved as competition progressed in the sampled 
population, and likely reflect heat acclimatization as evidenced by gradual increase in PV and 
reductions in Ttymp as the ultra-marathon progressed, with no changes in CON being observed 
(Costa et al. 2014, Costa et al. 2013b). In contrast to previous studies, no associations 
between GI symptoms with circulatory endotoxin concentration and cytokine responses were 
observed on this occasion. However, a strong relationship (r2= -0.665) between severe GI 
symptoms and perceptive thermal tolerance rating was confirmed (p< 0.001). 
 
As previously described in Chapter 4, the limitations in the sampled cohort are stated.  
 
In conclusion, multi-stage ultra-marathon competition in the heat resulted in a modest 
circulatory endotoxaemia accompanied by a pronounced pro-inflammatory cytokinaemia and 
compensatory anti-inflammatory responses. No incidences of exertional heat symptoms or 
illnesses were evident throughout competition. Even though severe GI symptoms were 
reported, no relationships with blood borne indices were identified. The expected exacerbated 





majority of runners, and thermoregulatory-induced adaptations and behaviours (e.g., heat 





























Circulatory Endotoxin Concentrations and Cytokine Profile During a 24 h Ultra-
Marathon in Temperate Ambient Conditions. 
Gill, S. K., Hankey, J., Wright, A., Marczak, S., Hemming, K., Allerton, D., Ansley-Robson, P., and Costa, R. J. 
S. (2015) ‘The Impact of a 24-hour Ultra-Marathon on Circulatory Endotoxin and Cytokine Profile’. 
International Journal of Sports Medicine 36 (8), 688-695 
    
7.1 Summary: The study aimed to determine circulatory endotoxin concentration, cytokine 
profile, and GI symptoms of UER (n= 17) in response to a 24 h continuous ultra-marathon 
competition (total distance range: 122-208 km) conducted in temperate ambient conditions 
(0-20°C) in mountainous terrain. BM and body temperature were measured, and venous 
blood samples were taken before and immediately after competition. Samples were analysed 
for gram-negative bacterial endotoxin, CRP, cytokine profile, and POsmol. GI symptoms were 
also monitored throughout competition. Mean exercise-induced BM loss was (mean ± SD) 
1.7 ± 1.8% in UER. Pre- and post-competition POsmol in UER was 286 ± 11 mOsmolkg
-1 and 
286 ± 9 mOsmolkg-1, respectively. Pre- to post-competition increases (p< 0.05) were 
observed for endotoxin (37%), CRP (2832%), IL-6 (3436%), IL-1β (332%), TNF-α (35%), 
IL-10 (511%), and IL-8 (239%) concentrations in UER, with no change in CON (n= 12) 
observed (p >0.05). GI symptoms were reported by 75% of UER, with no symptoms reported 
by CON.  IL-10 (r= 0.535) and IL-8 (r= 0.503) were positively correlated with GI symptoms. 
A 24 h continuous ultra-marathon competition in temperate ambient conditions resulted in a 
circulatory endotoxaemia and pro-inflammatory cytokinaemia, counteracted by a 











Even though exercising in hot ambient conditions per se appear to disturb intestinal epithelial 
integrity and promote an endotoxin-induced cytokine-mediated inflammatory response, it is 
plausible that extreme ultra-endurance competition, in the absence of heat-stress, but with 
prolonged exposure to a multitude of other multiple physiological stressors (Costa et al. 
2013a, Costa et al. 2013b), may also have the potential to impact intestinal epithelial 
integrity, and the subsequent cytokine-mediated inflammatory cascade in a similarly negative 
manner.  
 
With this in mind, the aims of the current study were to determine circulatory endotoxin 
concentration and cytokine profile of UER in response to a 24 h continuous ultra-marathon 
competition conducted in temperate ambient conditions; and additionally to determine the 
relationship between these responses with GI symptoms. Taking into account the nature of 
the event, it was hypothesised that a pronounced circulatory endotoxaemia would be seen 
after the event, and a pro-inflammatory cytokinaemic response would mirror the 
endotoxaemia. Additionally, it was hypothesised that correlations between circulatory 














Setting and participants. The study was conducted during the 2011 and 2012 Glenmore24 
Trail Race (www.glenmore24.com), held during the first week of September, in the 
Cairngorms National Park, Scottish Highlands, UK (Tamb range: 0-20°C, RH range: 54-82%). 
The 24 h continuous ultra-marathon was conducted on a 6 km looped-course on a variety of 
terrains; including off-road trails, paths, and grassland. Distance covered by participants 
ranged between 122-208 km at an estimated average intensity of 7.0 ± 1.3 METs (SenseWear 
7.0, Bodymedia, PA, Pittsburgh, USA), and in an altitude averaging 342 m above sea level. 
After ethical approval, a convenience sampling observational cohort was studied; whereby 25 
out of 48 UER entering the event volunteered to participate in the study; however complete 
blood sampling and biomarker data were only achieved in n= 17 (male n= 14, female n= 3: 
age 40 ± 7 y, height 177 ± 9 cm, BM 78.1 ± 11.9 kg). Additionally, 17 individuals who did 
not compete (absence of exercise stress), but were present at the race location, volunteered to 
participate in the study as part of the CON group for comparative purposes, however 
complete blood sampling and biomarker data were only achieved in n= 12 (male n= 4, female 
n= 8: age 30 ± 12 y, height 169 ± 10 cm, BM 68 ± 13 kg). All participants reported no illness 
and (or) infection in the twelve weeks leading up to the ultra-marathon. Additionally, no anti-
inflammatory agents of any form were consumed by all participants in the week leading up 
and during competition.  
 
Study design and data collection. Within the hour prior to commencement of competition 
(11:00h-12:00 h), BM measurements were taken, as previously described (Section 3.2). 
Participants were then required to sit in an upright position for 10 min before Ttymp was 





previously described (Section 3.6), for all participants (UER and CON). BM was re-
measured in those participants who needed to urinate prior to the start of competition. 
Immediately after competition (12:00 h the following day) and before any foods or fluids 
could be consumed, BM and Ttymp were measured, followed immediately by blood sampling, 
identical to pre-competition procedures. Also, within 1 h following competition, trained 
dietetic researchers conducted a standardised structured interview on participants to ascertain 
total foods and fluids ingested during the ultra-marathon. Severe GI symptoms (Pfeiffer et al. 
2012) were also explored at this time through a research-generated symptomology tool by 
trained researchers.  
 
Dietary analysis and hydration status. Dietary analysis and hydration status were determined 
as previously described in Section 3.3. Energy expenditure was measured by a triaxial 
accelerometer, which also included measurements of heat flux, skin temperature and galvanic 
skin responses (SenseWear 7.0, Bodymedia, PA, Pittsburgh, USA). Pre- and post-competition 
POsmol was determined as previously described in Section 3.3. The mean CV for energy, 
macronutrient, and water variables analysed was 0.8%, 1.4%, and 0.5%, respectively. The 
CV for POsmol was 3.5%. 
 
Blood sample analysis. Whole blood samples were analysed for circulatory concentrations of 
CRP, cytokines (IL-6, TNF-α, IL-1β, IFN-γ, IL-10, and IL-8) and gram-negative bacterial 
endotoxin, as previously described in Section 3.6.  
 
Data analysis. Data in text are presented as mean ± SD, otherwise specified. For clarity, data 
in figures are presented as mean ± SEM. Due to the commonly large individual variation in 





mean (lower and upper boundary). Data were processed and analysed in SPSS for Windows 
(SPSS v.17.0.2, Illinois, US). Prior to data analysis, outlying values for all variables were 
detected through box-plot analysis and appropriately removed. Diagnostic checks (Shapiro-
Wilks test of normality and Levene’s homogeneity of variance test) were performed prior to 
analysis. Where data violated the assumption of normality, data were log transformed, and 
the transformed data was analysed using parametric statistics, verified against non-parametric 
equivalents where appropriate. Paired-sample t-tests were applied to determine pre- to post-
competition variable differences; while independent-sample t-tests were applied for group 
comparisons (UER vs. CON, and distance covered (<160 km vs. ≥160 km)) (Pacque et al. 
2007, Peters and Bateman 1983). Due to insufficient female UER sample size, statistical 
analysis was not viable on this occasion, Spearman’s rank correlation analysis was used to 
assess associations between blood-borne variables with perceived GI symptoms. Individual 
participant ratios between IL-1β and TNF-α with IL-10 were calculated to determine the pro- 
to anti-inflammatory cytokine balance. Descriptive statistics were used to explore severe GI 

















Energy balance and hydration status. Total energy intake and energy expenditure over the 24 
h period was 21 ± 12 and 53 ± 11 MJ for UER, and 12.4 ± 1.3 and 13.6 ± 4.9 MJ for CON, 
respectively. Significant BM loss occurred pre- to post-competition (p= 0.001) in UER (pre-
competition: 78.1 ± 11.9 kg, post-competition: 76.8 ± 12.0 kg, 1.7 ± 1.8%). No significant 
difference in POsmol were observed pre- to post-competition in UER (pre-competition: 286 ± 
11 mOsmol·kg-1, post-competition: 286 ± 9 mOsmol·kg-1) and remained within normal 
clinical reference range (Thomas et al. 2008). Compared with CON, POsmol pre- and post-
competition was lower in UER (p= 0.05 and p< 0.001, respectively). 
 
Tympanic temperature. Ttymp was within normal range pre- and post-stage (36.0°C to 37.5°C) 
in UER and CON, with no difference between pre- and post-competition Ttymp observed in 
both groups. No difference in Ttymp was observed between UER and CON.  
 
Circulatory gram-negative bacterial endotoxin concentration. A pre- to post-competition 
increase in circulatory endotoxin concentration (overall mean change: 37%) was observed in 
UER (p= 0.009; Figure 7.1), with no significant change in CON evident (p= 0.005 vs. UER). 











Figure 7.1. Circulatory gram-negative bacterial endotoxin concentration of ultra-endurance 
runners participating in a 24 h continuous ultra-marathon. Mean ± SEM: UER (n= 17, ■) and 




Plasma C-reactive protein concentration. A pre- to post-competition increase in plasma CRP 
concentration (2832%) was observed in UER (p< 0.001; Figure 7.2), with no significant 
change in CON evident (p< 0.001 vs. UER). No difference in plasma CRP concentration was 












Figure 7.2. Plasma C-reactive protein concentration of ultra-endurance runners participating 
in a 24 h continuous ultra-marathon. Mean ± SEM: UER (n= 17, ■) and CON (n= 12, O). ** 




Plasma interleukin-6 concentration. A pre- to post-competition increase in plasma IL-6 
concentration (3436%) was observed in UER (p< 0.001; Table 7.1), with no significant 
change in CON evident (p< 0.001 vs. UER). Post-competition plasma IL-6 concentration was 
higher (p= 0.018) in UER totalling a distance ≥160 km compared to UER totalling a distance 
<160 km (Table 7.2).  
 
Plasma interleukin-1 beta concentration. A pre- to post-competition increase in plasma IL-1β 
concentration (332%) was observed in UER (p= 0.05; Table 7.1), with no significant change 
in CON evident (p= 0.032 vs. UER). No difference in plasma IL-1β concentration was 






Plasma tumour necrosis factor alpha concentration. A pre- to post-competition increase in 
plasma TNF-α concentration (35%) was observed in UER (p< 0.001; Table 7.1), with no 
significant change in CON evident. No difference in plasma TNF-α concentration was 
observed for distance covered.  
 
Plasma interferon gamma concentration. No significant change in pre- to post-competition 
plasma IFN-γ concentration was observed in UER or CON. No difference in plasma IFN-γ 
concentration was observed for distance covered.  
 
Plasma interleukin-10 concentration. A pre- to post-competition increase in plasma IL-10 
concentration (511%) was observed in UER (p< 0.001; Table 7.1), with no significant 
change in CON evident (p< 0.001 vs. UER). Post-competition plasma IL-10 concentration 
was higher (p= 0.002) in UER totalling a distance ≥160 km compared to UER totalling a 
distance <160 km (Table 7.2). 
 
Plasma interleukin-8 concentration. A pre- to post-competition increase in plasma IL-8 
concentration (239%) was observed in UER (p< 0.001; Table 7.1), with no significant 
change in CON evident (p< 0.001 vs. UER). A higher post-competition plasma IL-8 
concentration was observed in UER totalling a distance ≥160 km compared to UER totalling 











Table 7.1: Plasma cytokine profile of ultra-endurance runners before and immediately after a 







Plasma IL-6 concentration (pgml-1) 
 
UER 0.4 (0.3-0.5) 14.5 (9.3-19.7)**aa 
 
CON 0.6 (0.2-0.9) 1.8 (0.5-3.1) 
 
Plasma IL-1β concentration (pgml-1) 
 
UER 0.1 (0.0-0.3) 0.6 (0.1-1.1)*a 
 
CON 0.0 (0.0-0.1) 0.0 (0.0-0.1) 
 
Plasma TNF-α concentration (pgml-1) 
 
UER 2.8 (2.5-3.2) 3.8 (3.5-4.2)** 
 
CON 2.6 (1.8-3.3) 3.2 (2.4-4.0) 
 
Plasma IFN-γ concentration (pgml-1) 
 
UER 1.0 (0.6-1.4) 1.2 (0.3-2.2) 
 
CON 1.1 (0.6-1.6) 1.1 (0.6-1.6) 
 
Plasma IL-10 concentration (pgml-1) 
 
UER 2.1 (1.3-2.9) 12.8 (7.3-18.2)**aa 
 
CON 1.6 (0.1-3.2) 1.7 (0.1-3.3) 
 
Plasma IL-8 concentration (pgml-1) 
 
  
UER 11.4 (9.4-13.4) 38.7 (26.3-51.1)**aa 
 
CON 14.0 (10.2-17.7) 14.2 (11.1-17.2) 
 
Mean and 95% CI (lower and upper bound): UER (n= 17) and CON (n= 12). * p< 0.05 and 






Table 7.2: Pre- and post-competition circulatory gram-negative bacterial endotoxin 
concentration, plasma C-reactive protein concentration, and plasma cytokine profile of ultra-
endurance runners who completed ≥160 km and <160 km during a 24 h continuous ultra-







Circulatory gram-negative bacterial endotoxin concentration (EUml-1) 
 
≥160 km 3.5 (2.7-4.3) 4.5 (3.6-5.2) 
 
<160 km  3.1 (2.5-3.7) 4.7 (3.3-6.0) 
 
Plasma C-reactive protein concentration (µgml-1) 
 
≥160 km 0.5 (0.2-0.8) 22.2 (19.4-26.1) 
 
<160 km  1.0 (0.0-2.1) 23.4 (21.1-25.8) 
 
Plasma IL-6 concentration (pgml-1) 
 
≥160 km 0.5 (0.2-0.6) 19.8 (12.0-30.4)a 
 
<160 km  0.4 (0.3-0.5) 8.5 (5.6-11.5) 
 
Plasma IL-1β concentration (pgml-1) 
 
≥160 km 0.3 (0.0-0.7) 0.6 (0.0-1.6) 
 
<160 km  0.0 (0.0-0.0) 0.6 (0.0-1.4) 
 
Plasma TNF-α concentration (pgml-1) 
 
  
≥160 km 2.7 (1.8-3.4) 3.8 (3.3-4.4) 
 
<160 km  3.0 (2.7-3.3) 3.8 (3.2-4.5) 
 
Plasma IFN-γ concentration (pgml-1) 
 
≥160 km 1.0 (0.3-1.5) 1.2 (0.1-1.7) 
 










Plasma IL-10 concentration (pgml-1) 
 
≥160 km 2.0 (0.8-3.1) 19.7 (10.1-27.0)aa 
 
<160 km  2.2 (0.7-3.7) 4.9 (3.3-6.5) 
 
Plasma IL-8 concentration (pgml-1) 
 
≥160 km 11.5 (9.0-15.3) 47.7 (24.8-76.6)§ 
 
<160 km  11.3 (8.0-14.6) 28.5 (22.3-34.8) 
 
Mean and 95% CI (lower and upper bound): ≥160 km (n= 9) and <160 km (n= 8). a p< 0.05 
and aa p< 0.01 vs. <160 km, § p= 0.102 vs. <160 km 
 
Pro-inflammatory to anti-inflammatory cytokine ratio. A pre- to post-competition decrease in 
TNF-α: IL-10 ratio (72%; p< 0.001) was observed in UER, with no significant change in 
CON evident (p= 0.011 vs. UER). While a 32% decrease in IL-1β: IL-10 ratio was also 
observed in UER (p= 0.063 vs. CON), but this failed to reach significance (p> 0.05). Post-
competition TNF-α: IL-10 ratios were substantially lower (p= 0.008) in UER totalling a 
distance ≥160 km compared to UER totalling a distance <160 km. 
 
Gastrointestinal symptoms. Severe GI symptoms were a common feature amongst the cohort 
sampled for endotoxin and cytokine responses; with 75% of the cohort reporting at least one 
severe GI symptom (including 63% reporting nausea) during competition. Greater reports of 
severe GI symptoms were reported by UER totalling a distance ≥160 km compared to UER 
totalling a distance <160 km (p= 0.012). Spearman’s rank correlation analysis showed a 
positive correlation between reported rates of GI symptoms and plasma IL-10 (r= 0.535, p= 










Findings confirm that in the absence of heat-stress, but with prolonged exposure to other 
multiple physiological stressors, resultant endotoxaemia with accompanying cytokinaemia 
were characteristic of an acute infectious episode and in accordance with the aetiology of 
SIRS (Fehrenbach and Schneider 2006, Marshall 1998, Suzuki et al. 2002, Suzuki et al. 
1999). Severe GI symptoms were a common feature, with higher symptom occurrence 
associated with greater compensatory anti-inflammatory (i.e., IL-10) and immune activation 
(i.e., IL-8) responses. Additionally, post-competition IL-6, IL-10, and IL-8 responses were 
higher and TNF-α:IL-10 ratio was lower in those UER totalling a distance ≥160 km. 
 
In comparison to a 230 km multi-stage ultra-marathon conducted in hot ambient conditions 
(32°C to 40°C) (Chapter 6), whereby resting plasma CRP concentration increased 889% and 
circulatory endotoxin concentration peaked at 21% by Stage 5, plasma CRP and circulatory 
endotoxin concentration in the current study were markedly more pronounced despite the 
absence of heat stress, increasing 2832% and 37% post-competition, respectively. 
 
Despite temperate ambient conditions (0-20°C), the current study observed increases in pro-
inflammatory cytokine responses post-competition, similar to that of an acute infectious 
episode; whereby IL-6, IL-1β, and TNF-α increased 3436%, 332%, and 35%, respectively. 
Acute pro-inflammatory response is commonly accompanied by compensatory anti-
inflammatory (i.e., 511% increase in IL-10) and immune activation (i.e., 239% increase in 
IL-8) responses. As such, the observed decreases in TNF-α: IL-10 and IL-1β:IL-10 ratios in 
the current study suggest that the anti-inflammatory properties of IL-10 may have restricted 





ultra-marathon. Notably, those UER totalling a distance of ≥160 km had significantly greater 
post-competition IL-6 and IL-10 responses (overall mean: 19.8 pg·ml-1 and 19.7 pg·ml-1, 
respectively) compared to those UER totalling a distance <160 km (overall mean: 8.5 pg·ml-1 
and 4.9 pg·ml-1, respectively). Additionally, post-competition TNF-α: IL-10 ratio was 
substantially lower in UER totalling a distance ≥160 km compared to UER totalling a 
distance <160 km.  
 
In accordance with a recent multi-stage ultra-marathon study (Chapter 6), despite 58% of 
UER sampled for endotoxin and cytokine responses reporting severe GI symptoms during 
competition, and reporting being greater in UER totalling a distance ≥160 km compared to 
UER totalling a distance <160 km, no relationships between GI symptoms with circulatory 
endotoxin and pro-inflammatory cytokine concentrations was observed in the current study. 
Interestingly, an association between the reported number of severe GI symptoms and plasma 
concentrations of anti-inflammatory IL-10 (r= 0.535) and immune activator IL-8 (r= 0.503) 
was observed. 
 
In conclusion, a 24 h continuous ultra-marathon competition conducted in temperate ambient 
conditions with inclusion of multiple physiological stressors (i.e., sleep deprivation and 
energy deficit) resulted in endotoxaemia with accompanying cytokinaemia characteristic of 
an acute infectious episode. GI symptoms were commonly reported amongst UER, with 
higher symptom occurrence associated with greater compensatory anti-inflammatory 
responses and immune activation suggesting that alterations to intestinal motility and 








Acute Supplementation of Lactobacillus Casei on Salivary Anti-Microbial 
Proteins in Response to Exertional-Heat Stress. 
Gill, S. K., Teixeira, A. M., Rosado, F., Cox, M., and Costa, R. J. S. (2015) ‘High-Dose Probiotic 
Supplementation Containing Lactobacillus casei for 7 Days Does Not Enhance Salivary Antimicrobial Protein 
Responses to Exertional-Heat Stress Compared With Placebo’. International Journal of Sport Nutrition and 
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Summary 8.1: The study aimed to determine if acute high dose probiotic supplementation 
containing L.casei enhances S-AMP responses to EHS. Eight endurance trained male 
volunteers completed a blinded randomised cross-over design. Oral supplementation of the 
probiotic beverage (L.casei x 1011 CFU·day-1) (PRO) or placebo (PLA) was consumed for 
seven consecutive days before 2 h running exercise at 60% VO2max in hot ambient conditions 
(34.0°C and 32% RH). BM, unstimulated saliva and venous blood samples were collected 
one week before EHS (baseline), pre-EHS, during recovery (1 h, 2 h, and 4 h), and at 24 h. 
Saliva samples were analysed for S-IgA, S-α-amylase, S-lysozyme, and S-cortisol. Plasma 
samples were analysed for POsmol. BM and POsmol did not differ between trials. SFR remained 
relatively constant throughout the experimental design in PRO (overall mean ± SD: 601 ± 
284 µl·min) and PLA (557 ± 296 µl·min). PRO did not induce significant changes in resting 
S-AMP responses compared with PLA (p> 0.05).  Increases in S-IgA, S-α-amylase, S-
lysozyme, and S-cortisol concentration were observed after EHS (p< 0.05). No main effects 
of trial or time x trial interaction were observed for S-AMP and S-cortisol responses. Acute 
supplementation of a probiotic beverage containing L.casei for seven days before EHS does 
not provide any further oral-respiratory mucosal immune protection, with respect to S-AMP, 
over a PLA. Maintenance of hydration and exertional stress per se appears to have a more 






8.2 Introduction  
 
It has been suggested that probiotic supplementation may play a role in preventing or 
attenuating URSI during periods of compromised oral-respiratory mucosal status through 
alterations in S-AMP responses (Gill and Prasad 2008, West et al. 2009). For example, 
probiotic supplementation studies in active populations have reported mild decreases (Cox et 
al. 2010b; Gleeson et al. 2011a), but also no change (Kekkonen et al. 2007), in URSI. 
Considering the clinical significance of exertion-induced compromised S-AMP responses, 
with respect to URSI risk, the influence of probiotic supplementation on each individual S-
AMP (i.e., S-IgA, S-α-amylase, and S-lysozyme) and how these respond in combination to 
exertion has not yet been thoroughly investigated. It is thus plausible and proposed that 
repetitive exposure of a substantial non-toxic bacterial load at the oral-respiratory mucosal 
surface over an acute period may promote enhanced S-AMP responses (e.g. up-regulation of 
S-AMP secretion). L.casei is one of the most popular commercially available probiotics 
worldwide and appears to modulate mucosal surfaces beyond the GI tract (Spanhaak et al. 
1998).  
 
A lower dose of probiotic supplementation between two weeks to six months are generally 
used within clinical research models (Ford et al. 2014, Moayyedi et al. 2010). Considering 
that previous research has established that as dosage of probiotic supplementation increases, 
the proportion of bacteria specific positive subjects also increases (Christensen et al. 2006); 
providing a higher dosage over a shorter duration, which mimics athlete population 
consumption behaviours, replicates the supplemented bacterial load of previous lower dosage 
longer duration research models. From a practical perspective, long-term consumption of 





consumption of probiotics (e.g., beverage form) is common before event participation, during 
periods of intensified training, and in anticipation to international travel, with reported focus 
on prevention-management of URSI episodes (West et al. 2009; Walsh et al. 2011b). Indeed, 
high volumes of commercially available probiotic beverages consumption has been observed 
before multi-stage ultra-marathon competition (Chapter 4).  
 
With this in mind, the study aimed to determine if oral supplementation of a commercially 
available probiotic beverage containing L.casei (x 1011 CFU·day-1) for seven consecutive 
days can enhance S-AMP responses to EHS in an endurance trained population. It was 
hypothesised that enhanced S-AMP responses would be seen after one week of 



















8.3 Methods   
 
Participants. Eight non-heat acclimatised healthy endurance trained male runners (mean ± 
SD: age 26 ± 6 years, nude BM 70.2 ± 8.8 kg, height 1.75 ± 0.05 m, VO2max 59 ± 5 ml·kg
-
1·min-1; endurance sport competitive experience types include: triathlon, road and trail 
running, and ultra-endurance running) volunteered to participate in the study. All participants 
gave written informed consent, which received ethical approval from the local Ethics 
Committee that conforms with the 2008 Helsinki Declaration for Human Research Ethics. 
Participants confirmed that they had not consumed probiotics, in any form, within the 
previous three month period and consumption was prohibited during the study. Figure 8.1 is 












































Assessed for Eligibility (n= 14) 
Randomised (n= 8) 
Excluded (n=6) 
Illness within the 12 
weeks prior to 
intervention (n=2) 
Injury (n= 1) 
Refusal to 
participate (n= 3)  
Allocated to intervention 
(PRO) (n= 8) 
Received allocated 
intervention (n= 8) 
Allocated to intervention 
(PLA) (n= 8) 
Received allocated 













(PRO) (n= 8) 
 
Completed follow-up 
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Preliminary measures. Previous research has indicated that commercially available probiotics 
in the UK may lack the number of microbiota otherwise stated (Hamilton-Miller et al. 1996). 
Therefore, prior to the study, preparations were cultured in duplicate (CV: 2.5%) for 
Lactobacillus on DeMan-Rogosa-Sharpe agar to estimate the level of Lactobacillus contained 
within the probiotic beverage (stated count: 1.0 x 108 CFU·ml-1). The counts from these 
cultured plates were 1.9 x 108 CFU·ml-1. The commercially available probiotic beverage 
containing L.casei used was kept confidential to comply with product anonymity ethical 
procedures.  
 
Two weeks before the first experimental trial, height and nude BM were recorded. VO2max 
(Cortex MetaMax 3B, Biophysik, Leipzig, Germany) was estimated by means of a 
continuous incremental exercise test to volitional exhaustion on a motorized treadmill 
(h/p/cosmos Mercury 4.0, Nussdorf-Traunstein, Germany), as previously reported (Costa et 
al., 2009). From the VO2–work rate relationship, the treadmill speed at 60% VO2max and 1% 
gradient was extrapolated (9.9 ± 1.1 km·h-1). 
 
Experimental procedure. One week before the EHS trial (baseline) whole blood samples 
were collected, as previously described (Section 3.6). Participants then provided a 4 min 
saliva sample, as previously described (Section 3.5). Immediately after baseline samples, in a 
blinded randomised and counterbalanced order, participants were provided with either PRO 
or PLA for consumption over the subsequent seven consecutive days. The overall PRO and 
PLA dose was split into two equal boluses (500 ml) that were consumed between 08:00-
09:00 h and 16:00-17:00 h, respectively. The placebo formulation was similar in taste, 
consistency, colour and nutritional value to the probiotic formulation, but contained no 





100ml: 70 kCal, 14.7 g carbohydrate, 1.9 g protein, fat 0.1 g).  Dietary intake was assessed 
and analysed as previously reported (Costa et al. 2013a).  
 
On two occasions following seven consecutive days of either PRO or PLA, and separated by 
one month washout, participants reported to the laboratory at 8:00h after consumption of a 
standardised breakfast (526 kCal, 118 g carbohydrate, 9 g protein, and 2 g fat) with 400 ml of 
water (07:00h). Within 30 min before the EHS trial, participants were asked to void before 
nude BM measurements. Blood and saliva samples were then collected. Participants initiated 
(09:00h) running exercise on a motorised treadmill for 2 h at the previously determined 
treadmill speed that elicited 60% VO2max, dressed in athletic shorts, socks and shoes. The 2 h 
exercise bout was performed in an environmental chamber with ambient conditions of 34.0 ± 
0.4°C and 32 ± 2% RH. Heart rate (HR) measured by a short-range radiotelemetry monitor 
(Polar Electro, Kempele, Finland), rating of perceived exertion (RPE), thermal comfort rating 
(TCR), and Tre (CorTemp Core Body Temperature Sensor, Florida, USA) were recorded 
every 10 min during EHS (Costa et al. 2010). Participants were provided with water ad 
libitum. Immediately post-EHS, blood and saliva samples were collected, and nude BM was 
recorded, as previously described (Section 3.2, Section 3.5, and Section 3.6). Blood and 
saliva samples were additionally collected 1 h, 2 h, and 4 h post-EHS, and 24 h after the EHS 
protocol (09:00h the next morning). To reduce any seasonal heat acclimatisation, the 
experimental procedure was conducted in during winter (Costa et al. 2014).  
 
Sample analysis. POsmol was determined as previously described (Section 3.3). Saliva samples 
were analysed, as previously described (Section 3.5). On this occasion, due to sample 
availability, S-lysozyme was determined at baseline, pre-EHS, post-EHS, 2 h and 4 h post-





Statistical analysis. Based on the typical standard deviation of 73 µl·min-1, 33 U·min-1 and 3 
µl·min-1 for S-IgA, S-α-amylase, and S-lysozyme secretion rates to exertional stress, 
respectively (Costa et al. 2009, Chapter 4 and Chapter 5); using standard alpha (0.05) and 
beta values (0.8), a sample size of n= 8 is estimated to provide adequate statistical precision 
to detect a >29% change in S-AMP responses to exertional-heat stress (Costa et al. 2012, 
Fortes et al. 2012). Such reductions in S-AMPs (namely, S-IgA) have been associated with 
increased incidence of URSI (Gleeson et al. 2011a, Neville et al. 2008). Data in the text and 
tables are presented as mean ± SD. For clarity, data in figures are presented as mean ± SEM. 
The data were examined using two-way repeated-measures ANOVA, except for nude BM 
loss and water intake that were examined using paired sample t-test and Wilcoxon signed-
rank test where appropriate. Assumptions of homogeneity and sphericity were checked, and 
when appropriate adjustments to the degrees of freedom were made using the Greenhouse–
Geisser correction method. Significant main effects were analysed using a post hoc Tukey’s 







Energy intake and hydration status. No significant differences in total daily energy intake 
(mean ± SD: PRO 2329 ± 245 kCal·day-1, PLA 2449 ± 364 kCal·day-1; p= 0.190), 
carbohydrate (PRO 307 ± 72 g·day-1, PLA 320 ± 77 g·day-1; p= 0.304), protein (PRO 101 ± 
11 g·day-1, PLA 102 ± 19 g·day-1; p= 0.833), fat (PRO 76 ± 9g·day-1, PLA 82 ± 16 g·day-1; 
p= 0.503), and water intake (PRO 2.6 ± 0.4 L·day-1, PLA 2.8 ± 0.4L·day-1; P= 0.064) during 
the seven-days supplementation period were observed between PRO and PLA. 
 
No significant difference in ad libitum water intake during EHS was observed between PRO 
and PLA (1.7 ± 1.4 L and 1.9 ± 1.8 L, respectively). Exercise-induced BM loss occurred pre- 
to post-EHS on PRO (1.5 ± 1.5%; p= 0.030) and PLA (1.3 ± 1.4%; p= 0.029). Compared 
with pre-EHS values, no significant changes in immediate post-EHS and recovery POsmol 
were observed on PRO (pre-EHS: 296 ± 7 mOsmol·kg-1, post-EHS: 302 ± 10 mOsmol·kg-1, 
and overall recovery: 298 ± 12 mOsmol·kg-1) and PLA (pre-EHS: 294 ± 6 mOsmol·kg-1, 
post-EHS: 297 ± 11 mOsmol·kg-1, and overall recovery: 297 ± 8 mOsmol·kg-1). Moreover, 
POsmol did not differ between PRO and PLA throughout the experimental protocol.  
 
Cardiovascular and thermoregulatory strain. No significant difference in HR (165 ± 16 bpm) 
and 165 ± 16 bpm), Tre (38.6 ± 0.8°C and 38.6 ± 0.7°C), RPE (12 ± 3 and 13 ± 3), and TCR 
(11 ± 1 and 11 ± 1) were observed between PRO and PLA during EHS, respectively.  
 
Saliva flow rate. A significant main effect of time was observed (p= 0.004; Table 8.1), 





pre-EHS. No significant main effects of trial or trial x time interaction were observed for 
SFR.  
 
Table 8.1: Saliva flow rate in response to 2 h running at 60% VO2max in hot ambient 
conditions (exertional-heat stress) following seven consecutive days of probiotic and placebo 
supplementation. 




1 h post 
EHS 
2 h post 
EHS 





Saliva Flow Rate (μl·min-1)  
      † † 
PRO 472 ± 224 558 ± 280 543 ± 293 699 ± 300 659 ± 229 644 ± 360 631 ± 298 
 
PLA 435 ± 314 501 ± 355 430 ± 285 535 ± 214  648 ± 284 717 ± 367 631 ± 255 
        
Mean ± SD (n= 8). Main effect of time † p< 0.05 vs. pre-EHS. 
 
Salivary anti-microbial protein responses. PRO did not induce significant changes in resting 
pre-EHS S-IgA, S-α-amylase and S-lysozyme concentrations and secretion rates compared 
with PLA (Table 8.2). Significant main effects of time were observed for S-IgA 
(concentration p= 0.004 and secretion rate p= 0.005) and S-α-amylase (concentration p= 
0.011 and secretion rate p= 0.045) responses only. Whereby, S-IgA concentration and 
secretion rate were significantly higher immediately post-EHS (37% and 23%, respectively), 
but S-IgA concentration was lower at 24 h (32%), compared with pre-EHS values; and S-α-
amylase concentration and secretion rate were significantly higher immediately (267% and 
186%, respectively) and 1 h post-EHS (90% and 93%, respectively) compared with pre-EHS 
values (Table 8.2). No significant main effects of trial or trial x time interaction were 
observed for S-IgA, S-α-amylase, and S-lysozyme concentrations and secretion rates 





Table 8.2: Salivary anti-microbial protein responses to 2 h running at 60% VO2max in hot ambient conditions (exertional-heat stress) following 
seven consecutive days of probiotic and placebo supplementation. 




1 h post 
EHS 
2 h post 
EHS 




Salivary IgA concentration (μg·ml-1) 
   †    †† 
PRO 264 ± 110    396 ± 113                         527 ± 317 360 ± 215 423 ± 193 360 ± 225 283 ± 147 
 
PLA 383 ± 185    432 ± 182                            606 ± 170 448 ± 105 369 ± 128 396 ± 187 282 ± 160 
 
Salivary IgA secretion rate (μg·min-1) 
   †     
PRO 121 ± 84 229 ± 131 260 ± 183 255 ± 201 286 ± 157 203 ± 117 192 ± 126 
 
PLA 160 ± 160 196 ± 120 264 ± 182 245 ± 125 236 ± 116 223 ± 124 165 ± 94 
 
Salivary α-amylase concentration (U·ml-1) 
   †† †    
PRO 96 ± 91 139 ± 156 385 ± 302 200 ± 174 169 ± 145 134 ± 103 48 ± 41 
 
PLA 70 ± 41 67 ± 57 371 ± 380 191 ± 169 178 ± 205 173 ± 187 117 ± 127 
 
Salivary α-amylase secretion rate (U·min-1) 
   † †    
PRO 42 ± 32 97 ± 117 238 ± 226 162 ± 183 113 ± 94 100 ± 95 32 ± 33 
 








Salivary lysozyme concentration (μg·ml-1) 
        
PRO 4.4 ± 9.3 4.7 ± 10.4 7.4 ± 10.9 ---- 3.8 ± 8.7 5.1 ± 10.0 ---- 
 
PLA 2.8 ± 5.5 2.2 ± 2.6 
 
4.4 ± 7.9 ---- 4.3 ± 7.2 5.3 ± 10.6 ---- 
Salivary lysozyme secretion rate (μg·min-1) 
        
PRO 1.3 ± 2.1 1.9 ± 3.7 3.2 ± 5.4 ---- 2.4 ± 5.2 3.0 ± 5.7 ---- 
 
PLA 0.9 ± 1.3 1.0 ± 1.0 2.5 ± 4.5 ---- 3.0 ± 5.5 2.8 ± 4.4 ---- 
 















Figure 8.2: Changes in salivary IgA concentration (A) and secretion rate (B) in response to 2 
h running at 60% VO2max in hot ambient conditions (exertional-heat stress) following seven 
consecutive days of probiotic and placebo supplementation. Mean ± SEM (n= 8): PRO (O) 









Figure 8.3: Changes in salivary α-amylase concentration (A) and secretion rate (B) in 
response to 2 h running at 60% VO2max in hot ambient conditions (exertional-heat stress) 
following seven consecutive days of probiotic and placebo supplementation. Mean ± SEM 









Figure 8.4: Changes in salivary lysozyme concentration (A) and secretion rate (B) in 
response to 2 h running at 60% VO2max in hot ambient conditions (exertional-heat stress) 
following seven consecutive days of probiotic and placebo supplementation. Mean ± SEM 









Salivary cortisol responses. PRO did not induce significant changes in resting pre-EHS S-
cortisol concentration and appearance rate compared with PLA. A significant main effect of 
time was observed for S-cortisol concentration (p= 0.05), but not appearance rate (p= 0.072) 
(Table 8.3); whereby S-cortisol concentration was significantly higher immediately and 1 h 
post-EHS (84% and 47%, respectively), but lower 2 h and 4 h post-EHS (32% and 64%, 
respectively) compared with pre-EHS values. No main effects of trial or trial x time 
interaction were observed for S-cortisol concentration and appearance rate.  
 
Table 8.3: Salivary cortisol responses to 2 h running at 60% VO2max in hot ambient 
conditions (exertional-heat stress) following seven consecutive days of probiotic and placebo 
supplementation. 




1 h post 
EHS 
2 h post 
EHS 




Salivary cortisol concentration (μg·ml-1) 
   * † † ††  
PRO 22 ± 9 29 ± 13 55 ± 44 42 ± 22 20 ± 9 9 ± 4 35 ± 23 
 
PLA 32 ± 15 38 ± 20 68 ± 68 56 ± 44 25 ± 15 15 ± 10 30 ± 35 
 
Salivary cortisol appearance rate (μg·min-1) 
        
PRO 11 ± 7 16 ± 10 30 ± 23 31 ± 21 13 ± 6 5 ± 3 25 ± 22 
 
PLA 13 ± 11 17 ± 11 34 ± 39 28 ± 20 17 ± 13 10 ± 6 13 ± 10 
 
Mean ± SD (n = 8). Main effect of time † p< 0.05 and †† p< 0.01 vs. pre-EHS; main effect of 








The current study aimed to determine if oral supplementation of a commercially available 
probiotic beverage containing L.casei (x 1011 CFU·day-1) for seven consecutive days can 
enhance S-AMP responses to EHS in an endurance trained population. In contrast with our 
hypothesis, one week of PRO supplementation did not enhance S-AMP responses after or 
during recovery from EHS compared with PLA. Despite the large bacterial exposure, all 
resting S-AMP values were unaltered after seven days of PRO supplementation. S-AMP 
increased in response to EHS, with depressions in S-IgA seen after 24 h, and no difference 
between PRO and PLA observed. It is thus unlikely that acute high dose supplementation of a 
probiotic beverage containing L.casei prior to EHS provides any further oral-respiratory 
mucosal immune protection (i.e., prevention or reduction in URSI episodes), with respect to 
S-AMP, over a placebo.  
 
It is plausible that repetitive probiotic administration over consecutive days may lead to 
enhanced S-AMP responses, especially during compromised periods (Gleeson et al. 2011a). 
On the contrary, despite the high probiotic dosage of the current study, S-IgA responses were 
unaltered after seven days of supplementation, and did not differ from PLA immediately 
post-EHS and during the recovery period. Equally, no significant changes in S-IgA responses 
with probiotic supplementation (L.fermentum VRI-003) was observed over four months of 
winter training in elite male distance runners (Cox et al. 2010b); whilst no difference in S-
IgA responses was observed with probiotic supplements (L.casei DN-114 001) during three 
weeks of intensified military training followed by a five-days combat course compared with 






In the current study, no changes in S-α-amylase and S-lysozyme responses were observed 
after seven days of PRO; but on both trials, S-α-amylase responses increased after EHS, 
which likely reflect the degree of the exertional stress per se (Bosch et al. 2003b, Rosa et al. 
2014). Thus, the clinical relevance of probiotic use in populations exposed to EHS is unclear. 
It is possible that in immunocompromised and (or) illness-prone individuals partaking in 
exertional or EHS who commonly experience URSI may benefit from longer term low dose 
probiotic supplementation, given that previous research has shown mild reductions in severity 
and (or) duration of URSI (Gleeson et al. 2011a, Cox et al. 2010b). However, these outcomes 
are likely to be external to S-AMP responses.  
 
In conclusion, the results of the current study suggest that a daily oral supplementation of a 
commercially available probiotic beverage containing L.casei for seven consecutive days 
does not influence S-AMP responses and subsequent oral-respiratory mucosal immune status 
above placebo in response to EHS in an endurance trained population. During the trial 
periods, maintenance of hydration status (and SFR) and the exertional stress per se (e.g., 
increases in S-α-amylase responses) appear to have a more favourable impact on S-AMP 














Acute Supplementation of Lactobacillus Casei on Circulatory Endotoxin Concentrations 
and Cytokine Profile in Response to Exertional-Heat Stress. 
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Prolonged physical exertion with accompanying physiological stressors ((e.g., environmental 
extremes, sleep deprivation and compromised hydration and (or) nutritional status)) have all 
been individually reported to influence host defence through stimulation of neuroendocrine 
responses (namely cortisol and catecholamines), leading to alterations in immune responses. 
It is therefore plausible that participating in extreme physical exertion (e.g., activities such as 
ultra-endurance, adventure and exploration events, military training, expeditionary 
operations) with accompanying physiological stressors, particularly in unfamiliar 
environments harboured by pathogens unrecognisable by the immune system, may induce 
neuroendocrine responses to a greater extent, prompting amplified or cumulative 
perturbations to host defence and increasing susceptibility of unwanted clinically significant 
outcomes (Martinez-Lopez et al. 1993, Neville, Gleeson, and Folland 2008, Nieman 1997, 
Shephard, Castellani, and Shek 1998). Notably, due to the observational nature of the ultra-
marathon studies (Chapter 4 to Chapter 7) and a subsequent lack of adequate research 
control, determining which individual or combination of stressors responsible for the 
perturbations in immune variables observed is limited. 
 
More recently, probiotic consumption in active populations as a strategy to attenuate and (or) 
prevent immune perturbations and unwanted clinically significant outcomes associated with 
the aforementioned physiological stressors, has gained considerable research interest within 
exercise immunology. Known for their immunostimulatory effects, it is plausible that 





susceptibility to illness and infection and promoting sporting potential and performance 
amongst active populations. The probiotic-EHS studies (Chapter 8 and Chapter 9) was 
conducted using n= 8 and thus considered a relatively small sample size. Notably, a larger 
sample size would be considered more representative of the endurance running population 
and would have allowed for further sub-group analysis. 
 
The broad aims of this thesis were therefore to investigate: 1. oral-respiratory mucosal 
immune status (S-IgA, S-α-amylase and S-lysozyme), stress hormone response (S-cortisol) 
and incidence of URS in response to extreme physical exertion with accompanying multi-
stressors reported to disturb immune homeostasis; 2. intestinal epithelial integrity (assessed 
by circulatory endotoxin concentration), cytokine profile and incidence of GI symptoms in 
response to extreme physical exertion with accompanying multi-stressors reported to disturb 
immune homeostasis and finally, 3. acute high dose probiotic supplementation in the 
prevention of unwanted perturbations to oral-respiratory mucosal immune status and 















10.2 Salivary Anti-Microbial Protein Responses and Extreme Physical Exertion, With 
and Without Heat-Stress 
 
The field-based investigative studies presented in Chapter 4 and Chapter 5 provide a novel 
insight into the effects of ultra-marathon competition on oral-respiratory mucosal immunity. 
The first study (Chapter 4) aimed to determine the effects of a multi-stage ultra-marathon in 
hot ambient conditions, whilst the second study (Chapter 5) aimed to determine the effects 
of a 24 h continuous ultra-marathon in temperate ambient conditions. Previous studies have 
indicated that partaking in prolonged physical exertion is associated with depressions in S-
IgA and an increased susceptibility to URSI (Bishop and Gleeson 2009, Gleeson 2000, 
Neville, Gleeson, and Folland 2008, Nieman et al. 2006a, Nieman 1997, Nieman 1994) via 
mechanisms such as the degree of exercise-stress (e.g., duration), environmental extremes, 
increased circulatory stress hormone concentrations, and compromised hydration status and 
energy inadequacy (Costa et al. 2005, Fortes et al. 2012, Heath et al. 1991, Sabbadini and 
Berczi 1995, Saxon et al. 1978). Albeit, the influence of extreme physical exertion on S-IgA 
is extremely limited, whilst the influence of other S-AMPs on oral respiratory mucosal 
immune status have been investigated to a far lesser degree. To date, the study presented in 
Chapter 4 was the first to assess and track oral-respiratory mucosal immune parameters (S-
IgA, S-α-amylase, and S-lysozyme) during a multi-stage ultra-marathon in the heat; whilst 
the study presented in Chapter 5 was the first to assess and explore oral-respiratory mucosal 
immune parameters during a 24 h continuous ultra-marathon in the absence of heat stress but 
with inclusion of other physiological stressors known to perturb immune function. 
 
The field-based study conducted in Chapter 4 demonstrated that only mild alterations in S-





mild alterations may not have been large enough to promote and (or) increase pathogen 
adherence and infection incidence. Additionally, the lower incidence of the common cold 
during the mid-summer months is likely to have contributed to the low incidence of illness 
symptoms reported by runners.  
 
In the multi-stage ultra-marathon study, an average exercise-induced BM loss of 2.0% and a 
post-stage POsmol of 293 mOsmol·kg
−1 was observed along the ultra-marathon course. The 
consistent euhydration status observed in the majority of runners (≤1.5% BM loss in 67% of 
UER) may have prevented substantial depressions in SFR and provided protection against the 
drying of oral-respiratory mucosal surfaces that has been associated with URS (e.g., 
inflammation and exercise-induced asthma). Indeed, previous laboratory-controlled 
dehydration protocols (3.5% BM loss and POsmol of 297 mOsmol·kg
−1) have reported 
reductions in the SFR (67%), resulting in depressed S-AMP responses (Fortes et al. 2012). In 
the multi-stage ultra-marathon study, the pre- to post-stage reduction in the SFR ranged from 
20-37%, whereas the S-AMP responses generally remained unchanged or showed increased 
responses (Table 4.2). These results are in accordance with the findings of previous 
laboratory-based trials reporting 20-28% reductions in SFR, 1.9-2.4% exercise-induced BM 
loss, and S-AMP responses generally remaining unchanged or increased during the recovery 
period after 2 h of strenuous running (Costa et al. 2012, Costa et al. 2009). If larger numbers 
of UER had produced greater degrees of post-stage hypohydration (e.g., >3.0%), it is 
speculated that greater overall reductions in the SFR and larger overall perturbations to the S-
AMP responses may have been observed.  
 
It is likely that the changes in S-AMP responses observed (i.e., decreases in S-IgA secretion 





mechanistic differences in the storage and secretion (endocytosis vs. transcytosis) of S-AMPs 
(Bishop and Gleeson 2009) and (or) neuroendocrine influences. For instance, S-α-amylase 
and S-lysozyme are synthesized and stored within secretory granules, unlike S-IgA, which is 
produced by B-lymphocyte cells and transported across epithelial cells to the mucosal surface 
by PIgR activity (Bishop and Gleeson 2009). Because sympathetic activation alters saliva 
composition and elicits a high protein content secretion, exercise heat-induced stimulation 
may promote a greater secretion of S-α-amylase and S-lysozyme into the saliva (Bishop et al. 
2000, Chatterton et al. 1996). Alternatively, the contribution of different salivary glands and 
different stimuli activating specific glands may have also played a role in the observed altered 
responses of the S-AMPs (Noble 2000). Moreover, saliva secretions are under 
neuroendocrine control (Carpenter et al. 2000, Carpenter et al. 1998, Chicharro et al. 1998; 
Teeuw et al. 2004, Tenovuo 1998). Therefore, HPA activation and an increase in cortisol 
concentrations (Table 4.3) causing inhibitory effects on the transepithelial transport of IgA, 
rather than IgA synthesis (Hucklebridge, Clow, and Evans 1998), in conjunction with 
reductions in the SFR and altered saliva composition (Carpenter et al. 2000, Carpenter et al. 
1998, Chicharro et al. 1998, Teeuw et al. 2004, Tenovuo 1998), may in part, explain the pre- 
to post-stage reductions in the SFR on Stages 1-4 and the S-IgA secretion rates on Stages 2-5 
in UER, as well as the large discrepancies in pre-stage S-IgA values between UER and CON, 
although this failed to reach significance (Table 4.1).  
 
In the multi-stage ultra-marathon study, transient fluctuations were observed in all salivary 
immune markers throughout the ultra-marathon competition, with the post-stage changes 
being the most noticeable. Any observed reductions in post-stage S-IgA responses were 
compensated for by increases in S-α-amylase and S-lysozyme responses during the 





(Allgrove et al. 2008; Costa et al. 2012); they highlight the importance of collectively 
assessing oral-respiratory immune markers when determining oral-respiratory mucosal 
immune status in active populations and suggest no evidence of depressed oral-respiratory 
immune status in the majority of runners during a multi-stage ultra-marathon.  
 
Taking into account that S-AMPs act synergistically to protect the oral respiratory pathway 
from pathogen invasion, and more specifically, that S-α-amylase and S-lysozyme exhibit 
similar protective properties similar as S-IgA, the previously proposed “open window 
hypothesis”, whereby viruses and (or) bacteria may gain a hold on oral-respiratory mucosal 
surfaces, leading to illness and (or) infection (Nieman 1994), often attributed to the 
commonly observed transient decreases in S-IgA responses (Costa et al. 2009, Gleeson et al. 
2000, Neville et al. 2008), may be misleading. Given the low prevalence (n= 1)  of URS 
during and up to four weeks after competition, future studies should investigate alterations in 
S-AMPs, other than S-IgA, in relation to illness and (or) infection incidence during the 
common cold season. 
 
Often, illness symptoms are assessed through self-report because of the practical issues 
associated with medical diagnosis in a field-based setting. It is recognized that the illness 
symptoms reported by runners may simply reflect other conditions that mimic URS (Cox et 
al. 2010a; Cox et al. 2008, Robson-Ansley et al. 2012), and for this reason, it is difficult to 
distinguish causation (Spence et al. 2007). More recently, a ‘non-infectious’ hypothesis was 
developed, in which inflammatory factors (e.g., irritants, pollen, pollution, dust, other 
allergens) manifest as infectious URS (Spence et al. 2007, Robson-Ansley et al. 2012, Walsh 
et al. 2011a).This may explain, in part, these seemingly higher incidence of symptoms 





view of the extreme nature of multi-stage ultra-marathon competition, the illness symptom 
reports in the runners were extremely low. The effective management of allergy–respiratory 
illness symptoms (e.g., asthma) through the appropriate use of medication around 
competition; forecasts of low to moderate pollen counts across the region during the time of 
competition; low levels of environmental air pollution in the course vicinity; and (or) 
maintaining hydration status, thus preventing the drying of mucosal surfaces and ensuring the 
permanent presence of S-AMPs at the oral-respiratory mucosal surface (Anderson and 
Kipperlen 2008, Cox et al. 2010a, Cox et al. 2008, Robson-Ansley et al. 2012, Tenovuo 
1998) are all factors that may have contributed to the low incidence of URS. 
 
However, a potential limitation of the multi-stage ultra-marathon study is the failure to 
measure other S-AMPs (e.g., lactoferrin) with anti-bacterial and anti-viral properties, which 
act synergistically with those reported and play a significant role in maintaining oral-
respiratory mucosal immune status (Walsh et al. 2011a, West et al. 2006), giving a better 
global overview of salivary immune responses to consecutive days of EHS. Additionally, the 
extreme nature of the event and the invasive techniques used to determine blood borne 
hydration status at frequent points during the ultra-marathon created a potential barrier to 
obtaining full data sets from all the recruited participants (n =37). 
 
From a practical viewpoint, the findings from the multi-stage ultra-marathon study suggest 
that appropriate education (e.g., hydration maintenance, non-infectious episode management, 
medical management of established respiratory illness) and information (i.e., pollen and 
pollution counts at the competition location) may help prevent significant clinical and 
performance decrements from occurring in UER during multi-stage ultra-marathon 





The field-based study presented in Chapter 5 demonstrated reductions in some S-AMP 
secretion rates post-competition (i.e., S-IgA and S-lysozyme), and increases in others (i.e., S-
α-amylase). Despite the 24 h continuous exercise-stress, in which participants were exposed 
to a period of cold ambient conditions and energy inadequacy, no URS were reported by 
UER during and 4 weeks following the ultra-marathon.  
 
Given that S-α-amylase exhibits similar protective properties as other S-AMPs (Walsh et al. 
2011a, West et al. 2006), in the 24 h continuous ultra-marathon study, its enhanced response 
may have offset any potential negative impact of reduced S-IgA and S-lysozyme responses 
(Table 5.1). Similar increases in S-α-amylase responses have been observed during recovery 
from 2 h running at 75% VO2max in controlled laboratory trials (Costa et al. 2012, Costa et al. 
2009) and a 230 km multi-stage ultra-marathon competition (Chapter 4); although both 
studies also showed increased S-lysozyme responses, dissimilar to that of the 24 h continuous 
ultra-marathon study. 
 
The degree of S-α-amylase response has previously been associated with stress stimulus per 
se (Bosch et al. 2003b, Filaire et al. 2010, Filaire et al. 2009, Rosa et al. 2014). It is therefore 
not surprising that large increases were observed as a result of 24 h of extreme duration, 
physical exertion. Interestingly, the distance covered by UER did not influence the degree of 
S-α-amylase response on this occasion. Taking this into account, stress induced increases in 
S-α-amylase response may actually provide a protective mechanism to oral-respiratory 
immunity, when other protective components are compromised. Even though there exists 
evidence of S-AMPs responding to pathogenic microbial colonization (i.e., adherence and 
coadherence activity) on mucosal microflora (Bosch et al. 2003b) under stress conditions, it 





oral-respiratory immunity, and the degree of compensatory and collaborative mucosal 
immune activity under stress conditions. Future investigations could potentially aim at 
developing an oral-respiratory mucosal immune index which determines URTI risk based 
upon collective S-AMP values (e.g., S-IgA, S-α-amylase, S-lysozyme, S-lactoferrin) and 
acknowledges deviations in individual S-AMP activity and interactions with each other in 
response to stress stimulus.  
 
Given the extreme nature of ultra-endurance events, UER partaking in the 24 h continuous 
ultra-marathon study were free from illness in the twelve weeks before the ultra-marathon, 
thereby excluding mildly immunocompromised and (or) illness-prone individuals, whose 
training load may have been affected and their ability to complete the 24 h continuous ultra-
marathon markedly reduced. Illness-infection symptoms reported by runners, in field-based 
experimental models, are frequently assessed through self-reports due to the practical issues 
associated with medical diagnosis. Since verification of infectious upper respiratory episodes 
are rarely confirmed, the majority of studies reporting high incidences of URS are more 
likely to reflect non-infectious and (or) inflammatory factors that mimics infectious URS 
(Cox et al. 2010a, Cox et al. 2008, Robson-Ansley et al. 2012), generally induced by 
environmental influences (e.g., irritants, pollen, pollution, dust, and (or) other allergens). In 
the 24 h continuous ultra-marathon study, forecasts of low to moderate pollen counts across 
the region during the time of competition, reduced risk of opportunistic infections due to the 
isolated competition location and low population aggregation, low levels of environmental air 
pollution in the course vicinity, seasonal variations in levels of Vitamin D that are highest 
during the late summer, and (or) optimal prevention and management strategies of 
established respiratory illness, are all factors that may have contributed to the low incidence 





Daviskas 2000, Cox et al. 2010a, Cox et al. 2008, Robson-Ansley et al. 2012, Tenovuo 
1998).  
 
In the 24 h continuous ultra-marathon study, amplified cortisol concentrations were observed 
post-competition (Figure 5.2). Such hormone derived S-AMP responses are potentially 
irrespective of hydration status (Fortes et al. 2012, Oliver et al. 2007). For example, 
euhydration was seen in the majority of UER (≤2% BM loss in 63% of UER, POsmol <300 
mOsmol·kg-1 in all UER), with only 29% of UER having a ≥3% BM loss post-competition 
indicative of a hypohydrated state (Sawka et al. 2007), shown to be necessary to substantially 
impact upon S-AMP responses (Fortes et al. 2012). Interestingly, SFR and S-AMP responses 
in the 24 h continuous ultra-marathon study did not differ according to hydration status 
(≤1.5% vs. ≥3.0% BM loss). Despite modest reductions in SFR observed in the hypohydrated 
group (40%), reductions were considerably less than previous dehydration protocols 
reporting 62-67% decreases in SFR with BM losses ≥3.0% (Oliver et al. 2007, Walsh et al. 
2004a). Moreover, favourable environmental conditions (i.e., high RH) during competition 
may have played a role in preventing airway drying, and subsequently attenuating mucosal 
surface irritation, inflammation, and symptom presentation and (or) aggravation (Anderson 
and Kipperlen 2008, Anderson and Daviskas 2000, Robson-Ansley et al. 2012).   
 
Reflecting on the current findings which acknowledges no reports of URS in response to 
extreme physical exertion, effective management strategies of non-infectious respiratory 
illnesses (i.e., allergies and asthma) and providing environmental information before ultra-
endurance events (i.e., RH, pollen and pollution counts at competition location) may help to 
prevent and manage sub-clinical and (or) clinical manifestations of URS from occurring 





strategies (i.e., administration of pre-event medications based on environmental information, 
carrying allergy medications, and (or) ensuring sufficient fluids to optimise hydration). In 
addition, such preventative and management strategies can also be applied to those 
populations exposed to similar physiological strains (e.g., military personnel, adventure-
expedition crews (i.e., medical, health, and media), miners, and (or) park rangers) who 
regularly undertake occupational-related activities in extreme environmental conditions for 
prolonged periods of time. 
 
A particular strength of the 24 h continuous ultra-marathon study was the assessment of 
multiple salivary immune biomarkers, as reported previously (Costa et al. 2012); but 
measurements of other salivary proteins (e.g., lactoferrin and (or) -defensin), with known 
antibacterial-viral properties, would have complemented the current findings. Due to practical 
constraints, S-AMP measurements were limited to pre- and immediately post-competition; 
therefore the time-course of S-AMP recovery was not determined on this occasion. In 
accordance with previous studies, it is likely that perturbations observed in S-AMPs would 
have returned to similar baseline levels within 4 h into recovery, and fully recovered within 
24 h (Costa et al. 2013a, Costa et al. 2012). 
 
From a practical viewpoint, effective management of non-infectious episodes, favourable 
environmental conditions, maintaining euhydration, and the isolated location of the ultra-









10.3 Circulatory Endotoxin, Cytokine Profile and Extreme Physical Exertion With and 
Without Heat-Stress 
 
The field-based investigative studies presented in Chapter 6 and Chapter 7 present a new 
aspect into the effects of ultra-marathon competition on intestinal epithelial integrity 
(assessed by circulatory endotoxin concentration). The third study (Chapter 6) aimed to 
determine circulatory endotoxin concentration and cytokine profile of UER throughout a 
multi-stage ultra-marathon competition conducted in hot ambient conditions; whilst the 
second study (Chapter 7) aimed to determine the effects of a 24 h continuous ultra-marathon 
in temperate ambient conditions. Previous studies have indicated that partaking in prolonged 
physical exertion is associated with disruption to intestinal epithelial integrity and increases 
in intestinal permeability, leading to endotoxaemia and responsive cytokinaemia (Camus et 
al. 1998, Camus et al. 1997, Lambert 2009, van Wijck et al. 2012) via mechanisms such as 
the degree of exercise-stress, environmental extremes (and subsequent hyperthermia), 
splanchnic ischemia-hypoperfusion and tissue hypoxia, direct mechanical trauma and 
compromised hydration status (Lambert et al. 2008, Rehrer and Meijer 1991, ter Steege and 
Kolkman 2012, van Wijck et al. 2012). In a military setting, exertional-heat illness continues 
to be a problem during training and operations with epidemiological data showing marked 
increases in the hospitalization rate of heat stroke from 1980 to 2001 (Carter et al. 2005). To 
date, the study presented in Chapter 6 was the first to explore and track intestinal epithelial 
permeability of endotoxins and cytokine profile over consecutive days of exercise-heat stress 
and to determine the relationship between these responses with severe GI symptoms and 
perceptive thermal tolerance rating; whilst the study presented in Chapter 7 was the first to 
investigate intestinal epithelial permeability and cytokine profile during a 24 h continuous 





to perturb intestinal epithelial integrity, to determine whether a similar rendotoxaemic and 
cytokinaemic response would be observed. Additionally, to determine the relationship 
between these responses with GI symptoms. 
 
The field-based study presented in Chapter 6 showed modest circulatory endotoxaemia 
accompanied by a pronounced pro-inflammatory cytokinaemia which was counteracted by a 
compensatory anti-inflammatory cytokine response. Circulatory endotoxin concentration, 
pro- and anti-inflammatory responses were sustained throughout competition at rest and post-
stage. Strength of the findings is supported by the control group showing no change in 
circulatory endotoxin concentration and cytokine profile (except IL-1β) throughout the ultra-
marathon period. 
 
Even though UER presented no heat-related medical issues during the multi-stage ultra-
marathon study, the endotoxin and cytokine responses observed provide a novel and valuable 
insight into a potentially high-risk situations, whereby individuals with predisposition and 
multiple risk factors for deranged pro-inflammatory and compensatory anti-inflammatory 
responses are likely to develop consequential clinically significant issues. For example, the 
degree of cytokinaemia observed has been linked to the aetiology of heat stroke, septic shock, 
autoimmune disease, GI disease, and chronic fatigue (Caradonna et al. 2000, Lim and 
Mackinnon 2006, Morris et al. 2014, Opal 2010, Robson 2003).  
 
Plasma CRP concentration, which is normally low and undetectable in the circulation of 
healthy populations, is an acute phase reactant that dramatically rises in the presence of 
inflammation (e.g., induced by trauma, bacterial infection, and (or) inflammatory responses). 





response to EHS (increasing by Stage 2) and remained elevated throughout competition; 
while no change in CON was observed. These responses are similar to that observed during a 
six-days (total distance: 468 km) endurance mountain bike event (Robson-Ansley et al. 
2009), whereby plasma concentrations were significantly elevated at rest for the duration of 
the event. However, the level of rise in plasma CRP concentration was less pronounced in 
comparison to levels (1.9 to 18.4 mg·l) reported in ultra-endurance athletes after six-days of 
track based running race totalling 622 km (Fallon 2001), and after the 246 km Spartathlon 
ultra-marathon race (0.65 to 97.3 mg·l) (Margeli et al. 2005). Taking into account the 
responsive nature of CRP to general inflammation, the wide variations in plasma 
concentrations observed in the current and previous ultra-endurance studies likely reflect 
multi-influential stimulating factors, such as intestinal originated bacterial endotoxin leakage 
into circulation (r2= 0.343, p= 0.001) and soft tissue damage (e.g., exertional 
rhabdomyolysis) (Clarkson 2007). It is possible that persistent elevations in CRP at rest in 
UER may contribute to progressive perceptions of fatigue and subsequent impaired 
performance over the given time course (Neubauer, Konig, and Wagner 2008, Robson 2003). 
 
Interestingly, males showed high plasma CRP concentration throughout competition 
compared with females.  The reason for this observation is unclear; it is however likely to be 
attributed to muscle originated responses (Steensberg et al. 2000), taking into account greater 
plasma IL-6 concentrations concomitant with lower IL-1β and TNF-α responses observed in 
males compared with females.  Due to practical limitations in monitoring parameters after 
competition (i.e., ultra-endurance athletes returning to country of origin after cessation of the 
ultra-marathon), the multi-stage ultra-marathon study was not able to determine the recovery 
time course of CRP. However, such responses have been shown to remain elevated above 





Ironman triathlon event) (Neubauer, Konig, and Wagner 2008), suggesting time course for 
full recovery of altered inflammatory status is considerably delayed.  
 
In comparison with previous endurance and ultra-endurance studies observing mild (e.g., 
marathon, 160 km ultra-marathon, and Ironman distance triathlon: 5 to 15 pg·ml) (Camus et 
al. 1997, Jeukendrup et al. 2000) and substantial (e.g., 89.4 km ultra-marathon whereby 81% 
of runners had concentrations >100 pg·ml and an ultra-distance triathlon reporting 81 to 294 
pg·ml) (Bosenberg et al. 1988, Brock-Utne et al. 1988) increases in circulatory endotoxin 
concentrations, the current ultra-marathon resulted in modest increases in post-stage 
circulatory endotoxin concentrations throughout competition (i.e., 30 pg·ml average increase 
from pre- to post-stage, with the highest increase observed at 92 pg·ml). However, a novel 
finding was the gradual increase in resting levels as the ultra-marathon progressed (i.e., 60 
pg·ml average increase from Stage 1 to 5, with 32% of runners had concentrations >100 
pg·ml and the highest increase observed at 130 pg·ml), possibly attributed to a delayed and 
sustained intestinal leakage upon exercise cessations, which is accompanied by a 
redistribution of blood flow into the splanchnic region (van Wijck et al. 2012). The 
cumulative affect observed as the ultra-marathon progressed suggests a reduced tolerance for 
EHS induced endotoxin leakage, subsequent to anti-endotoxin antibodies not restoring to 
their optimal level on consecutive occasions (Leon and Helwig 2010). For example, 
depressed anti-endotoxin antibodies have been reported after a marathon race, which 
remained below pre-exercise values for 24 h (Camus et al. 1997). Moreover, a 100-fold range 
difference in endotoxin neutralizing capacity in plasma has been observed between 
individuals (Warren et al. 1985), likely associated with training adaptations (Bosenberg et al. 
1988). Indeed, higher circulating concentrations of endotoxin and anti-endotoxin antibodies 





Selkirk et al. 2008). The proposed gained adaptation to endotoxin tolerance in trained 
individuals is likely attributed to repetitive endotoxin challenge resulting from exercise-stress 
inducing endotoxin intestinal leakage and subsequent ‘self-immunisation’ (Bosenberg et al. 
1988, Brock-Utne et al. 1988). Therefore during the current ultra-marathon, it is possible that 
the experience level of UER and frequent endotoxin exposure induced as part of their 
competition preparation may have initiated training adaptations favouring an attenuated 
circulatory endotoxin peak along competition (i.e., UER developing adaptations that enhance 
resistance and resilience to enteric pathogenic endotoxin exposure); such plausibility, 
however, warrants further investigation. Favourable adaptations would reduce the risk of 
developing clinically significant issues associated with endotoxaemia and subsequent 
cytokinaemia during consecutive days of EHS with or without additional stressors. 
Conversely, inadequate training and not being physically prepared for such an extreme event 
would potentially increase the risk.  
 
Even though no differences in endotoxin was seen between running speeds, pre-stage plasma 
IL-1β, TNFα, and IFN-γ concentrations were substantially higher in SR throughout the ultra-
marathon compared with FR; potentially suggesting greater intestinally originated endotoxin 
exposure above capable clearance capacity in less trained UER. This explanation however 
also warrants further investigation (e.g., role of intestinal originated endotoxin in training 
adaptions-immune competence), and may provide valuable findings into the role of endotoxin 
leakage in physiological adaptations to exercise stress, especially in environmental extremes. 
Moreover, it has also been suggested that plasma endotoxin concentrations may reach 
equilibrium during endurance exercise, whereby endotoxin influx from the GI tract into 





Selkirk et al. 2008); which may in part explain why only modest fluctuations in circulatory 
endotoxin concentrations were observed.  
 
The increases in resting pre-stage and pre- to post-stage plasma IL-6, IL-1β, TNFα, and IFN-
γ concentrations remained elevated throughout competition; mirroring that of an acute 
infectious episode and is similar to pro-inflammatory cytokine responses seen after endotoxin 
(e.g., LPS) infusion in both animal (Givalois et al. 1994) and human (van Deventer et al. 
1990) models. These results are in accordance with previous endurance based (e.g., 
marathon) experimental designs observing modest increases in IL-6, IL-1β, and TNFα; which 
were also accompanied by a compensatory anti-inflammatory response (i.e., an increase in 
plasma IL-10 and IL-1ra concentrations) (Nieman et al. 2006b, Ostrowski et al. 1999, Suzuki 
et al. 2003). It is possible that the anti-inflammatory properties of IL-10, with adjunct IL-1ra 
in the multi-stage ultra-marathon study may have restricted the magnitude of pro-
inflammatory cytokine production along competition as reflected by the IL-1β:IL-10 and 
TNF-α:IL-10 ratios. Interestingly, no differences in pro- and anti-inflammatory cytokine 
responses were observed between UER that ingested and did not ingest oral anti-
inflammatory agents. This observation may suggest that exposure to EHS induced by the 
event far outweighs any impact of inconsistent use of low dose anti-inflammatory medication 
on cytokine responses, and questions the efficacy of such inconsistent ingestion of anti-
inflammatory pharmaceutical agents within medical management of UER during extreme 
events. 
 
In well trained individuals where the EHS may be better tolerated (Costa et al. 2014), anti-
inflammatory responses predominated, off-setting potential clinically significant episodes 





Nielsen and Pederson 2007, Okita et al. 2004, Pischon et al. 2003, Suzuki et al. 2006). It is 
however concerning that inadequately trained individuals may not present such competent 
anti-inflammatory responses, and may be a prime risk population for developing heat illness 
from immune aetiology (i.e., exertional-heat stroke, SIRS) (Leon and Helwig 2010, 
O’Connor et al. 2010, Rav-Acha et al. 2004). Indeed, SR presented higher resting pro-
inflammatory cytokine profile compared with FR. It also needs to be taken into consideration 
that SR were on the course routes for a greater amount of time than FR; and thus SR may 
have been exposed to greater volumes of EHS and a time-dependant effect on cytokine 
production during recovery may produce delayed anti-inflammatory responses in SR. 
 
The recovery time course of cytokine responses after the ultra-marathon was not determined 
on this occasion due to practical limitations; however previous ultra-endurance studies (e.g., 
long-distance triathlon and ultra-marathon running) have observed variations in cytokine 
responses during the recovery period. For example, IL-6 and TNF-α returned to baseline by 
24 h after a 50 km ultra-marathon (Mastaloudis et al. 2004); whilst IL-6 returned to baseline 
values 16 h, with no significant changes observed in TNF-α, after a long-distance triathlon 
(Jeukendrup et al. 2000). Furthermore, on cessation of two endurance events of similar 
duration (long-distance triathlon, 100 km run), IL-6, IL-10, and IL-1ra peaked after 
competition, returning to baseline values seven days after the events (Gomez-Merino et al. 
2006). Whereas after a long distance triathlon, IL-6 remained elevated on day one (345%) 
and day five (79%); while IL-10 was elevated on day one (37%), declining by 4% below pre-
competition concentrations on day five (Neubauer, Konig, and Wagner 2008). These 
observations suggest the time course for full recovery of altered cytokine profile in response 
to extreme events are considerably delayed, and may play a role in the aetiology of undefined 





potential role of extreme event induced immune perturbations initiating autoimmune disease 
in individuals with predisposition warrants attention since chronic elevations in cytokine 
responses are reported in many autoimmune conditions (e.g., systemic lupus erythematosus, 
fibromyalgia, myalgicencephalomyelitis, idiopathic inflammatory myopathies, arthritic 
conditions, and inflammatory bowel diseases) (Caradonna et al. 2000, Morris et al. 2014, 
Thomas 2013, Woolley et al. 2005).  
 
Despite amplified cytokine responses similar to that of an acute infectious episode and in 
accordance with the aetiology of heat-related illnesses, none of the current n= 19 UER were 
diagnosed with heat related symptoms or illnesses. Previously, only n= 1 UER competing in 
the five-days 2010 Al Andalus Ultra-Trail race suffered heat-related problems (Scheer and 
Murray 2011), reported to be due to UER experience (e.g., training status), the hot ambient 
conditions, and the nature of the race course (e.g., limited shade availability). 
 
In the multi-stage ultra-marathon study, perceptive thermal comfort rating improved as the 
competition progressed.  Interestingly, the two UER that originated from countries with hot 
ambient conditions at the time of competition showed similar circulatory endotoxin and 
cytokine responses to the main cohort, with substantial increases in Pv indicative of heat 
acclimatization still being observed in these UER (pre-Stage 1 to pre-Stage 5: UER 1= 30.4% 
and UER 2 = 24.9%); suggesting exertional stress is an essential key feature of heat adaptions 
(Costa et al. 2014). In view of the unique and challenging characteristics of ultra-marathon 
competitions (i.e., prolonged physical exertion, sleep deprivation, environmental extremes, 
acute periods of under-nutrition and hypohydration) and associated factors (i.e., training 
status, inadequate rest, tolerated injury and trauma) having the potential to disturb intestinal 





of hydration status in the majority of runners, thermoregulatory-induced adaptations, and 
cooling behaviours throughout competition may have contributed to improved heat tolerance 
despite prolonged exposure to EHS (Armstrong et al. 2007, Costa et al. 2014, Costa et al 
2013b, ter Steege and Kolkman 2012). 
 
The systemic endotoxin and cytokine responses seen in the multi-stage ultra-marathon study 
have previously been associated with symptomatic manifestations of GI symptoms 
(Jeukendrup et al. 2000, Lambert 2009, Lambert 2008, van Leeuwen et al. 1994), commonly 
associated with prolonged exposure to EHS (Øktedalen et al. 1992, Peters et al. 1999, 
Pfeiffer et al. 2012, Rehrer et al. 1992). For example, GI symptoms, such as nausea and 
vomiting, have been observed in endurance athletes presenting endotoxaemia after an 
Ironman triathlon event (Jeukendrup et al. 2000).  
 
In the multi-stage ultra-marathon study, no assocations between GI symptoms with 
circulatory endotoxin and cytokine concentrations were observed. However, a strong 
relationship (r2= -0.665) between severe GI symptoms and thermal tolerance was confirmed 
(p< 0.001). These results suggest that severe GI symptoms likely originate from heat stress 
during exercise, potentially through splanchnic hypoperfusion and hypoxia (i.e., exercising in 
the heat creating greater redistribution of blood flow away from the splanchnic  area) (ter 
Steege and Kolkman 2012, van Wijck et al. 2012, van Wijck et al. 2011) Such physiological 
changes in splanchnic blood flow, which have symptomatic outcomes, likely lead to 
disturbances in intestinal mucosal and epithelial integrity that enhances local enteric 
endotoxin leakage and subsequent cytokinaemia; and not necessarily that endotoxaemia and 






In regards to future directions, it is still unknown how the degree of exertional stress, with or 
without environmental extremes and between different exercise modes, impacts on overall 
intestinal epithelial integrity. Additionally, does the nutritional and hydration status before 
exertional stress, and the changes that occurs to status during physical exertion, influence the 
degree of GI disturbance? Conducting a set of laboratory-controlled experiments assessing 
varying Tamb, exercise intensities, durations and modes whilst assessing intestinal epithelial 
integrity measures (van Wijck et al. 2012) would contribute substantially to the current 
knowledge base and provide a foundation to investigate potential strategies to overcome GI 
complications associated with EHS. For example, dietary strategies during physical exertion, 
development of gut training protocols, functional foods, heat acclimation protocols, external 
pre-cooling (e.g., cold water bath or cooling vest) and (or) during physical exertion internal 
cooling (e.g., cold beverages) are proposed strategies that may attenuate EHS induced GI 
perturbations. Indeed, due to gut plasticity, there is potential for the GI tract to adapt to a 
challenge load (‘training the gut’) (Jeukendrup and McLaughlin 2011). Whereas, previous 
investigations have demonstrated favourable effect of prebiotic oligosaccharides (e.g., inulin 
and oligofructose) and probiotic bacteria (e.g., Lactobacillus casei and Bifidobacterium) on 
markers of GI integrity; albeit within inflammatory diseases of the gut (Sator 2004). 
Knowledge into the impact of such biotics on gut integrity during EHS is, however, scarce. 
Anecdotal evidence during the multi-stage ultra-marathon study highlighted that UER who 
consistently consumed commercial probiotic product in the week leading up to the ultra-
marathon presented no incidence of GI symptoms; suggesting further controlled investigation 
is needed to confirm any beneficial effects of biotics on intestinal epithelial integrity in 






Multi-stage ultra-marathon competition in the heat resulted in a modest circulatory 
endotoxaemia accompanied by a pronounced pro-inflammatory cytokinaemia and 
compensatory anti-inflammatory responses, both of which were sustained throughout 
competition at rest (pre-stage) and after stage completion. The findings from the multi-stage 
ultra-marathon study suggest that appropriate informed training (e.g., physically trained to 
complete the required distance in environmental extremes) and competition preparation (e.g., 
effective and evidence-based heat acclimation protocols, hydration maintenance and (or) 
cooling strategies) may help prevent significant exertional-heat related subclinical and 
clinical manifestations from occurring in high-risk UER competing in extreme events.  
 
The field-based study presented in Chapter 7 demonstrated that in the absence of heat-stress, 
but with inclusion of other multi-stressors, endotoxaemia with accompanying pro-
inflammatory cytokinaemia ensued, counteracted by a compensatory anti-inflammatory 
response. 
 
Despite temperate ambient conditions, the markedly more pronounced increases in plasma 
CRP (Figure 7.2) and circulatory endotoxin concentration (Figure 7.1) in the 24 h 
continuous ultra-marathon study (2832% and 37% post-competition, respectively), compared 
to that of Chapter 6 (889% and 21%, respectively) suggest that amplified CRP 
concentrations likely reflect other multi-factorial influences, such as the degree of the 
exertional stress, sleep deprivation, energy deficit, and bacterial endotoxin presence in 
circulation simultaneously. Whereas, the endotoxin leakage was likely induced by 
disturbances to intestinal epithelial integrity (i.e., splanchnic hypoperfusion, ischemia, and 
mechanical trauma), associated with the physical exertion volume; despite endotoxin leakage 





al. 1988). Due to practical limitations in monitoring parameters after competition (i.e., 
participant follow-up at race location during the acute and prolonged recovery period), the 24 
h continuous ultra-marathon study was not able to determine the recovery time course of 
CRP. However, such responses have been shown to remain elevated above pre-exercise 
values for a considerable period of time (i.e., up to nineteen days after an Ironman triathlon 
event) (Neubauer, Konig, and Wagner 2008). 
 
The pro-inflammatory cytokinaemic response observed post-competition are similar to 
previous field-based studies that have observed cytokinaemia during EHS (Bosenberg et al. 
1988, Brock-Utne et al. 1988, Jeukendrup et al. 2000, Suzuki et al. 2003). For example, 
increases in IL-6 (152%), IL-1β (95%), TNF-α (168%), and IFN-γ (102%) were consistently 
observed post-stage during a 230 km multi-stage ultra-marathon conducted in hot ambient 
conditions (Chapter 6). Likewise, the increased pro-inflammatory response was 
accompanied by a compensatory anti-inflammatory response (Table 7.1). 
 
Results from the 24 h continuous ultra-marathon study suggest that in well-trained 
individuals, where the exertional stress is well tolerated, compensatory anti-inflammatory 
responses may off-set potential clinically significant episodes associated with profound and 
prolonged cytokine profile disturbance (Fehrenbach and Schneider 2006, Goldhammer et al. 
2005, Nielsen and Pederson 2007, Suzuki et al. 2006); thus acting as a safeguard. Indeed, 
disturbances to cytokine profile have been linked to the aetiology of GI and autoimmune 
diseases (Caradonna et al. 2000, Elenkov and Chrousos 2002); while the fatigue inducing 
properties of certain cytokines, especially IL-6, have recently been confirmed and established 
(Morris et al. 2014, Robson-Ansley, Blannin, and Gleeson 2007, Robson-Ansley et al. 2009, 





an altered cytokine response (i.e., pro- to anti-inflammatory balance) after a standardised bout 
of treadmill running compared with healthy runners who have a more proportionally 
regulated cytokine response (Cox et al. 2007). Therefore, it is plausible that in illness-prone 
individuals partaking in prolonged physical exertion who experience impaired cytokine 
regulation (i.e., over-exaggerated cytokine-mediated inflammatory response) not adequately 
counteracted by anti-inflammatory responses, the resulting cytokine imbalance may 
potentially contributing to pathophysiology (Fehrenbach and Schneider 2006). Investigation 
into the role of challenging compensatory anti-inflammatory responses through internal (e.g., 
endotoxin challenge) and external (e.g., physical strain) mechanisms is warranted, and may 
act to strengthen tolerance to exertional exposure with or without additional stressors (e.g., 
heat stress, sleep deprivation, and (or) compromised nutrition) in illness-prone individuals.  
 
As previously reported, due to practical limitations, the 24 h continuous ultra-marathon study 
was not able to determine the recovery time course of the cytokine profile. Previous ultra-
endurance studies (e.g., long-distance triathlon and ultra-marathon running) have however 
observed variations in cytokine recovery. For example, IL-6 and TNF-α returned to baseline 
by 24 h after a 50 km ultra-marathon (Mastaloudis et al. 2004); whilst IL-6 returned to 
baseline values after 16 h, with no significant change observed in TNF-α after a long-distance 
triathlon (Jeukendrup et al. 2000). Furthermore, on cessation of two endurance events of 
similar duration (i.e., long-distance triathlon and 100 km running event), IL-6, IL-10, and IL-
1ra peaked after competition, returning to baseline values seven days after the events 
(Gomez-Merino et al. 2006). Whereas, after a long distance triathlon, IL-6 remained elevated 
on day one (345%) and day five (79%); while IL-10 was elevated on day one (37%), 







Circulatory endotoxin and pro-inflammatory cytokine responses seen in the 24 h continuous 
ultra-marathon study have previously been associated with symptomatic manifestations of GI 
distress (Jeukendrup et al. 2000, Lambert 2009, Lambert 2008, van Leeuwen et al. 1994). In 
the 24 h continuous ultra-marathon study, the association between the reported number of 
severe GI symptoms and plasma concentrations of anti-inflammatory IL-10 and immune 
activator IL-8 suggest that alterations to intestinal motility and mechanical trauma (i.e., 
repetitive jarring) associated with the prolonged running period may have promoted intestinal 
epithelial disturbance and potential damage (Rehrer et al. 1992, Rehrer and Meijer 1991), 
inducing GI symptoms and stimulating immune responses into protection and repair; and not 
necessarily that endotoxaemia and cytokinaemia causes symptoms. 
 
Further research is required to clarify the impact of over-exaggerated cytokine-mediated 
inflammatory responses, similar to those observed in the 24 h continuous ultra-marathon 















10.4 Probiotics, Salivary Anti-Microbial Protein Responses, Circulatory Endotoxin,  
Cytokine Profile and Exertional-Heat Stress  
 
The laboratory-controlled experimental trials presented in Chapters 8 and 9 are the first to 
determine the effects of acute high dose probiotic supplementation on multiple markers of 
oral-respiratory mucosal immunity (Chapter 8), intestinal epithelial integrity (assessed by 
circulatory endotoxin concentration), and cytokine profile (Chapter 9) during exposure to 
EHS. All participants confirmed through self-report that the full amount of probiotic (and 
placebo) were consumed over the seven day supplementation period. Participants were 
instructed to split the doses into two equal boluses (500ml between 08:00 h-09:00 h and 
500ml between 08:00 h-09:00h). This was to increase overall compliance and to make the 
total daily dose (1000 ml) more manageable to consume. A higher dosage of probiotic 
supplementation over a shorter duration was chosen as this mimics athlete population 
consumption behaviours. Additionally, there is currently limited probiotic research in the area 
of exercise immunology and to date, whilst probiotics have been shown to induce 
immunomodulatory effects, research investigating the dose-response effect of probiotic 
supplementation (typical dosages: x 1010 CFU·100ml-1·day-1) and the ‘ideal’ dose to induce a 
definitive pharmaceutical effect on S-AMP responses and in the management of 
endotoxaemia and responsive cytokinaemia is absent. Therefore, to date, it is possible that the 
disparities between previous research results simply reflect the concentration and (or) the 
volume of probiotic provided to participant and theoretically, it is plausible that a 
substantially larger probiotic dose may induce a greater oral-respiratory mucosal immune 
response (e.g., up regulation of S-IgA) and (or) attenuate disturbances to intestinal epithelium 
integrity and a subsequent endotoxin-induced cytokine-mediated inflammatory response. 





conditions is associated with greater perturbations to oral-respiratory mucosal immunity (via 
mechanisms such as compromised hydration status depressing SFR and amplified stress 
hormone release) and intestinal epithelial integrity (via mechanisms such as hyperthermia, 
splanchnic ischemia-hypoperfusion and tissue hypoxia, direct mechanical trauma and 
compromised hydration status), the studies in Chapter 8 and 9 present a novel aspect into the 
effects of probiotic supplementation prior to and upon exposure to EHS. To date, the study 
presented in Chapter 8 was the first to investigate the effects of an acute high dose probiotic 
on multiple markers of oral-respiratory mucosal immunity (i.e., S-IgA, S-α-amylase, and S-
lysozyme) prior to and upon exposure to EHS; whilst the study presented in Chapter 9 was 
the first to investigate the effects of an acute high dose probiotic on intestinal epithelial 
integrity (i.e., circulatory endotoxin concentration) and cytokine profile prior to and upon 
exposure to EHS. 
 
The laboratory-controlled study presented in Chapter 8 demonstrated that daily high dose 
probiotic supplementation did not enhance resting S-AMP values after seven days, nor did 
supplementation enhance S-AMP responses after or during recovery from EHS compared 
with placebo. 
 
To date, research into the mechanisms of action by which probiotics exerts an effect on oral-
respiratory mucosal immunity is limited. Previously, it has been suggested that strain-specific 
probiotic supplementation can enhance mucosal immunity through stimulation of lymphoid 
tissue (e.g., Peyer’s patches) in the GI tract resulting in localised effects (i.e., up-regulation of 
S-IgA) at other mucosal sites (i.e., URT) (Glück and Gebbers 2003). Alternatively, it is 
possible that colonisation and probiotic interaction at the oral mucosal epithelium may affect 





production of anti-microbial substances and epithelial barrier function (Stamatova and 
Meurman 2009). On the contrary, despite the high probiotic dose in the probiotic-EHS study, 
S-IgA responses were unaltered after seven days of supplementation, and did not differ from 
PLA immediately post-EHS and during the recovery period (Figure 8.1). 
 
Taking into account the impact of hydration status on SFR (Walsh et al. 2004a), it is possible 
that the maintenance in S-IgA responses in the probiotic-EHS study are partly due to the 
maintenance of euhydration observed during and after EHS, which may have contributed 
towards attenuating substantial depressions in SFR and thus maintaining S-AMP responses. 
This response is irrespective of the increases in S-cortisol immediately post-EHS in both 
trials (Table 8.3), which have been associated with inhibitory effects on the transepithelial 
transport of S-IgA and reductions in SFR (Chicharro et al. 1998, Teeuw et al. 2004). For 
example, the overall mean exercise-induced BM loss for the PRO and PLA trial was 1.5% 
and 1.3%, respectively; while POsmol remained within clinical reference ranges (280-300 
mOsmol·kg-1) throughout recovery (PRO: 298 mOsmol·kg-1 and PLA: 297 mOsmol·kg-1). 
These results are consistent with a previous studies showing greater S-AMP responses in 
euhydration compared with dehydration (Fortes et al. 2012, Chapter 4), suggesting hydration 
status play a more important role in oral-respiratory mucosal immunity than probiotics, and 
may account for the discrepant outcomes observed in previous research (i.e., hydration status 
not reported, controlled, or accounted for in the majority of previous research). 
 
Studies investigating the influence of probiotic supplementation on oral-respiratory mucosal 
immune status have predominantly focused on S-IgA responses. It is however conceivable 
that the reported immunostimulatory properties of probiotics may induce changes in other 





other S-AMP may provide a clearer interpretation of oral-respiratory mucosal immune status. 
Indeed, whilst reductions in S-IgA responses are commonly reported after prolonged physical 
exertion, adjunct increases in S-α-amylase and S-lysozyme responses have recently been 
reported (Costa et al. 2012, Costa et al. 2009). In the probiotic-EHS study, no changes in S-α-
amylase and S-lysozyme responses were observed after seven days of daily high dose 
probiotic supplementation, whilst the increases in S-α-amylase responses after EHS is likely a 
reflection of the degree of the exertional stress per se (Bosch et al. 2003b, Rosa et al. 2014). 
Moreover, considering all participants in the probiotic-EHS study showed higher S-AMP 
profiles (i.e., either S-IgA, S-α-amylase, or S-lysozyme relative to pre-EHS values) on PLA 
compared with PRO, the current sample size provides sufficient power to reject the 
hypothesis and clearly show that acute high dose probiotic supplementation does not enhance 
S-AMP responses over placebo. However, considering PRO showed consistently lower S-
AMP responses during recovery from EHS compared with PLA (i.e., relative to pre-EHS 
values), but which failed to reach significance on this occasion, the limited sample size in this 
instance did not confirm a clear negative effect of acute high dose probiotic supplementation. 
 
Given that S-α-amylase and S-lysozyme exhibits similar protective properties as S-IgA, it is 
suggested that acute stress induced increases in these S-AMP may actually provide a 
protective mechanism to oral-respiratory mucosal immunity. For example, increases in S-α-
amylase and S-lysozyme responses have been consistently observed after each stage of a 230 
km multi-stage ultra-marathon and after a 24 h continuous ultra-marathon resulting in low 
occurrence of URSI in both events, despite depressions in S-IgA responses (Chapter 4 and 
Chapter 5). It is also important to highlight the large individual variation in responses 
observed in the probiotic-EHS study, especially in relation to S-α-amylase and S-lysozyme. 





‘responder’ and ‘non-responder’ outcome, which may actually result in a compromised S-
AMP status (e.g., dampened exercise-induced increases in S-α-amylase in adjunct with 
depressed S-IgA responses)  in individuals that are sensitive to an oral probiotic exposure, 
compared with avoiding exposure altogether. 
 
While the mechanisms by which probiotic supplementation may possibly enhance immune 
function remains controversial, further research is required to determine whether probiotic 
supplementation can translate into immunocompromised active populations and (or) those 
who commonly present clinically significant symptoms as a possible form of ‘health 
insurance’ when other nutritional measures are unable to be maintained.  
 
The laboratory-controlled study presented in Chapter 9 demonstrated that daily high dose 
probiotic supplementation did not reduce concentrations of circulatory endotoxin and 
inflammatory cytokines after EHS or during the recovery period on the probiotic trial 
compared with placebo. Although mild in nature, the data actually shows circulatory 
endotoxin concentration and inflammatory cytokine responses were generally higher post-
EHS and during recovery from EHS on PRO compared with PLA. However, from an 
overview standpoint, it appears that an acute high dosage of oral supplementation of a 
commercially available probiotic beverage containing L.casei induces inconsequential effects 
on intestinal endotoxin translocation and cytokine responses after EHS.  
 
The results of the probiotic-EHS study showing modest increases in endotoxaemia are 
comparable to some studies (Camus et al. 1997, Jeukendrup et al. 2000), but not all (Chapter 
4). Discrepancies in such results compared to that of the probiotic-EHS study are likely due 





recovery between exercise bouts and presence of other stressors (e.g., hydration status) 
known to compromise intestinal epithelial integrity and promote endotoxin translocation 
(Lambert et al. 2008). Indeed, body temperature and hydration status appear to be 
contributing factors towards the degree of EHS induced endotoxaemia (Lambert et al. 2008, 
Selkirk et al. 2008). For example, in contrast with previous laboratory-controlled studies that 
have observed increases in circulatory endotoxin concentrations (3.8 pg·ml-1 at baseline to 
16.5 pg·ml-1) in trained subjects, concomitant with considerable elevations in Tcore at 
exhaustion (36.9°C at baseline to 39.7°C) (Selkirk et al. 2008), the current experimental 
design instigated relatively mild Tcore elevations in comparison (PRO: 38.6°C and PLA: 
38.6°C), which may in part, account for the milder endotoxaemia observed. Moreover, 
participants in the probiotic-EHS study were provided with fluid ad libitum, potentially 
lessening the negative impact of dehydration during EHS on intestinal epithelial integrity. It 
could be speculated that if Tcore was higher (i.e., >39.0°C) and exercise-induced dehydration 
greater, a higher endotoxaemia may have been observed. Indeed, those participants in the 
probiotic-EHS study who had an exercise-induced BM loss of >2% and a POsmol >300 
mOsmol·kg-1 showed higher average circulatory endotoxin concentrations (e.g., up to 40 
pg·ml-1). These results are reflected in another laboratory controlled study that observed 
significant increases in intestinal permeability after 60 min of treadmill running at 70% 
VO2max without fluid intake resulting in 1.5% BM loss (Lambert et al. 2008); suggesting that 
increases body water losses may exacerbate perturbations to intestinal epithelial integrity.  
 
In contrast to previous studies showing enhancement of gut-barrier function with probiotic 
administration (Ohland and MacNaughton 2010, Rodes et al. 2013), the current data show 
that, although mild in nature, circulatory endotoxin concentrations were higher on PRO 





mechanisms for this outcome cannot be fully explained and warrant further exploration, it is 
clear that the circulatory endotoxin flux in the post-EHS period was quenched by competent 
anti-endotoxin antibody responses in both trials, likely associated with training adaptations 
(Bosenberg et al. 1988, Selkirk et al. 2008).  
   
In the probiotic-EHS study, the increases in IL-6, TNF-α, IL-10, and IL-8 on PRO and PLA 
observed (Table 9.1) are in accordance with previous field-based studies (Bosenberg et al. 
1988, Brock-Utne et al. 1988). Indeed, increases in IL-6 (152%), TNF-α (168%) and IL-10 
(1271%) were observed post-stage during a 230 km multi-stage ultra-marathon conducted in 
hot ambient conditions (Chapter 6). Such results, including those of the probiotic-EHS 
study, suggest that the compensatory anti-inflammatory response of IL-10 may have 
restricted the magnitude and counteracted any further exacerbation of pro-inflammatory 
cytokine responses. Notably, in relation to pre-EHS values, the cytokineamic response was 
generally higher in the PRO trial, which is not surprising given the greater circulatory 
endotoxin concentrations observed after exposure to EHS. 
 
Results also suggest that if individuals are well-trained (i.e., adaptations to exercise and 
environmental stress) and prepared (e.g., hydration maintenance) for EHS, these 
characteristics per se may help dampen EHS induced endotoxaemia, and responsive 
cytokinaemia. Despite the probiotic-EHS study not primarily focusing on intestinal epithelial 
mechanistic responses, future research could potentially establish the degree to which varying 
heat stress models during exercise, with or without a state of dehydration, impacts on 
intestinal permeability through the lactulose-rhamnose sugars test in adjunct to circulatory 






Furthermore, whilst long-term probiotic supplementation is not generally practiced amongst 
active populations, further adequately controlled studies are required to assess whether longer 
term probiotic use has a greater influence on changes in immune variables. The probiotic 
intervention period ranges between two weeks to six months in clinical research models to 
promote optimal colonisation in the GI tract. Despite the differences in intestinal epithelial 
surface area, probiotic dosage in human trials are based on animal models. Furthermore, 
dose-response studies are limited. It is unknown whether different probiotic strains (single or 
in combination) and species may induce differing immunological effects dependent upon the 
disease state. Consequently, it is extremely difficult to extrapolate the inconsistent results of 
previous studies.  
 
Similar to the current findings, Shing et al. (2013) reported that whilst pre- and post-exercise 
LPS concentrations were lower following four weeks of probiotic supplementation, there was 
no significant difference between the probiotic and placebo group, nor were differences 
evident in cytokine responses. At present, acute high dose probiotic beverage consumption 
prior to EHS is not justified, and it would be advisable to withhold intake before EHS due to 
the potential unknown and (or) underlying hidden outcomes. For example, increases in 
intestinal permeability, endotoxin translocation and cytokine responses which may accelerate 













The major conclusions from this thesis are:  
 
1. S-AMP responses appear to be maintained throughout multi-stage ultra-marathon 
competition. The observed unfavourable reductions in S-IgA responses were offset by 
favourable increases in S-α-amylase and S-lysozyme responses. A low prevalence 
(n=1) of URS were reported during and up to 4 weeks after the competition. 
 
2. Modest depressions in some S-AMP responses (S-IgA and S-lysozyme) were 
counteracted by increases in others (S-α-amylase) after a 24 h continuous overnight 
ultra-marathon. No incidences of URS were evident during or following competition.  
 
To date, the influence of extreme exercise models in the investigation of oral-
respiratory mucosal immune status, in addition to the tracking of S-MAP status over 
time is extremely limited; whilst reporting multiple salivary immune variables 
allowed for a more comprehensive overview of oral-respiratory mucosal immune 
status. Equally, the inclusion of additional salivary immune variables such as S-
lactoferrin, determining the time-course of recovery and conducting the research 
protocol during the winter months when the risk of an infectious episode is greater 
would have provided further insight into the impact of extreme physical exertion on 
immune variables. Furthermore, the lack of research control limits data interpretation.  
 
3. Modest circulatory endotoxaemia accompanied by a pronounced pro-inflammatory 
cytokinaemia and compensatory anti-inflammatory responses were observed 





symptoms or illnesses were evident throughout competition. Even though severe GI 
symptoms were reported, no relationships with blood borne indices were identified.  
 
4. Circulatory endotoxaemia with accompanying cytokinaemic characteristics of an 
acute infectious episode were observed after a 24 h continuous overnight ultra-
marathon. GI symptoms were commonly reported amongst UER, with higher 
symptom occurrence associated with greater compensatory anti-inflammatory 
responses (IL-10).  
 
To date, the influence of extreme exercise models in the investigation of intestinal 
epithelial integrity (as assessed by circulatory endotoxin concentrations) and cytokine 
profile, in addition to the tracking of endotoxin and cytokine responses over time is 
extremely limited. Equally, the inclusion of additional variables (e.g., anti-endotoxin 
antibodies), measurements (e.g., Tcore) and determining the time-course of recovery of 
cytokine profile would have provided further insight into the impact of extreme 
physical exertion on immune variables. The lack of research control (e.g., sporadic 
use of NSAIDs) limits data interpretation.  
 
5. Acute supplementation of the probiotic L. casei for a period of one week does not 
enhance S-AMP responses after or during recovery from EHS compared with 
placebo.   
 
6. Acute supplementation of the probiotic L. casei for a period of one week does not 
prevent or attenuate EHS induced circulatory endotoxaemia or cytokinaemia; nor is it 






To date, laboratory controlled studies exist investigating the influence of probiotic 
supplementation on oral-respiratory mucosal immune status and intestinal epithelial 
integrity (as assessed by circulatory endotoxin concentrations) and cytokine profile 
during prolonged EHS is absent. Equally, a larger sample size would be considered 
more representative of the endurance running population, whilst a longer probiotic 
supplementation period to promote optimal colonisation and in accordance with 
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Appendix B: Participant Information and Informed Consent Form   
 
 
Coventry University: Sports & Exercise Science Applied Research Group 
 
Oral-Respiratory Mucosal Immune, Circulatory Endotoxin and Cytokine Responses, 
Assessment of Nutrition & Hydration Status, and Illness & Infection Rates During 
Multi-Stage Ultra-Marathon Competition in Hot Ambient Temperatures. 
 
2011 Al Andalus Ultra Trail 
 
Participant Information & Informed Consent Form 
 
Thank you for agreeing to take part in this research study. This form explains what you will 
be asked to do. If you have any questions about this research please ask one of the researcher 
team. 
 
Research Investigators: Samantha Gill and Dr. Ricardo Costa. 
 
The aims of the research are: 
1. Determine oral-respiratory mucosal immune responses during a multi-stage ultra-marathon 
competition in a hot ambient environment. 
2. Determine circulatory endotoxin concentrations and pro and anti-inflammatory cytokine 
responses during a multi-stage ultra-marathon competition in a hot ambient environment. 
3. Assess the rates and severity of upper respiratory and gastrointestinal symptoms during and 
the month following a multi-stage ultra-marathon competition in a hot ambient environment.  
4. Assess nutrition and hydration status of ultra-endurance runners during a multi-stage ultra-
marathon competition in a hot ambient environment. 
 
 
What will I have to do? 
You are only required to follow YOUR NORMAL COMPETITION STRATEGIES. In 
addition: 
 Have your body mass taken before and after each stage. 
 Provide one urine, saliva and blood sample before and after each stage. 
 Let the research team conduct a ~10min interview each evening between 6-10pm. 
 
 
What will I get from this? 
1. You will gain an insight into the scientific aspects of the study and you may find it interesting 
to know what we are trying to achieve or how various measurements are recorded.  
 
2. You will gain an insight into how your immune system responses to an ultra-marathon 
competition in the heat. From this information the research team and provide some advice on 
strategies to avoid unwanted immune profiles associated with the ultra-marathon competition. 
 
3. After the ultra-marathon, you will be provided with individual feedback on the measurements 
made during the research. Advice will be given to help you improve your dietary habits for 
subsequent ultra-marathon competition. 
 
By signing this form you agree to take part in the study. However, please note that you 





Foreseeable risks or discomforts? 
Blood sampling: Only qualified phlebotomy trained researchers with experience at performing this 
procedure will collect blood samples. To ensure you are completely comfortable with giving blood 
samples, we will familiarise you with the blood sample collection procedure. The amount of blood 
collected during each blood sampling will be (18 ml), which will not impact upon your normal 
physical functioning during strenuous exercise in a hot ambient environment.  
 
No risks are associated with urine sampling, or saliva sampling that will be collected via an 
unstimulated passive dribble method. 
 
We will require ~10mins of your time every evening to conduct an interview of the days dietary 
activities and recovery. We have a very sympathetic and qualified team, which will make the 
interview a pleasant experience.  
 
What will happen to your data? 
Confidentially will be maintained throughout data collection. All data is annonymised as soon as it is 
collected and will be stored electronically using participant codes so that individuals cannot be 
identified. Any data from your participation in the study will be used by the research team. It may also 
be disseminated externally, however your name or identity will remain anonymous. 
 
I confirm that I have read the participant information. The nature, demands and risks of the project 
have been explained to me. Any additional enquiries about the project have been answered 
satisfactorily by the researchers.  
 
I knowingly assume the risks involved and understand that I may withdraw my consent and 
discontinue participation at any time without penalty and without having to give any reason. 
 
I hereby give my consent to participate in this research project.  
 
Participant’s signature: _________________________________Date _____________ 
 
Participant’s email: _____________________________________________________ 
 
Researcher’s signature: ________________________________Date _____________ 
 
 
For any further questions or specific research information please feel free to contact 
any of the research team. 
 
Samantha Gill:gills19@coventry.ac.uk Dr Ricardo Costa:ricardo.costa@coventry.ac.uk  
 
Illness reported four weeks prior to participation:  Yes  No 
 













Appendix B: Participant Information and Informed Consent Form  
 
 
Coventry University: Sports & Exercise Science Applied Research Group 
 
Oral-Respiratory Mucosal Immune, Circulatory Endotoxin and Cytokine Responses, 
Assessment of Nutrition & Hydration Status, Energy Expenditure, and Illness & 
Infection Rates During a 24 hour Ultra-Endurance Running Competition Conducted in 
the Scottish Highlands 
 
2011 & 2012 Glenmore 24h 
 
Participant Information & Informed Consent Form 
  
Thank you for agreeing to take part in this research study. This form explains what you will 
be asked to do. If you have any questions about this research please ask one of the researcher 
team. 
 
Research Investigators: Samantha Gill, Dr. Ricardo Costa, Dr. Andrew Murray & Mike 
Adams 
 
The aims of the research are: 
5. Determine oral-respiratory mucosal immune responses during a 24 hour ultra-endurance 
running competition. 
6. Determine circulatory endotoxin concentrations and pro and anti-inflammatory cytokine 
responses during a 24 hour ultra-endurance running competition. 
7. Assess the rates and severity of upper respiratory and gastrointestinal symptoms during and 
the month following a 24 hour ultra-endurance running competition. 
8. Assess nutrition and hydration status of ultra-endurance runners during a 24 hour ultra-
endurance running competition. 




What will I have to do? 
You are only required to follow YOUR NORMAL COMPETITION STRATEGIES. In 
addition: 
 Have your body mass taken before and after the 24 hour race. 
 Provide one urine, saliva and blood sample before and after the 24 hour race. 
 Wear an armband during the 24 hour race, which will measure your energy expenditure. 
 Let the research team conduct a ~10 minute interview after the 24 hour race. 
 
 
What will I get from this? 
4. You will gain an insight into the scientific aspects of the study and you may find it interesting 
to know what we are trying to achieve or how various measurements are recorded.  
 
5. You will gain an insight into how your immune system responses to an ultra-endurance 
competition. From this information the research team and provide some advice on strategies 






6. After the 24 hour race, you will be provided with individual feedback on the measurements 
made during the research. Advice will be given to help you improve your dietary habits for 
subsequent ultra-endurance performance. 
 
By signing this form you agree to take part in the study. However, please note that you 
are free to stop taking part at any time. 
 
Foreseeable risks or discomforts? 
Blood sampling: Only qualified phlebotomy trained researchers with experience at performing this 
procedure will collect blood samples. To ensure you are completely comfortable with giving blood 
samples, we will familiarise you with the blood sample collection procedure. The amount of blood 
collected during each blood sampling will be (6 ml), which will not impact upon your normal physical 
functioning during strenuous exercise.  
 
No risks are associated with urine sampling, or saliva sampling that will be collected via an 
unstimulated passive dribble method. 
 
We will require ~10 minutes of your time at the end of the 24 hour races to collect the armband and 
conduct an interview of the 24 hour’s dietary activities and symptoms experienced. We have a very 
sympathetic and qualified team, which will make the interview a pleasant experience.  
 
What will happen to your data? 
Confidentially will be maintained throughout data collection. All data is annonymised as soon as it is 
collected and will be stored electronically using participant codes so that individuals cannot be 
identified. Any data from your participation in the study will be used by the research team. It may also 
be disseminated externally, however your name or identity will remain anonymous. 
 
I confirm that I have read the participant information. The nature, demands and risks of the project 
have been explained to me. Any additional enquiries about the project have been answered 
satisfactorily by the researchers.  
 
I knowingly assume the risks involved and understand that I may withdraw my consent and 
discontinue participation at any time without penalty and without having to give any reason. 
 
I hereby give my consent to participate in this research project.  
 
Participant’s signature: _________________________________Date _____________ 
 
Participant’s email: _____________________________________________________ 
 
Researcher’s signature: ________________________________Date _____________ 
 
 
For any further questions or specific research information please feel free to contact 
any of the research team. 
 
Samantha Gill:gills19@coventry.ac.uk Dr Ricardo Costa:ricardo.costa@coventry.ac.uk  
 
Illness reported four weeks prior to participation:  Yes  No 
 






Appendix B: Participant Information and Informed Consent Form 
 
 
Coventry University: Sports & Exercise Science Applied Research Group 
 
Oral-respiratory mucosal immune responses, and circulatory endotoxin concentration 
and cytokine responses to exercise-heat stress: Does probiotic supplementation play a 
role in mucosal health during exercise-heat stress. 
 
Participant Information & Informed Consent Form 
 
Thank you for agreeing to take part in this research study. This form explains what you will 
be asked to do. If you have any questions about this research please ask one of the researcher 
team. 
 
Research Title: Oral-respiratory mucosal immune responses, and circulatory endotoxin 
concentration and cytokine responses to exercise-heat stress: Does probiotic supplementation 
play a role in mucosal health during exercise-heat stress. 
 
Research Investigators: Samantha Gill; gills19@coventry.ac.uk 
     Dr. Ricardo Costa; ricardo.costa@coventry.ac.uk 
 
Invitation to take part 
You have been invited to take part in a research investigation. Before you do so, it is 
important for you to understand why the research is being conducted and what you will be 
required to do once you agree to be involved. Please read the following information carefully. 
You should ask us if there is anything that is not clear or if you would like more information. 
 
Do I have to take part? 
This is entirely your decision. If you decide to take part you will be given an information 
sheet to keep and be asked to sign a consent form. If you decide to take part you are still 
free to withdraw at any time, without giving a reason. If you decide not to participate or 
withdraw during the study, your decision will not affect your relationship with the Health and 
Life Sciences faculty, or any of the investigators involved in the study. 
 
Background 
Current research suggests that prolonged, strenuous exercise in the heat is associated with 
disturbances to mucosal immunity, potentially increasing the risk of illness and infection. The 
general consensus is that probiotics are safe in healthy population groups and side effects (if 
any) tend to be mild with high doses failing to exhibit any toxicity. To date, only a handful of 
studies have investigated probiotic supplementation specifically in athletes with results 
demonstrating some immune modulating effects. However, there is insufficient evidence to 
set recommendations for the athletic population and limitations apply to a number of studies. 
Currently, the use and effectiveness of probiotic supplementation in athletes to reduce 
immune disturbances and prevent exercise-heat stress occurrence and severity is currently 
unknown and warrants further investigation. In summary, the aims of this study are to 
examine the effects of probiotic supplementation on oral-respiratory mucosal immune status 







The aims of the research are: 
10. Determine oral-respiratory mucosal immune and stress responses during a 120 minute 
exercise bout in two treatment groups in a hot environment. 
11. Determine circulatory endotoxin concentrations and cytokine profile during a 120 
minute exercise bout in two treatment groups in a hot environment. 
12. Assess the rates and severity of upper respiratory symptoms and gastrointestinal 
symptoms during each treatment group. 
13. Assess nutritional status during the weeks of supplementation. 
 
What will I have to do?  
Prior to completing a trial you will be expected to: 
 Complete an initial assessment through performance of a maximal aerobic test (10-15 
minutes) on an electric treadmill. This test will be used to measure your aerobic 
fitness (maximal oxygen uptake). Briefly, the treadmill speed and gradient will be 
increased every 3 minutes until you reach volitional exhaustion. This test will require 
you to run at your maximal aerobic capacity for approximately 1 minute. We will 
require you to wear a face mask during this fitness test so that we can make 
measurements on your expired air; the facemask is not uncomfortable and will not 
impede your breathing.  
 
Completing a trial 
1. 120 minute exercise bout, 60% VO2max in a hot environment (30-35ºC) with placebo. 
2. 120 minute exercise bout, 60% VO2max in a hot environment (30-35ºC) with probiotic 
supplementation. 
 
Whilst completing the experimental trials you will be expected to: 
 On 2 separate occasions perform a 2h run at 60% of your maximal exercise capacity 
on an electric treadmill. 
 To have blood samples taken from the antecubital vein by a trained researcher. These 
will occur one week prior to the exercise trial, immediately before the exercise trial, 
immediately after the exercise trial and 1h, 2h, 4h and 24h after the exercise trial. This 
totals 14 blood samples for the course of the study (7 blood samples per exercise 
trial). To provide 126ml blood for each exercise trial. 
 To provide a 4 minute timed saliva sample one week prior to the exercise trial, 
immediately before the exercise trial, immediately after the exercise trial and 1h, 2h, 
4h and 24h after the exercise trial via a dribble method that will be explained to you. 
This will total 14 saliva samples for the course of the study (7 saliva samples per 
exercise trial). 
 To provide one urine sample one week prior to the exercise trial, immediately before 
the exercise trial, immediately after the exercise trial and 1h, 2h, 4h and 24h after the 
exercise trial. This will total 14 urine samples for the course of the study (7 urine 
samples per exercise trial). 
 Consume 1000ml yoghurt drink per day (AM and PM) during the study (a total of 7 
days for each exercise trial). On two of the treatment groups, the yogurt drink will 
contain probiotics. On the other two treatment groups, the yogurt drink will contain 
no probiotics. However, you will be unaware which one you are consuming 
throughout the study. 
 Wear a rectal probe during exercise. The rectal probe is a thin flexible cable that you 






 Wear a heart rate monitor during exercise. 
 Complete a food and fluid diary & training log during the weeks of supplementation. 
 Complete an illness log assessing upper respiratory and gastrointestinal symptoms 
during the weeks of supplementation. 
 Complete a compliance log for the yogurt drink consumed during the weeks of 
supplementation. 
 
If you decide to take part in this study, there will be a number of constraints placed 
upon your normal everyday life and activities. 
 You will be asked to refrain from consuming any other types of probiotics (i.e. 
drinking yogurts, capsules, tablet forms). 
 You will be asked to refrain from consuming any dietary supplements one month 
prior to and during the study. 
 
Advantages of taking part 
By taking part in this study you will contribute to our knowledge about the influence of 
probiotics on immune function. Currently, there are insufficient therapeutic treatment options 
to enhance defence mechanisms, particularly in an athletic population group. Indeed, immune 
function appears to be lowered after heavy exercise, possibly accounting for the increased 
illness and infection incidence at this time; as such, any information about how to improve 
host defence after exercise would be most welcome. This information will be useful to sports 
scientists and research outcomes will have considerable relevance, not only catering for 
recreational and elite endurance athletes routinely performing strenuous exercise for extended 
durations in the heat, but additionally, can be largely applied across a wide range of other 
sports (teams, international competition) and professional activities (military personnel, 
expedition crews (medical, health or media), and/or park rangers) regularly exposed to hot 
environmental conditions. 
 
You will gain an insight into the scientific aspects of the study and you may find it interesting 
to know what we are trying to achieve or how various measurements are recorded.  
 
You will gain an insight into how your immune system responds to a strenuous bout of 
exercise in a hot and thermo-neutral environment and the influence of probiotic 
supplementation on immune responses and symptoms. From this information, the research 
team can provide some advice on strategies to avoid unwanted immune profiles associated 
with strenuous exercise in the heat. 
 
You will receive comprehensive feedback on the results and measurements made during the 
research, with full explanations; for your fitness level, immune system status and advice on 
strategies to avoid unwanted immune profiles associated with strenuous exercise in the heat. 
 
Disadvantages of taking part 
The disadvantages of taking part in this study, which you will probably be most concerned 
about are: blood sampling, physical exertion, and time commitment.  
 
1.Blood sampling 
Only qualified phlebotomy trained researchers with experience at performing this procedure 
will collect blood samples. To ensure you are completely comfortable with giving blood 
samples, we will familiarise you with the blood sample collection procedure during the initial 





multiple blood collections before and during the recovery period. The amount of blood 




The physical components of this study include; the incremental aerobic fitness test, and 2 2h 
exercise bouts at 60% of maximal effort. The incremental aerobic fitness test will only 
require you to run at your maximal capacity for approximately 1 minute. You most probably 
feel that the same type of exhaustion and fatigue for longer periods during your normal 
training and competition habits. The 2 2h exercise bouts at 60% of maximal effort may 
promote post-exercise fatigue. However, they are of a similar volume and intensity of effort 
to that experienced during your training and competitions. As such, the 2h runs can also be 
seen as useful intensive and prolonged training sessions. You will be closely supervised 
during the exercise trials and by monitoring your body temperature; we will stop the trial 
should your body temperature rise too quickly.  
 
3.Time commitment 
To complete all aspects of the study we will require you to visit the laboratory on 7 occasions 
for a total of approximately 10 hours.  
 
As the study involves prolonged, strenuous exercise in extreme conditions, all safety 
measures will be discussed with you prior to any testing. You will also be asked to complete 
a heath/medical history questionnaire prior to any testing. It is important that we closely 
monitor your body temperature during exercise to ensure you do not get too hot; we will 
withdraw you from the exercise trial if this happens. 
 
What will happen to your data? 
Confidentially will be maintained throughout data collection. All information collected 
during the study will be coded and treated confidentially. All data is annonymised as soon as 
it is collected and will be stored electronically using participant codes so that individuals 
cannot be identified. Any data from your participation in the study will be used by the 
research team. It may also be disseminated externally, however your name or identity will 
remain anonymous. 
 
I confirm that I have read the participant information. The nature, demands and risks of the 
project have been explained to me. Any additional enquiries about the project have been 
answered satisfactorily by the researchers.  
 
I knowingly assume the risks involved and understand that I may withdraw my consent and 
discontinue participation at any time without penalty and without having to give any reason. 
 
You will excluded if you are a smoker or if you are on specific types of medication, 
supplements or take probiotics on a regular basis. Asthmatics and Diabetes patients are 
also prohibited.  You should not take part if you have a medically diagnosed cardiac 
condition, are currently on any cardiac related medication (e.g. beta-blockers) or have a 
physical injury that may prevent you from completing the task.  
 
If you have or recently had (within one month) an infection, illness, injury, and/or 






If you experience any illness/infection during the course of the study, testing will be 
terminated. 
IN TOTAL, THE STUDY WILL REQUIRE YOU TO GIVE UP ~ 10 HOURS OF 
YOUR TIME. 
Please tick boxes 
1 I confirm that I have read and understand the Participant 
Information Sheet dated................. for the above study. I have 
had the opportunity to consider the information, ask questions 






2 I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving a reason, without 






3 I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving a reason. If I do 
decide to withdraw I understand that it will have no influence 
on the outcome of my period of study or members of staff 
within Health and Life Sciences. 
 
4 I understand that I may register any complaint  I might have 
about this experiment with the Head of Sport Science, and that I 
will be offered the opportunity of providing feedback on the 













Name of participant __________________________________________________________ 
 
Participant’s signature: _________________________________Date __________________ 
 
Participant’s email: __________________________________________________________ 
 
Name of Researcher _________________________________________________________ 
 
Researcher’s signature: ________________________________Date __________________ 
 
 
For any further questions or specific research information please feel free to contact 
any of the research team. 
 







WHEN COMPLETED: ONE COPY TO PARTICIPANT, ONE COPY TO 
RESEARCHER FILE 
 
Appendix C: Health Screen Questionnaire  
 
 
Name of Participant __________________________________________________________ 
 
Date of Birth _____________________________ 
 
 
General Physical Fitness 
 
How often do you take regular physical exercise? 
 Less than once a week 
 Once a week 
 Two to three times a week 
 
How long have you been exercising at this frequency? 
 Less than 1 month 
 1-6 months 
 More than 6 months 
 
Is your current body weight: 
 Normal range 
 Overweight 
 Underweight  
 
Smoking habits (circle all that apply) 
 Never smoked 
 Gave up more than 1 month ago 
 Total years smoked for ………… 
 Smoke/used to smoke less than 20 cigarettes per day 




Do you suffer or have you ever suffered from the conditions below? (give details if yes) 
 Heart disease and/or circulatory problems 
 Diabetes 
 High blood pressure 
 High cholesterol 
 Asthma or any other type of lung disease 
 Kidney disease 
 Clotting disorders 
 Anaemia or other blood disorders 











Do you regularly take: 
 Any prescribed medicines 
 Any over the counter medicines 
 Any other drugs 





















Your Health Today 
 
Have you had any of the following health problems in the last few days: 
 Coughs/colds 
 Headaches 
 Shortness of breath 
 Muscle/joint pain 







Do you currently have any of the following symptoms: 
 Sore throat or blocked nose 
 Shortness of breath 
 Headache and/or dizziness 
 Nausea 

























I confirm that I have given details of any information that may affect my suitability to 
participate as a subject today.  
 
I have also completed a consent form for this experiment which stated the tests to be 
carried out and any adverse effects. 
 
 




Signature _________________________ Date _________________________ 
Experimenter 
 
 
 
 
 
 
 
 
